Toll-ähnliche Rezeptoren - Mittler zwischen angeborener und erworbener Immunität by Braedel-Ruoff, Sibylla
  
Toll-like Receptors – 
Link between Innate and Adaptive Immunity 
 
Toll-ähnliche Rezeptoren - 
Mittler zwischen angeborener und erworbener Immunität 
 
 
 
D I S S E R T A T I O N 
 
der Fakultät für Chemie und Pharmazie 
der Eberhard-Karls-Universität Tübingen 
 
zur Erlangung des Grades eines Doktors 
der Naturwissenschaften 
 
2007 
 
vorgelegt von 
Sibylla Braedel-Ruoff 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tag der mündlichen Prüfung: 18. Januar 2007  
 
Dekan:    Prof. Dr. L Wesemann    
1. Berichterstatter:   Prof. Dr. H.-G. Rammensee 
2. Berichterstatter:   Prof. Dr. H. Schild 
 
 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
4 
 
 
  TABLE OF CONTENTS 
  5 
Table of Contents 
Abbreviations .......................................................................................................................6 
Summary ..............................................................................................................................9 
Zusammenfassung..............................................................................................................10 
 
Chapter 1 General Introduction ....................................................................................11 
 
Outline of this Thesis .........................................................................................................65 
 
Chapter 2 Legionella pneumophila Mediated Activation of Dendritic 
Cells Involves CD14 and TLR2   
Journal of Endotoxin Research 11 [2], 89-96(8) (2005) .............................67 
 
Chapter 3 Aspergillus fumigatus Antigens Activate Innate Immune Cells 
via Toll-like Receptors 2 and 4   
British Journal of Haematology 125 [3], 392-399 (2004) ..........................81 
 
Chapter 4 The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 
Activates Dendritic Cells via the Toll-like Receptor 2/4 Pathway   
Journal of Biological Chemistry 277 [23], 20847-20853 (2002) ...............97 
 
Chapter 5 Glycoprotein 96-activated Dendritic Cells Induce a CD8-
biased T-Cell Response   
Cell Stress Chaperones 10 [3], 221-229 (2005) ........................................115 
 
Chapter 6 Impacts of Toll-like Receptor Signaling on Priming of 
Cytotoxic T-Lymphocytes in vivo   
(submitted) .................................................................................................131 
 
Chapter 7 Résumé.......................................................................................................149 
 
References........................................................................................................................157 
List of publications ..........................................................................................................196 
Danksagung......................................................................................................................198 
Curriculum vitae ..............................................................................................................200 
Akademische Lehrer ........................................................................................................203 
Lebenslauf........................................................................................................................204 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
6 
Abbreviations 
For peptide sequences the one- or three-letter amino acid code was used. SI units and 
standard abbrevations are not explained in the table. 
 
ABTS 2,2’-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) 
AIRE Autoimmune regulator  
AP-1 Activator protein 1 
APC Antigen presenting cell 
BCR B cell receptor 
BMDC Bone marrow-derived dendritic cells 
BSA Bovine serum albumin 
CD Cluster of differentiation 
CD154 Also called CD40 ligand 
CD80 Also called B7.1 
CD86 Also called B7.2 
CFSE Carboxyfluorescein diacetate succinimide ester 
CLIP Class II-associated invariant chain peptide 
CMV Cytomegalovirus 
CpG DNA motif Cytosine-phosphate-guanine DNA motif 
CRP C-reactive protein 
CTL Cytotoxic T lymphocyte 
CTLA-4 Also called CD152 
DC Dendritic cell 
DD Death domain 
DNA Deoxyribonucleic acid 
DNA-PK DNA-dependent protein kinase 
DRiPs Defective ribosomal products 
dsRNA Double-stranded RNA 
ECSIT Evolutionarily conserved signalling intermediate in Toll pathways 
ER Endoplasmic reticulum 
ERAAP Endoplasmic reticulum aminopeptidase associated with antigen processing 
ERK Extracellular-regulated kinase 
FCS Fetal calf serum 
FITC Fluorescein isothiocyanate 
GM-CSF Granulocyte-macrophage colony-stimulating facto 
Gp96 96-kDa glycose-regulated protein 
HAU Haemagglutinating units 
HCV Hepatitis C virus 
Hib Haemophilus influenzae type b 
HIV Human immunodeficiency virus  
HLA Human leukocyte antigen 
Hsp Heat-shock protein 
HSV-1 Herpes simplex virus 1 
Ig Immunoglobulins 
Ii protein Invariant chain protein 
IKKs IκB kinases 
IL Interleucin 
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INF Interferon 
IRAK4, IRAK1 IL-1R-associated kinase 4, IL-1R-associated kinase 1 
 ISRE Interferon-stimulated response elements 
ITAM Immunoreceptor tyrosine-based activation motif  
IB Inhibitor of NF-B 
JNK JUN N-terminal kinase 
kDa Kilo Dalton 
LBP Lipopolysaccharide binding protein 
LCMV Lymphocytic choriomeningitis virus 
LDL Low density lipoprotein 
LPS Lipopolysaccharide, also called endotoxin 
 LRR motif Leucin-rich repeat motif 
LTA Lipoteichonic acid 
MAL MyD88-adaptor-like protein 
MALP-2 Macrophage-activating lipopeptide-2 kDa 
MALT Mucosa-associated lymphoid type 
MAP Mitogen-associated protein 
MARCO  Macrophage receptor with collagenous structure 
MBL Mannan-binding lectin 
MCMV Murine cytomegalovirus 
MHC Major histocompatibility complex 
MIIC MHC class II compartments 
MLA Monophosphoryl lipid A 
MM-LDL Minimally modified-LDL 
MSR Macrophage scavenger receptors  
MTB Mycobacterium tuberculosis 
MyD88 myeloid differentiation factor 88, myeloid differentiation primary-response protein 88 
NF- κB Nuclear factor-κB  
NOD Nucleotide-binding oligomerization domain 
ODN Oligodeoxynucleotide 
PA28 Proteasome-activator 
 Pam3Cys (S)-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-N-palmitoyl-(R)-cysteine 
PAMP Pathogen associated molecular pattern 
PE Phycoerythrin 
pH Potentia Hydrogenii 
PI3K Phosphatidylinositol 3-kinase 
PKR IFN-inducible dsRNA-dependent protein kinase 
Poly(I:C) Polyinosine-polycytidylic acid (dsRNA analogue) 
PPR Pattern recognition receptor 
 RNA Ribonucleic acid 
RP105 CD180, radioprotecitve 105 
RSV Respiratory syncytial virus 
SAP Serum amyloid protein 
SAPK Stress-activated protein kinases 
SAP-kinase Stress-associated protein kinase  
SIGIRR Single immunoglobulin IL-1R-related molecule 
SLE Systemic lupus erythematosus 
SOCS  Suppressor of cytokine signalling 
ssRNA Single-stranded RNA 
TAB1/TAB2/TAB3 TAK1-binding proteins 
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TAK1 Transforming growth factor-β(TGF-β)-activated kinase 
TAP Transporter associated with antigen processing 
TAPA-1 Also called CD81 
TCR T cell receptor 
TH T helper cell 
TICAM1 TIR-domain-containing molecule 1, also known as TRIF 
TICAM2 TIR-domain-containing molecule 2, also known as TRAM 
TIR domain Toll/IL-1 receptor domain 
TIRAP TIR domain containing adaptor protein, also known as MAL 
TLR Toll-like receptor 
TNF Tumor necrosis factor 
TOLLIP Toll-interacting protein 
TRAF Tumor-necrosis factor (TNF)-receptor-associated factor 
TRAM TRIF-related adaptor molecule, also known as TICAM2 
TRIF TIR domain-containing adapter inducing IFN-β, also known as TICAM1 
VV Vaccinia virus 
 
Figures are numbered for each chapter separately. If not otherwise stated, the 
mentioned figure numbers refer to the figures in the same chapter. 
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Summary 
Toll-like receptors (TLR) function as pattern recognition receptors (PRR) and 
recognize highly conserved pathogen-associated molecular patterns. They not only 
activate an immediate innate immune defense but are additionally able to induce an 
adaptive immune response. The questions, which substances are recognized via TLRs, 
which specific TLRs are involved by a given danger signal and which mechanisms 
finally lead to the activation of the adaptive immune system, were the focus of this 
thesis.  
Investigation of the bacteria Legionella pneumophila, the causative agent of 
Legionnaires’ disease, revealed that lipopolysaccharide (LPS) purified from the cell 
wall as well as the whole bacteria activate antigen-presenting cells (APC) via TLR2-
dependent signal transduction. Thus, LPS was identified as the main structure for the 
recognition of L. pneumophila by the innate immune system (Chapter 2).  
Furthermore, TLRs play a central role in the activation of the innate immune system 
by antigens of the fungus A. fumigatus, which causes invasive aspergillosis. Thereby, 
the involvement of TLR2 and TLR4 results in the release of different pro-
inflammatory cytokines by APCs (Chapter 3). TLRs, however, do not only recognize 
exogenous pathogen-derived molecules, but also endogenous alarm structures. This 
could be demonstrated for the ER-resident heat shock protein Gp96, which, as carrier 
of tumor-specific peptides, is able to elicit protective immunity against tumors. The 
Gp96-induced activation of dendritic cells via TLR4 and TLR2 (Chapter 4) finally 
leads to the expansion of antigen-specific CD8-positive T cells in vivo and in vitro 
(Chapter 5). The relevance of TLR-mediated activation of the immune system for the 
induction of adaptive immune responses could also be demonstrated in a more general 
system: “priming” of cytotoxic T cells (CLTs) during a virus infection requires either 
CD4+ T helper cells or TLR-mediated signals. In the absence of both, CTL priming is 
impaired. In a system of weaker immunogenic antigens, TLR signals are even strictly 
required (Chapter 6).  
Toll-like receptors are more than recognition receptors of the innate immune system – 
they link innate and adaptive immunity. 
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Zusammenfassung 
Toll-ähnliche Rezeptoren (TLR) erkennen als Pattern-Recognition- Rezeptoren (PRR) 
stark konservierte Pathogen-assoziierte molekulare Strukturen. Sie aktivieren nicht nur 
eine sofort einsetzende angeborene Immunabwehr, sondern sind zudem in der Lage, 
eine adaptive Immunantwort auszulösen. Die Fragen, welche Substanzen als 
Gefahrensignale über TLRs erkannt werden, welche speziellen TLRs diese Aufgabe 
für individuelle Gefahrenmoleküle übernehmen und welche Mechanismen schließlich 
zur Aktivierung des erworbenen Immunsystems führen, standen im Mittelpunkt dieser 
Arbeit. 
Untersuchungen des Bakteriums Legionella pneumophila, des Erregers der 
Legionärskrankheit, zeigten, dass sowohl das Bakterium als Ganzes als auch aus der 
Zellwand isoliertes Lipopolysaccharid (LPS) Antigen-präsentierende Zellen (APC) 
über TLR2 aktivieren. LPS wurde somit als Hauptstruktur zur Erkennung von L. 
pneumophila durch das angeborene Immunsystem identifiziert. (Kapitel 2). Auch 
Antigene des Pilzes Aspergillus fumigatus, der die invasive Aspergillose hervorruft, 
wurden als TLR-vermittelte Gefahrensignale identifiziert. Dabei führt die Involvierung 
von TLR2 und TLR4 zur Freisetzung unterschiedlicher pro-inflammatorischer 
Zytokine durch APCs (Kapitel 3). TLRs erkennen aber auch endogene 
Gefahrenstrukturen. Dies konnte für das ER-ständige Hitzeschockprotein Gp96, das 
als Trägermolekül von tumorspezifischen Peptiden eine protektive Immunität gegen 
Tumoren hervorruft, gezeigt werden. Die Gp96-induzierte Aktivierung dendritischer 
Zellen über TLR4 und TLR2 (Kapitel 4) mündet schließlich in eine Expansion von 
antigen-spezifischen CD8+ T Zellen (Kapitel 5). Die Bedeutung der TLR-vermittelten 
Aktivierung des Immunsystems für die Entwicklung einer adaptive Immunantwort 
konnte auch in einem verallgemeinerten Modell verdeutlicht werden: Für das 
„Priming“ cytotoxischer T-Zellen während einer Virusinfektion sind entweder CD4+ 
T-Helferzellen oder aber TLR-vermittelte Signalwege nötig. Sind beide Signalwege 
blockiert, findet kein Priming statt. In einem System mit schwächer immunogenen 
Antigenen sind TLR-Signale sogar absolut notwendig (Kapitel 6). 
TLRs sind mehr als nur Erkennungsrezeptoren des angeborenen Immunsystems – sie 
verknüpfen angeborene und erworbene Immunität.  
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No living being can exist on its own. During its life, it never ceases to interact with 
other life forms. These interactions can be of mutual avail, as is the case for symbiotic 
relationships. In most cases, however, such interactions are harmful or even lethal for 
at least one of the protagonists. To protect themselves against affection by parasitizing 
or even live-threatening microorganisms, multicellular organisms have developed a 
whole plethora of defense strategies, which are subsumed under the term immune 
system. In vertebrates, its present form consists of two pillars: the innate and adaptive 
immunity. 
The evolutionarily ancient innate immune system is specific for pathogenic nonself 
and senses infections through a limited number of germ line encoded receptors that 
recognize conserved pathogen-associated key molecules. The adaptive immune system 
is specific for virtually all nonself antigens and gains this ability via a random and 
highly diverse receptor repertoire. This is not germ line encoded but is generated out 
of a set of inherited gene segments through somatic recombination and other intricate 
mechanisms. The price to be paid for this high specificity is a delayed adaptive 
immune response. This gap is bridged by the innate immune system, which, upon 
recognition of an infectious agent, reacts immediately in order to keep the pathogen in 
check until the more sophisticated and versatile adaptive immune system is ready for 
battle. But the innate immunity is not just the advance guard, on the contrary, the 
innate effector mechanisms induce and instruct the development of adaptive immune 
responses. Thus, the adaptive immunity is to a certain extent under the control of the 
innate immunity. 
 
Adaptive immunity 
Specificity and memory are the hallmarks of adaptive immunity: these unique features 
enable the adaptive immune system to recognize virtually every potential antigen 
specifically and to retain this ability throughout the lifetime. This memory provides 
enhanced protection against re-infection and is the basic principle of active 
immunization.  
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The nearly unlimited possible antigenic structures are recognized by distinct antigen 
receptors unique to every single B and T lymphocyte. This vast receptor diversity is 
not germline encoded per se but is generated by random rearrangement of a limited 
group of inherited receptor gene subunits during lymphocyte development (Tonegawa, 
1983; Tonegawa, 1993). However, this randomized process bears the risk of 
generating antigen receptors that are specific for self antigens. Normally, these self-
reactive lymphocytes are eliminated early in cell development in order to prevent 
autoimmunity.  
 
Prior to infection, the number of lymphocytes specific for any given antigen is 
relatively small. But upon recognition of their specific antigen, B and T lymphocytes 
rapidly divide in a process called clonal expansion and differentiate into effector cells 
able to fight against the infectious agent. This is why adaptive immune responses 
occur only after a delay of several days. The thus generated effector cells have only a 
limited life-span but a subset of the clonally expanded cells, which have proven to be 
useful during the first infection, differentiates into memory cells. These in turn can 
rapidly be reactivated upon subsequent encounter with the same pathogen thereby 
providing lasting protective immunity (Immunobiology, Janeway, 6th edition). 
 
Lymphocyte antigen recognition receptors 
B cell receptor (BCR) 
Immunoglobulins (Ig) are the antigen-recognition molecules of B lymphocytes and 
exist in two forms: the membrane bound form functions as antigen receptor and is 
known as B-cell receptor (BCR). Upon antigen recognition by virtue of their 
membrane-bound Ig, naïve B cells differentiate into plasma cells, which are able to 
secrete Ig of the same antigen specificity as soluble antibody. Both Ig forms, the BCR 
and the antibody, differ only in a small C-terminal region which contains a 
hydrophobic sequence for anchoring the BCR in the membrane or a hydrophilic 
sequence allowing the secretion of the antibody. 
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The large Ig molecules (150 kDa) are composed of two types of protein chains (Figure 
1), heavy chains (50 kDa) and light chains (25 kDa). Two identical heavy (H) chains 
and two identical light (L) chains (either lambda or kappa) are joined by disulfide 
bonds in such a way that each  H chain is linked to a L chain and the two H chains are 
linked together forming a Y-shaped structure with three equal-sized portions. The two 
identical antigen-binding sites are at the tips of the arms, which are tethered to the 
trunk of the Y by a flexible hinge region allowing simultaneous binding of two 
identical antigenic structures by both arms of the antibody. 
 
Decisive for the three dimensional structure of the Ig molecule are the so-called Ig 
domains that comprise about 110 amino acids. In this distinctive immunogloblulin 
fold, strands of polypeptides chains are linked together by a disulfide bridge to form a 
roughly barrel-shaped structure. The H chain contains four of these Ig domains, the L 
chain two.  
 
Only the first amino-terminal Ig domain of the H and L chains are variable in their 
sequence and are therefore called variable (V) domains. The V domains of one heavy 
and one light chain together make up the variable antigen binding site. The remaining 
domains are constant (C) domains and build up the C region. Several different genes 
encode for the C domains of the heavy chain and can be linked sequentially with the 
same variable region by DNA recombination, a process known as isotype switching. 
The resulting five major classes or isotypes of immunoglobulin, namely IgM, IgD, 
IgG, IgA and IgE, differ in structure, effector function, localization and serum 
concentration. As mentioned, IgM is the first Ig to appear on the B cell surfaces and 
the first to be secreted, whereas IgG is the most abundant class of immunoglobulins 
found in the plasma. IgD is expressed as surface immunoglobulin on mature naïve B 
cells but its function is more or less unknown. IgA isotype is secreted mainly by 
mucosal lymphoid tissues. IgE is involved in allergic reactions. Again, Igs of all 
isotypes can be produced either as a membrane-bound B-cell receptor or as a secreted 
antibody by alternative RNA splicing. 
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T cell receptor (TCR) 
The heterodimeric T cell receptor (TCR) is composed of two glycosylated polypeptide 
chains (Figure 1), TCRα and TCRβ, and structurally and functionally resembles the 
N-terminal part of an immunoglobulin molecule: each TCR chain consists of an 
aminoterminal variable region and an adjacent constant region, and again, two Ig 
domains form these characteristic structures. TCRα and TCRβ are connected to each 
other by a disulfide bond within a short hinge region. Both subunits are membrane-
anchored by an unusual positively charged transmembrane segment, which is followed 
by a short cytoplasmic tail. A minor subset of T cells bears an alternative, but 
structurally similar γδ TCR. 
In contrast to the B cell immunoglobulin, the TCR bears only one antigen-binding site 
and exists only in the membrane-bound but not in the secreted form. 
 
Figure 1. Schematic representation of antibody and T cell receptor. Description in main 
text. 
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Generation of B and T cell receptor diversity 
Nature has evolved an elegant mechanism to create a tremendous repertoire of diverse 
lymphocyte receptors out of a limited number of inherited genes. The variable antigen-
recognizing domains of the lymphocyte receptors are not encoded by just one single 
gene. Instead, separate shorter gene segments - with each segment present in multiple 
copies in the germline genome - are combined in a process of gene rearrangement 
called somatic recombination to yield a variable-region gene. This occurs in distinct 
stages during lymphocyte development. The light chain of the immunoglobulin 
molecule and the α chain of the TCR are made up of two different types of gene 
segments , V (variable) and J (joining), whereas the diversity of the heavy chain of the 
immunoglobulin and the β chain of the TCR is further augmented by a third gene 
segment type, D (diversity). The number of multiple copies of each gene segment type 
in the human genome ranges from 2 up to about 80. Additionally, the immunoglobulin 
light chain is encoded in two loci (κ and λ). Since the selection of gene segments 
occurs at random and since heavy- and light chain and α- and β chain, respectively, 
pair to form together the antigen-binding site, these two sources of combinatorial 
diversity give theoretically rise to approximately 1.9 x 106 different immunoglobulins 
and 5.8 x 106 different TCRs. Furthermore, the joining of the gene segments is 
imprecise and thus, junctional diversity further increases the repertoire of possible 
different immunoglobulins and TCRs to approximately 5 x 1013 and 1 x 1018, 
respectively. An additional source of diversification in case of B cells takes place, 
once a naïve B cell is activated by its specific antigen in the periphery along with 
signals from activated T cells: in activated B cells, point mutations are introduced at a 
very high rate in the V regions of rearranged heavy- and light chains. If by chance, 
such a somatic hypermutation confers improved antigen affinity on a particular clone 
(a process called affinity maturation), it is subsequently selected for proliferation and 
differentiation into plasma cells. It is this ingenious interplay of several strategies 
which creates that enormous diversity of lymphocyte antigen receptors, which 
theoretically allows the immune system to recognize nearly all possible antigenic 
structures. 
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Establishment of primary lymphocyte pools: positive and negative selection  
However, these sophisticated mechanisms bear their own risks: the creation of antigen 
receptors that are directed against self-components. To solve this problem, clonal 
selection of lymphocytes has to select potentially foreign-reactive lymphocytes while 
autoreactive lymphocytes have to be deleted or inactivated in order to prevent 
autoimmunity (Burnet, 1957; Klinman, 1996; Rajewsky, 1996). In order to ensure self-
tolerance of the antigen receptor repertoire, the developing lymphocytes must undergo 
major control steps, called positive and negative selection. As soon as a developing 
lymphocyte expresses an antigen receptor on the cell surface, the receptor is tested for 
its antigen-recognition properties, which comprises specificity and affinity. As test 
ligands serve molecules present in the immediate environment that is the bone marrow 
and fetal liver for B-cells and the thymus for T cells. In general, a developing 
lymphocyte whose receptor interacts weakly with self antigen is selected to survive 
(positive selection), whereas another whose receptor binds strongly to self antigen 
receives death signals and is removed from the repertoire (negative selection). For 
example, the adult mouse bone marrow produces about 15 million immature B cells 
per day, but only about 10% exit the marrow, and fewer than half of these new émigrés 
survive to join the mature peripheral B cell pool (Allman et al., 1993; Rolink et al., 
1998). 
 
The fate of an immature B cell that successfully rearranged its immunoglobulin genes 
to express IgM on the cell surface is guided by the signals it receives through its B cell 
receptor. Strong autoantigens that crosslink the IgM receptor lead to the elimination 
(negative selection) of theses autoreactive B cells mediated either through cell death 
(Nossal and Pike, 1975; Nemazee and Buerki, 1989) by apoptosis (Chen et al., 1995; 
Norvell et al., 1995) or through the replacement of the receptor by receptor editing. In 
the latter process, the B cell continues light chain gene rearrangement opening the 
possibility to be rescued by creating a self-tolerant receptor (Gay et al., 1993; Radic et 
al., 1993; Tiegs et al., 1993). Thus, receptor editing is an important salvage mechanism 
for immature B cells that failed positive selection (Diamant et al., 2005). If the 
developing B cell encounters an only weakly cross-linking autoantigen of low valence, 
such as a small soluble protein, it becomes permanently unresponsive. This so-called 
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anergy is accompanied by downregulation of surface IgM and defective signal 
transduction (Goodnow et al., 1988), and the anergic cell dies relatively quickly due to 
the failure of survival signals from T cells. Another potential fate of a self-reactive B 
cell is ignorance. The binding affinity to its autoantigen is so low that only little, if 
any, intracellular signals are generated. Last but not least, some autoreactive B cells 
may not encounter their antigen during development as it is not present in the 
compartments of lymphopoisis. Positive selection of B lymphocytes was 
controversially discussed in the past, but there is accumulating evidence that positive 
selection events play a quite important role in mediating differentiation, lineage 
commitment, and longevity of B cells (reviewed in Cancro and Kearney, 2004). Apart 
from BCR signal strength, both the ultimate positive and negative selective fate are 
further determined by the composite influence of clonotypic composition, the 
developing cohort, cellular microenvironment (Cyster et al., 1994; Cyster, 1997), and 
selecting ligands. Although self-epitopes serve as selecting ligands for the 
establishment of the primary B cell repertoire, they are rather useless to induce 
survival signals for memory B cells, since those have possibly lost their sufficient self-
affinity upon affinity maturation. Instead, it has been found that besides noncognate T 
cell help constitutive expression of Toll-like receptors (which are to be discussed later) 
can maintain B cell memory (Bernasconi et al., 2002).   
 
For T lymphocytes, the generation of the immature T cell pool is even more 
complicated, since T cells recognize antigen as peptides bound to self-MHC (major 
histocompatibility complex) molecules. That means that on the one hand, negative 
selection must prevent auto-reactivity, but on the other hand, positive selection must 
ensure that mature T cells are able to interact functionally with the self-structure of 
MHC molecules (Zinkernagel et al., 1978). T lymphocytes, whose TCRs bind strongly 
to ubiquitous self antigens presented by dendritic cells or macrophages, are eliminated 
in the thymus by apoptosis. Only T cells binding moderately to self-antigens on the 
thymic cortical epithelial cells are positively selected to survive. However, there are 
many tissue-specific self-antigens that would not be expected to be expressed in the 
thymus. Interestingly, some stromal cells present in the thymic medulla have been 
found to express such otherwise extrathymic proteins in a process controlled by a gene 
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called the autoimmune regulator (AIRE) (Anderson et al., 2002; Anderson et al., 
2005). Nevertheless, self-antigens restricted to the periphery are the main source of 
potential auto-reactivity for both, B and T lymphocytes. Therefore, the immune system 
has evolved a complex system of checks and balances. Without help from a T cell, a 
mature B cell recognizing a self-antigen in the periphery becomes anergic and dies. 
Without co-stimulatory signals provided by a professional antigen presenting cell, a 
mature T cells encountering autoantigen on peripheral tissues is rendered unfunctional.  
 
B cell effector function 
The effector function of B cells makes up the humoral immune response. It is 
mediated by antibodies secreted by plasma cells after they have encountered their 
specific antigen in extracellular spaces. These antibodies protect the host from 
infection by binding to structures on the surface of pathogens. Thus, neutralization by 
antibodies prevents attachment to and entrance of the invaders into the host cells but 
can also clear destructive agents such as bacterial toxins. A second antibody effect 
called opsonization is achieved by coating the pathogen with antibodies thereby 
promoting phagocytosis and subsequent elimination of the pathogen. As a third 
possibility, antibodies can mediate the activation of the complement system, which 
strongly enhances opsonization but can also directly kill certain bacterial cells by 
forming pores in their membranes. The type of effector mechanism engaged in a 
particular response depends in part on the isotype or on the class of antibodies 
produced by the effector B cell. 
 
In order to carry out its effector function, the B cell has to transmit the antigen 
recognition signal into the cells’ interior. The BCR itself is not able to generate this 
signal, but needs the help of an associated heterodimer composed of antigen-
nonspecific invariant signaling molecules: Ig and Ig. Each of them contains a 
conserved cytosolic amino acid sequence called immunoreceptor tyrosine-based 
activation motif (ITAM). Upon antigen binding, the tyrosine residues within these 
ITAMs become phosphorylated by receptor-associated Src-family tyrosine kinases. 
The ITAMs are then able to recruit a second family of protein tyrosine kinases, called 
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Syk, thus initiating further signaling pathways including the MAP kinases and NF-B 
pathways. BCR signaling is further enhanced up to 10,000-fold by aggregation with 
the so-called B-cell co-receptor complex, which is expressed on mature B cells and 
comprises the cell-surface molecules CD21, CD19 and CD81 (also called TAPA-1). 
Activation of CD21 by binding of the complement fragment C3dg promotes co-
ligation of the complex with the BCR. This induces phosphorylation of tyrosine 
residues in the cytoplasmic domain of CD19 by BCR-associated tyrosine kinases 
thereby recruiting Src-family kinases. CD19 signaling also plays an important role in 
regulation of positive selection and maturation of B cells, and lack of CD19 imposes 
developmental arrest of immature B cells and consequential stimulation of receptor 
editing (Diamant et al., 2005). Finally, these antigen signaling pathways lead to the 
activation of several transcription factors that trigger proliferation and lymphocyte 
maturation resulting in clonally expanded plasma cells. 
 
Passive immunization impressively demonstrates the action of humoral immune 
responses. Already in the 1890s, von Behring discovered the specific antitoxic activity 
of serum derived from animals immune to diphtheria or tetanus and could thereby treat 
patients infected shortly before. The injection of antibody or immune serum into a 
naïve recipient confers short-lived immunity.  
 
B cell activation by armed helper T cells 
Besides performing antibody responses, B cells function as professional antigen 
presenting cells. The BCR delivers the bound antigen to intracellular compartments for 
degradation and presentation on the B-cell surface as peptides bound to MHC 
molecules. This in turn is a prerequisite for the maturation of the B cell itself. A 
general mechanism of adaptive immunity to avoid autoimmune responses implies that 
naïve antigen-specific lymphocytes are difficult to activate by antigen alone. Instead, 
naïve B cells require accessory signals that can be provided by an armed helper T cell 
or, in rare cases, directly from microbial constituents ensuring a rapid response to 
many important pathogens. However, only the interaction of antigen-stimulated B cells 
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with helper T cells can induce somatic hypermutation and isotype switching leading to 
more variable and more functionally versatile antibodies.  
 
T cell antigen recognition in the context of MHC molecules 
In contrast to B cells, that defense extracellular spaces by secreting antibodies capable 
of binding to pathogenic structures, T cells evolved the ability to sense and destroy 
cells infected with intracellular pathogens. These cells display protein fragments 
(peptides) derived from invaded virus or bacteria on their cell surface (Townsend et 
al., 1985). These peptides are delivered to the cell surface by specialized host-cell 
glycoproteins, the major histocompatibility complex (MHC) molecules. The genes 
encoding the MHC proteins are located within the MHC region on chromosome 6 for 
human and chromosome 17 for mice, and are called human leukocyte antigen (HLA) 
genes or histocompatibility antigen 2 (H-2), respectively. The term MHC was chosen 
as their most prominent protein product, the MHC-molecules (first named 
transplantation antigen by Peter Gorer in the 1930s), are predominantly responsible of 
histocompatibility, that means the acceptance or rejection of tissue- and organ 
transplants. They present self and foreign peptides derived from endocytosed 
extracellular or from cytosolic proteins on the cell surface for recognition by T 
lymphocytes. 
 
Two classes of MHC molecules can be distinguished according to their function and 
structure as well as their expression pattern on different cell types. MHC class I 
molecules are expressed on nearly all nucleated cells, although the level of constitutive 
expression varies with the cell type. They consist of a MHC-encoded, membrane-
bound - or heavy chain (43 kDa), which comprised three extracellular 
immunoglobulin-like domains (1-3), a transmembrane region, and a short cytoplasmic 
stretch. The extracellular part of the heavy chain is non-covalently associated with the 
non-MHC encoded -chain, called 2-microglobulin (12 kDa). 
MHC class II molecules are normally expressed only by specialized antigen-presenting 
cells (APCs) such as dendritic cells, macrophages, B lymphocytes, and thymic stromal 
cells. They are formed by two transmembrane heavy chains,  (34 kDa) and           
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(29 kDa). Each chain consists of two extracellular immunoglobulin-like domains (1-2, 
1-2), a transmembrane region, and a short cytoplasmic part. The extracellular parts of 
the - and -chain are non-covalently linked to each other.  
The structural basis for the presentation of peptides by MHC-molecules is the 
formation of the peptide binding groove. For MHC-class I molecules, the two N-
terminal 1 and 2 domains of the heavy chain fold into a basal -sheet and two -
helices thereby forming a binding cleft that is relatively closed at both ends. This 
implies that the bound peptides are restricted in their length to 8 to 10 amino acid 
residues. In a similar way, the 1- and 1-domains of MHC-class II molecules together 
create a binding groove, which, however, is more open at both ends, thus allowing the 
binding of peptides of variable lengths (between 9 and 25 amino acids).  
The diverse T cell receptor does not recognize the presented peptide alone, but makes 
intense contacts with both, the MHC molecules and the bound antigenic peptide 
(Garboczi et al., 1996). MHC restriction, (Zinkernagel and Doherty, 1974) therefore 
affects the antigen specificity of T cells and is based on the great variation in MHC 
molecules enabling them to present a broad range of peptides. The MHC locus is 
characterized by polymorphism and polygenicity, meaning that it contains several 
different MHC class I and MHC class II genes and that, within the population as a 
whole, there are multiple alleles of each gene.  
Although the MHC portion in the MHC:peptide:TCR complex influences the binding 
properties significantly, many MHC residues at the TCR interface are conserved, and 
the highly polymorphic regions are favorably found in residues within the peptide 
binding cleft. The specific binding groove of the MHC molecule is capable of binding 
a variety of very different peptides with significant affinity while other peptides cannot 
be bound at all. Besides the length of the peptide, two or three so-called anchor amino 
acid residues are responsible for the binding characteristic between the peptide and the 
MHC molecule. Thus, most peptides that are able to bind to and to stabilize a given 
MHC allele display the same or chemically related amino acids at these anchor 
positions. Hence, it is possible to describe a peptide binding motif for every MHC 
variant (Rotzschke et al., 1990; Falk et al., 1991; Stevanovic and Jung, 1993). For 
MHC class I molecules, additional interaction occurs between the free N- and C-
termini of the peptide with invariant regions of the MHC groove (Bouvier and Wiley, 
  1- GENERAL INTRODUCTION 
  23 
1994). The crystal structure of MHC molecules gives impressive insights into these 
binding features (Bjorkman et al., 1987; Saper et al., 1991).  
 
Altogether, the peptide sequence restriction to only two or three anchor positions 
ensures the presentation of a large number of different peptide fragments, generated in 
a cell, by a given MHC molecule. And, as a result of polygenicity and polymorphism 
of both classes of MHC molecules and the codominant expression of several MHC 
genes, each cell of an individual expresses several different MHC variants, each 
presenting a different peptide repertoire. Thus, each cell is able to display its entire 
protein content in a very detailed and exhaustive manner to ensure best surveillance by 
the immune system. To give an idea, a normal cell presents around 104 different 
peptides on its 105 to 106 MHC class I molecules. Last but not least, the great variation 
among MHC molecules within the population contributes to the ability of the immune 
system to respond to the multitude of different and rapidly evolving pathogens and 
reflects the selective pressure imposed by these nearly unlimited possible infectious 
agents. 
 
T cell effector function 
T cells are grouped into two major classes that differ in their effector functions. The 
two classes can be distinguished by the class of MHC molecules they recognize and by 
the expression of the co-receptors CD4 and CD8. Activation of naïve T cells not only 
requires the formation of the trimeric MHC:antigen:TCR complex but also the 
interaction of the co-receptor with invariant sites on the MHC molecule. CD8+ T cells 
recognize antigen in the context of MHC class I molecules which are expressed by 
nearly all cell types. They untiringly recirculate through the body on the search of 
foreign or unexpected peptides presented by MHC class I molecules as a sign of 
infection or illness. Their effector function is the elimination of these dangerous 
infected or mutated cells, and they are therefore named cytotoxic T lymphocytes 
(CTL) or killer cells. They destroy their target cells by releasing cytotoxins such as 
perforin, granzymes or granulysin or through the action of their Fas-ligand (CD178). 
Perforin polymerizes in the target-cell membrane to form transmembrane pores, 
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whereas granzymes, granulysin, and binding of the Fas-ligand to Fas (CD95) on the 
target cell (Suda et al., 1993; Fisher et al., 1995) induce death by apoptosis with 
granulysin having additionally antimicrobial functions (Shiver et al., 1992; Lieberman, 
2003).  
 
CD4+ T cells recognize peptides presented by MHC class II molecules, which are 
generally solely expressed by professional antigen presenting cells, but whose 
expression can be induced in normal tissue cells upon IFN- stimulation. CD4+ T cells 
are conferred to as helper T cells and comprise two functional subtypes: TH1 and TH2. 
TH1 cells secrete as main cytokine IFN-, which activates macrophages that are 
infected by or have ingested pathogens. In addition, they produce lymphotoxin (also 
called TL- or TNF-), which activates macrophages, concomitantly inhibits B cells 
and is directly cytotoxic for some cells. Thus, TH1 cells function mainly as 
inflammatory immune cells. TH2 cells, however, act predominantly as regulators in 
humoral immune responses as they secrete the B-cell growth factors IL-4, IL-5, IL-9, 
and IL-13, and thereby provide the help required for activation of naïve B cells and 
their differentiation into plasma cells and memory B cells. On the other hand, they can 
inhibit macrophage activation by secreting IL-10. Furthermore, CD4+ T cells mediate 
activation of B cells, macrophages and dendritic cells by ligation of CD40 ligand 
(CD40L) on the T cell with CD40 on the APC resulting in increased antigen-
presentation and co-stimulatory capacity (Schoenberger et al., 1998; Seder and 
Ahmed, 2003). 
 
Although binding of the MHC:antigen complex by the TCR and the co-receptor is 
sufficient to trigger armed effector T cells into action, this specific signal is not able on 
its own to prime naïve T cells. Instead, clonal expansion of naïve T cells and their 
differentiation into armed effector T cells requires the antigen specific signal plus a 
second signal, the co-stimulatory signal, simultaneously delivered by the same 
antigen-presenting cell. The requirement for one APC to deliver these two independent 
signals is crucial for preventing immune responses to self antigens. Antigen 
recognition by a naïve T cell in the absence of co-stimulation leads to anergy and thus 
induces tolerance in the peripheral T cell population. Co-stimulatory molecules are 
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exclusively expressed by APCs upon activation and subsequent maturation. The best-
characterized co-stimulatory molecules are the glycoproteins CD80 (B7.1) and CD86 
(B7.2), whose interaction with receptor CD28 on the T cell surface induces the 
activated T cell to synthesize the T cell growth factor IL-2 and its high affinity 
receptor. IL-2 then induces in an autocrine and paracrine way T cell proliferation and 
clonal expansion and also promotes differentiation into armed effector T cells.  
As mentioned before, APCs themselves require activation and maturation in order to 
upregulate co-stimulatory molecules. Thereby, T cell activation and APC activation go 
hand in hand in a ‘T-cell:APC dialogue’, which ensure a rapid immune response. 
Upon activation, naïve T cell express CD40 ligand (CD154), whose binding to CD40 
on APCs transmits activating signals to both cell types. Another receptor-ligand pair of 
co-stimulatory molecules with such a bidirectional stimulatory effect is the 4-1BB 
(CD137) on T cells and 4-1BBL on APCs (DeBenedette et al., 1995). To avoid an 
endless circle of activation, the interaction between CD28 and CD80/CD86 must be 
disturbed thereby limiting IL-2 production. To this end, activated T cells are 
programmed to express CTLA-4 (CD152) that binds CD80 or CD86 about 20 times 
more avidly than does CD28 and delivers an inhibitory signal to the T cell. Apart from 
this T-cell:APC dialogue, upregulation of co-stimulatory molecules on APCs can also 
be initiated independent on T cell interaction via innate immune recognition 
mechanisms, as will be discussed later. 
 
The three paths of antigen presentation 
Classical MHC class I processing pathway 
The peptides presented by MHC molecules derive from different exogenic and 
endogenic protein sources and, therefore, their generation involves distinct antigen 
processing pathways (Morrison et al., 1986). Most of the peptides presented on MHC 
class I molecules are processed in the cytosol (Stoltze et al., 2000a). They derive from 
self protein or from viruses or certain bacteria that replicate in the cytosol or in the 
contiguous nuclear compartment. Not only aged and unemployed but otherwise 
flawless proteins removed by the normal protein turnover constitute the peptide 
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source, but rather the major contribution to the peptide pool comes from defective 
ribosomal products (DRiPs) (Yewdell et al., 1996; Reits et al., 2000; Schubert et al., 
2000). These are faulty or misfolded polypeptide chains that result from a premature 
termination during the error prone translation process of RNA into proteins by 
ribosomes. 
The immune system benefits from this apparently rather wasteful production process, 
since the immediate processing of the DRiPs and subsequent peptide presentation give 
the T cells a ‘head start’ (Schild and Rammensee, 2000b) in recognizing infected cells.  
 
The MHC class I processing pathway begins with the degradation of cytosolic proteins 
by the proteasome, a large multicatalytic protease complex. Stimulation with IFN- 
replaces the constitutive proteasome, found in all cells, by the immunoproteasome 
(Tanaka and Kasahara, 1998) and induces the production of the PA28 proteasome-
activator molecules (Dick et al., 1996; Groettrup et al., 1996). Together, the formation 
of the immunoproteasome due to replacement of three catalytic subunits by their 
inducible counterparts and the induction of the PA28 activator changes the cleavage 
specificity of the proteasome. As a result, the immunoproteasome preferably produces 
peptide fragments of 8 to 11 amino acid residues in length (Wenzel et al., 1994; Ehring 
et al., 1996; Kisselev et al., 1998) and with C-terminal residues that are preferred 
anchor residues for binding to most MHC class I molecules.  
Downstream of the proteasome, the generated peptide fragments are shortened at their 
N-terminus by cytosolic (Stoltze et al., 1998; Beninga et al., 1998; Geier et al., 1999; 
Stoltze et al., 2000b) proteases. Only a small number of these peptides escapes further 
degradation to the amino acid level and is translocated into the ER lumen by the 
‘transporter associated with antigen processing’ (TAP). Here, the imported peptides 
can be further trimmed by the INF- inducible aminopeptidase ERAAP (endoplasmic 
reticulum aminopeptidase associated with antigen processing (Saric et al., 2002; 
Serwold et al., 2002; York et al., 2002) to generate the correct epitope. In the ER, the 
newly synthesized MHC class I molecule is associated with the TAP via tapasin, and 
chaperones such as Calnexin, Erp57 and calreticulin stabilize the MHC molecule, until 
loading with a peptide completes the folding of the MHC molecule. The successfully 
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assembled peptide:MHC complex is then released from the TAP and finally 
transported through the Golgi apparatus to the cell surface. 
 
Classical MHC class II processing pathway 
The peptides presented by MHC class II molecules are processed and loaded in 
acidified endocytotic vesicles. Besides self proteins that reside in or pass through 
endosomal compartments, the peptide antigen source are extracellular foreign 
antigens, such as bacteria or bacterial products that have been taken up by unspecific 
or receptor-mediated endocytosis, as well as invaded parasites or bacteria that replicate 
in intracellular vesicles. In the endosomes, the progressively decreasing pH activates 
acid proteases such as Cathepsin B, C, S und L, which degrade the engulfed proteins 
(Nakagawa et al., 1998; Nakagawa et al., 1999).  A complex biosynthetic process has 
evolved for the synthesis of the MHC class II molecules in the ER, their loading in 
uncomfortably acidic environment and their subsequent transport to the cell surface. 
The newly synthesized MHC class II - and -chains associate with the invariant chain 
(Ii) protein to form first a trimeric complex and finally a nonameric (/-Ii)3 complex 
(Cresswell, 1996; Pieters, 1997). Thereby, a part of Ii occupies the MHC binding cleft 
which prevents premature binding of peptides to the MHC molecule.  
Additionally, Ii targets the MHC complex for transport to specialized late endosomal 
compartments (MIIC, MHC class II compartments), the place where MHC class II 
peptide loading occurs. During this transport, Ii is selectively truncated by acid 
proteases, leaving only a short peptide, CLIP (class II-associated invariant chain 
peptide) in the MHC binding groove. Subsequently, an MHC class II-like molecule, 
HLA-DM, catalyses the release of the CLIP fragment and allows the binding of 
peptide to the binding groove (Fling et al., 1994; Morris et al., 1994; Kropshofer et al., 
1997). In a process of ‘peptide editing’ it stabilizes the empty MHC molecule  (Denzin 
and Cresswell, 1995) and keeps removing unstably bound peptides thus selecting for 
high affinity peptides. In thymic epithelial cells and B cells, a second atypical MHC 
class II molecule, HLA-DO, act as potential negative regulator of the HLA-DM 
dependent peptide loading onto different allo-specific class II molecules. It raises the 
selection pressure in antigen loading and, thus influences the peptide reservoir of the 
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MHC class II molecules. Once successfully loaded with antigenic peptide, the MHC 
molecule is released from the associated chaperons, continues its travel to the cell 
surface and now waits for the checking by passing lymphocytes.  
Alternative pathway: Cross-presentation  
The previously described differentiation between the classical MHC class I and II 
antigen processing pathways is based on the distinction between endogenous and 
exogenous sources of proteins to be processed. Exogenous proteins are uptaken by 
APC cells and processed in the MHC class II pathway for recognition by CD4+ T 
helper cells. Endogenous cytosolic proteins, however, are presented on MHC class I 
molecules for recognition by CD8+ T cells, which is the basis for elimination of virus-
infected cells via CD8+ killer cells. Thus, a viral infection leads to the presentation of 
endogenous viral proteins by MHC class I molecules, which targets the virus-infected 
cells for elimination by specific CD8+ killer cells. However, the priming of naïve 
CD8+ T cells implies that the same antigen presenting cell provides both activation 
signals, the antigenic signal in form of the antigenic peptide presented on MHC class I 
molecules and the co-stimulatory signal. That means that APC, the only cells to 
provide co-stimulatory signals, must be susceptible to all kinds of virus infections. But 
some viruses do not infect professional APC, such as the human papillomavirus, which 
infects exclusively peripheral tissues, or some viruses, such as the herpes simplex 
virus, downregulate co-stimulatory molecules thereby subverting the ability of DCs to 
prime T cell in the classical way (Mueller et al., 2002; Bosnjak et al., 2005).  
Nevertheless, these pathogens elicit potent adaptive immune responses characterized 
by virus-specific CD8+ T cells. This paradox was solved, when it was found that MHC 
class I-restricted CTL responses can be induced against peptides derived from 
exogenous or extracellular protein sources (Bevan, 1976b; Bevan, 1976a). This 
phenomenon of transferring exogenous antigen into the MHC class I antigen 
processing machinery has been termed cross-presentation. And the physiological 
outcome may either be priming of CD8+ T cells referred to as cross-priming or 
induction of tolerance (cross-tolerance). 
These mechanisms are of great physiological relevance, not only for viral antigens, but 
also for self antigens or tumor antigens that cannot efficiently access the classical 
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MHC class I processing pathway of DCs. For naturally occurring CTL responses 
against tumor cells, cross-presentation is elementary, since most tumor cells neither 
express MHC class II molecules nor co-stimulatory molecules, and – of course - do 
not infect DCs. Nevertheless, necrotic tumor material can be uptaken by surrounding 
stroma cells, which are able to present the tumor derived proteins on MHC class I 
molecules. However, cross-presentation of tumor-derived antigens requires sufficient 
APC activation (van Mierlo et al., 2002).  
 
Although cross-presentation has also been observed in some macrophages 
(Kovacsovics-Bankowski et al., 1993; Rock et al., 1993), B cells (Ke and Kapp, 1996; 
Heit et al., 2004) and even in liver endothelial cells (Limmer et al., 2000) in vitro, the 
major cell type known for its capacity in vivo to cross-present antigens are DCs. Thus, 
transient DC depletion of murine bone-marrow derived CD11c+ DCs abrogated 
priming of CTLs to exogenous cell-associated antigens, which displays the crucial role 
of DC in CTL response induction (Jung et al., 2002).  In another setting, a subset of 
murine spleenic DCs, the CD8a+ population, was shown to shuttle endogenous 
antigens constitutively and most efficiently in the cross-presentation pathway (den 
Haan et al., 2000; Pooley et al., 2001). In contrast, CD8a- DCs gain these abilities only 
after activation e.g. by ligation of their Fcγ-Receptor (den Haan and Bevan, 2002). 
Because of their activation-independent cross-presentation ability, CD8+ DCs are 
thought to ensure tolerance to peripheral antigen through the mechanisms of cross-
tolerization, when no DC activating stimuli are present. 
 
Protein antigens are most efficiently uptaken and cross-presented if they are delivered 
in apoptotic bodies (Albert et al., 1998), immune complexes (Rodriguez et al., 1999; 
Regnault et al., 1999) or exosomes, which are small membrane vesicles secreted by 
living tumor cells and many other cell types (Zitvogel et al., 1998; Wolfers et al., 
2001; Stoorvogel et al., 2002), or shuttled by heat-shock proteins (Srivastava et al., 
1994; reviewed in Srivastava, 2002), which play a special role in chaperoning non-
cell-associated free antigens to APCs (Zheng et al., 2001). The cross-priming 
efficiency of antigens in these forms is achieved through specific receptor-mediated 
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uptake of these structures by immature DCs (Albert et al., 1998; Arnold-Schild et al., 
1999; Singh-Jasuja et al., 2000b).   
The precise mechanisms for cross-presentation, however, are not yet fully understood. 
In the peptide exchange model, internalized exogenous proteins are degraded in the 
endocytic pathway and the thus newly generated peptides replace previous loaded 
peptides on MHC class I molecules (Chefalo and Harding, 2001; Pfeifer et al., 1993) 
that could have been endocytosed from the cell surface (reviewed in Ackerman and 
Cresswell, 2004). Although partial proteolysis may occur in the endocytic pathway, 
exogenous proteins must be further processed in the cytosol for effective cross-
presentation (Rock, 1996). This model involves classical MHC class I processing 
mechanisms, such as proteasomal proteolysis, TAP-mediated translocation to the ER 
(Kovacsovics-Bankowski and Rock, 1995; Norbury et al., 1997) and C-terminal 
trimming of the MHC epitope in the ER (Castellino et al., 2000). Unraveling the exact 
molecular mechanisms of cross-presentation will ultimately define the still 
controversially discussed (Freigang et al., 2003) physiological relevance of cross-
presentation and emphasize its critical role in the initiation of immune responses. 
 
Innate immunity: Pattern recognition 
During a possible infection, the immune system has to take the decision to respond or 
not to respond.  However, reliable detection of pathogens is a difficult task due to their 
molecular heterogeneity and rapid evolution. One strategy of sensing infection is based 
on innate immune recognition of a limited number of microbial ‘molecular signatures’, 
the pathogen associated molecular patterns (PAMPs) (Janeway, Jr. and Medzhitov, 
2002). This implies that PAMPs are produced only by pathogens and not by host cells 
allowing the distinction between ‘self’ and ‘microbial nonself’. Furthermore, the 
recognized motifs are essential for the pathogen’s survival and cannot be mutated for 
escape strategies by the pathogen without life-threatening loss of function and in most 
cases, they are expressed constitutively. Indeed, many known PAMPs are typical 
nucleic acids or conserved components of cell wall structure from microorganisms. 
Moreover, the highly conserved PAMPs are invariant between microorganisms of a 
given class. This allows the detection of PAMPs by a limited number of pattern 
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recognition receptors (PRRs), which include membrane-bound receptors in the cell 
surface or in intracellular compartments, or soluble proteins secreted into the blood 
stream and tissue fluids. In contrast to the variable lymphocyte antigen receptors of the 
adaptive immune system, the PRRs of the innate immune system are defined in the 
genome, and each cell of a given subtype is able to produce the same limited set of 
receptors. The ancient innate immune system developed a self-foreign discrimination 
by defined PRRs as perfect as possible, whereas the self-nonself recognition by the 
variable lymphocyte antigen receptors of the adaptive immune system is error-prone 
due to the aim to generate a diversity as high as possible by mechanisms such as 
random gene rearrangement and despite all the control mechanisms to avoid self-
reactivity.   
 
Toll-like receptors 
Toll-like receptors (TLRs) form a group of pattern recognition receptors with a great 
variety of different ligand specificities (Table 1). Their discovery in 1997 by cloning 
and characterization of TLR4 (Medzhitov et al., 1997) gave new impulses in the field 
of innate immunity and in the understanding how innate and adaptive immunity are 
tightly interwoven. TLRs are type I transmembrane glycoproteins characterized by an 
extracellular leucine-rich repeat domain and a conserved intracellular domain, which is 
homologous to the cytosolic domain of the IL-1 receptor and therefore named Toll/IL-
1 receptor (TIR) domain. The TIR domain is found in numerous transmembrane and 
cytosolic proteins in animals and plants, and most of them play a role in host defense.  
 
Drosophila Toll: selectivity in insect immune defense 
The Toll gene of the fruit fly Drosophila melanogaster was the first member of the 
Toll family identified. It was discovered due to its essential function for the dorso-
ventral axis formation during embryogenesis (Anderson et al., 1985). However, the 
transmembrane receptor Toll also plays an important role in a very effective innate 
immune system in insects that is based on pattern recognition (in (Hoffmann and 
Reichhart, 2002). In contrast to vertebrates, insects do not have any kind of adaptive 
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immune system and immunological memory. Nevertheless, they are able to fight 
immediately and very effective against invading microbes by producing specific anti-
microbial peptides. This immune defense is even selective: dependent on the type of 
infection, anti-bacterial or anti-fungal peptides are expressed. Thereby, the selective 
activation of the Toll pathway plays a key role. Drosophila Toll mutants do not 
survive fungal infections due to the failure to produce the antifungal peptide 
Drosomycin (Lemaitre et al., 1996). Fungal infection triggers cleavage of the 
extracellular polypeptide Spaetzle by a serine protease generating the endogenous 
ligand for Toll. The physiological active Spaetzle then induces ligand-dependent Toll 
receptor dimerization (Levashina et al., 1999). But the upstream events leading to Toll 
activation are not yet fully understood. An induced mutant, semmelweis (seml), which 
involves a gene encoding for a peptidoglycan-recognition protein, blocks Toll 
activation by Gram-positive bacteria but does not affect Toll activation by fungal 
infection (Michel et al., 2001). This finding suggests that two different pathways are 
triggered by infection with Gram-positive bacteria and fungi, respectively, leading to 
spaetzle cleavage.  
In contrast, Gram-negative bacteria are not recognized by Drosophila Toll (Lemaitre 
et al., 1995). Instead, responses to these pathogens are abolished in immune deficiency 
(imd) mutants, a recessive mutation in a gene encoding a cytosolic protein containing a 
death domain. The Imd pathway triggered by Gram-negative bacteria has similarities 
to the mammalian tumor necrosis factor-α signaling pathway. However, it is unknown 
which receptor links Gram-negative infection to the Imd pathway. 
The involvement of Drosophila Toll in insect immune responses to fungal infections 
had a pioneering effect for the identification of Toll-like receptors in mammals. 
 
Mammalian Toll-like receptors in immune defense 
Today, thirteen different mammalian TLRs have been identified, with their genes 
dispersed throughout the genome. Individual TLRs are differentially expressed among 
immune cells and various tissues, they respond to different stimuli and differ in the 
signal transduction pathways they activate. 
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Receptor 
  
PAMP PAMP origin Synthetic analogues  
[Fully synthetic small 
molecules] 
Triacyl lipopeptides Bacteria and 
mycobacteria 
Triacyl lipopeptides 
TLR1 
Soluble factors Neisseria meningitidis  
Lipoproteins/lipopeptides Various pathogens Di- and triacyl 
lipopeptides 
Peptidoglycan Gram-positive bacteria  
Lipoteichoic acid Gram-positive bacteria  
Lipoarabinomannan Mycobacteria  
Phenol-soluble modulin Staphylococcus 
epidermidis 
 
Glycoinositolphospholipids Trypanosoma cruzi  
Glycolipids Treponema 
maltophilum 
 
Porins Neisseria  
Atypical LPS Leptospira interrogans  
Atypical LPS Porphyromonas 
gingivalis 
 
Zymosan Fungi  
Hsp 70* Host  
TLR2 
Gp96* Mouse  
TLR3 Double-stranded RNA Viruses Poly I:C 
LPS Gram-negative bacteria LPS/lipid A mimetics, 
such as 
monophosphoyl lipid A 
(MPL) 
[Synthetic lipd A, 
E5564] 
Taxol Plants  
Fusion protein Respiratory syncytial 
virus 
 
Envelope protein Mouse mammary-
tumor virus 
 
Hsp60* Chlamydia pneumoniae  
Hsp70* Host  
TLR4 
Gp96* Mouse  
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Receptor 
  
PAMP PAMP origin Synthetic analogues  
[Fully synthetic small 
molecules] 
Type III repeat extra 
domain a of fibronectin* 
Host  
Oligosaccarides of 
hyaluronic acid* 
Host  
Polysaccaride fragments of 
hepara sulphate* 
Host  
TLR4 
continued 
Fibrinogen* Host  
TLR5 Flagellin Bacteria Discontinuous 13-
amino-acid peptide 
Diacyl lipopeptides Mycoplasma Diacyl lipopeptides 
Lipoteichoic acid Gram-positive bacteria Oligonucleotides 
[Imidazole quinolines 
(imiquimod, 
resiquimod) 
Guanosine nucleotides 
(loxoribine)] 
TLR6 
Zymosan Fungi  
Imidazoquinoline Synthetic compounds  
Loxoribine Synthetic compounds  
Bropirimine Synthetic compounds  
TLR7 
Single-stranded RNA Viruses  
Imidazoquinoline Synthetic compounds [Imidazol quinolines 
(imiquimod)] TLR8 
Single-stranded RNA Viruses  
TLR9 CpG-containing DNA Bacteria and viruses CpG oligodeoxy-
nucleotides 
TLR10 N.D N.D.  
N.D Uropathogenic bacteria  
TLR11 
profilin-like molecule  Toxoplasma gondii  
TLR12 N.D. N.D.  
TLR13 N.D. N.D.  
 
Table 1. Toll-like receptors (TLRs) and the corresponding pathogen-associated molecular 
patterns (PAMPs) from various pathogens. Table content is based on (Akira and Takeda, 2004). 
*These ligand preparations might be contaminated with lipopolysaccaride and/or other potent 
microbial components, so more-precise analysis is required to conclude that TLRs recognize these 
endogenous ligands. N.D.: not determined. 
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TLR2 (TLR1 and TRL6)  
Early reports on TLR ligands suggested that, in a transfection model, TLR2 is 
involved in LPS (lipopolysaccharide) signaling (Kirschning et al., 1998; Yang et al., 
1998). However, cells carrying a null allele for TLR2 display a normal response to 
LPS (Heine et al., 1999). Almost simultaneously, TLR4 was shown to be required for 
LPS signaling by using TLR4-deficient and TLR4-knockout mice (Sultzer, 1968; 
Poltorak et al., 1998a; Qureshi et al., 1999). Subsequently, it could be demonstrated, 
that highly pure LPS does not signal via TLR2. It is rather the overexpression of TLR2 
in transfection models which renders cells sensitive to minor protein-contaminations in 
LPS preparations thus pretending a contribution of TLR2 to LPS signaling (Hirschfeld 
et al., 2000). Thereafter, it became a paradigm that LPS-signaling requires the four 
molecules LBP, CD14, MD-2, and TLR4 (as described below for TLR4). In the mean 
time, however, TLR2 was found to function as a receptor for atypical LPS produced 
by Leptospira interrogans (Werts et al., 2001), Porphyromans gingivalis (Hirschfeld 
et al., 2001), Rhizobium species (Girard et al., 2003), and Legionella pneumophila 
(Girard et al., 2003; Braedel-Ruoff et al., 2005) which are structurally different from 
the prototypic enterobacterial LPS. 
 
Additionally, lipoproteins and lipopeptides from different organisms have been 
identified as TLR2 ligands (Aliprantis et al., 1999; Brightbill et al., 1999; Hirschfeld et 
al., 1999; Takeuchi et al., 2000). Lipoproteins are proteins carrying lipid covalently 
linked to N-terminal cysteines and are produced by a variety of organisms, including 
Gram-negative and Gram-positive bacteria and mycoplasmas. Moreover, TLR2 
recognizes cell wall components from different pathogens including peptidoglycan 
(PGNS) from Gram-positive bacteria (Schwandner et al., 1999; Takeuchi et al., 1999), 
zymosan of yeast (Underhill et al., 1999), mycobacterial lipoarabinomannan (Means et 
al., 1999; Underhill et al., 1999), modulin produced by Staphylococcus epidermidis 
(Hajjar et al., 2001), glycosylphosphatidylinositol anchors from Trypanosoma Cruzi 
(Campos et al., 2001), as well as Glycolipid and lipoteichoic acid (LTA) from 
Treponema (Opitz et al., 2001; Schwandner et al., 1999). 
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This unusual broad range of ligands recognized by TLR2 is – to some extent – 
explained by cooperation of TLR2 with other TLRs. It was found that 
homodimerization of TLR2 does not induce cytokine production in macrophages upon 
receptor stimulation (Ozinsky et al., 2000), whereas heterodimerization of TLR2 with 
other TLRs, such as TLR1 or TLR6, conferres functionality as well as some ligand 
specificity. Thus, bacterial lipoproteins, which are mostly triacylated at the N-terminal 
cysteines, trigger immune responses via TLR2 upon heterodimerization with TLR1.  
In contrast, mycoplasmal macrophage-activating lipopeptide-2 kDa (MALP-2), which 
is only diacylated, requires in addition to TLR2 the presence of TLR6: in a mouse 
model, TLR6-/- cells are unresponsive to the diacylated MALP-2, but respond normally 
to triacylated lipopeptides from other bacteria. However, TLR2-/--cells fail to recognize 
either type of lipopeptide. Reconstitution experiments in TLR2-/-/TLR6-/--cells reveal 
that co-expression of both, TLR2 and TLR6, is absolutely required for MALP-2 
responsiveness. So, it seems that TLR6 is responsible for discriminating between the 
N-terminal lipoylated structures of MALP-2 and lipopeptides derived from other 
bacteria (Takeuchi et al., 2001). Subsequently, it was observed for human cells, that 
TLR6 colocalizes with TLR2 at the plasma membrane and that TLR2-TRL6 signaling 
does not require endosomal maturation (Nakao et al., 2005). Blockage of TLR6 using 
specific antibodies inhibits recognition of synthetic MALP2 or peptidoglycan, which 
indicates that TLR6 recognizes its ligands at the cell surface. But TLR6 is not 
sufficient for MALP2 signaling: in the absence of functional TLR2, MALP2 failed to 
induces cell stimulation even in the presence of TLR6 (Nakao et al., 2005). 
However, the model proposing that triacylated lipopeptides signal through TRL2-
TLR1 heteromers, whereas diacylated lipopeptides induce signaling through TLR2-
TRL6 heteromers has been reanalyzed using new synthetic lipopeptide derivates. As 
result, not only triacylated, but also diacylated lipopeptides like Pam2CSK4 and 
MALP2-SK4 induced proliferation of B lymphocytes independently of TLR6. These 
results redefine the role of TLR2 heteromers: both the lipid and the N-terminal 
peptides of lipoproteins seem to contribute to the specificity of recognition by TLR2 
heteromers (Buwitt-Beckmann et al., 2005).  
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In addition, TLR2 is also involved in viral defense: it recognizes the outer coat protein 
hemagglutinin (H) of wild-type measles virus. In attenuated strains, however, a single 
amino acid mutation in the H protein abolishes the ability to activate the innate 
immune system via TLR2 (Bieback et al., 2002).  Furthermore, TLR2 and CD14 
control the inflammatory cytokine response to human cytomegalovirus (CMV) virions 
during the prereplication phase of the virus. However, inflammation induced by CMV 
may not lead to viral clearance but may rather facilitate its replication and 
dissemination (Compton et al., 2003). For Herpes simplex virus 1 (HSV-1), TLR2-
mediated induction of inflammatory cytokines is not protective, but associated with 
lethal viral encephalitis upon HSV-1 infection (Kurt-Jones et al., 2004). The 
mycobacterium tuberculosis (MTB) evades host immune surveillance and persists 
inside macrophages through the action of a 19-kDa lipoprotein that inhibits MHC class 
II expression and antigen processing in a TLR2-dependent manner (Noss et al., 2001). 
Thus, TLR activation is a double-edged sword, protective or detrimental, depending on 
the pathogen and the location of the infection. 
 
TLR3  
Double-stranded RNA (dsRNA) is a molecular pattern associated with viral infection, 
since it is produced by most viruses at some point during their replication cycle (and is 
absent in non-infected cells). Its immunostimulatory activity is known since long, 
partly because it is able to activate the dsRNA-dependent protein kinase PKR 
(Williams, 1999). However, cells derived from PKR-deficient mice are still capable to 
respond to dsRNA and to polyinosine-polycytidylic acid (poly(I:C)), a synthetic 
dsRNA analogue, suggesting the existence of another receptor. This receptor is 
thought to be TLR3, as TLR3-deficient mice showed reduced responsiveness to 
poly(I:C), as well as to viral dsRNA (Alexopoulou et al., 2001).  
TLR3 was also demonstrated to directly contribute to the immune response of 
respiratory epithelial cells to influenza A virus, a highly contagious single-stranded 
RNA virus responsible for the “flu” syndrome, and hereby, the viral replicative 
intermediate dsRNA is a prerequisite (Guillot et al., 2005) and critical for the outcome 
of the infection (reviewed in Jacobs and Langland, 1996; Majde, 2000). 
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However, recently, the challenge of TLR3-deficient mice with different viruses 
(lymphocytic choriomeningitis virus (LCMV), vesicular stomatitis virus (VSV), 
murine cytomegalovirus (MCMV), and retroviruses) hints that TLR3 is not universally 
required for induction of antiviral responses, because the absence of TLR3 does not 
alter viral pathogenesis or impair induction of adaptive antiviral responses to these 
viruses (Edelmann et al., 2004). 
 
A possible explanation for the controversial role of TLR3 in antiviral responses is 
offered by a recent publication showing that TLR3 plays a role in cross-priming in 
vivo against virus-infected cells. DC activation by dsRNA present in virally infected 
cells but absent from uninfected cells requires signaling through TLR3. Thus, TLR3 
permits cross-priming of CTLs against viruses that do not directly infect antigen-
presenting cells (Schulz et al., 2005). TLR3 is not expressed on the cell surface but is 
intracellularly located, as shown for various cell types (Matsumoto et al., 2003), 
human dendritic cells; (Guillot et al., 2005), epithelial cells) and therein coincides with 
TLR7 and TLR9, all of which are involved in the recognition of nucleic-acid-like 
structures. Thus, the importance of TLR3 in antiviral immunity remains to be further 
investigated. 
 
Apart from this, some viral proteins have been found to subvert the host TLR3 defense 
system for the virus’ own benefit. For example, the A52R protein of the vaccinia virus 
(VV), the poxvirus used to vaccinate against smallpox, blocks the activation of the 
transcription factor NF-kB by TLR3 and other TLRs by associating with two key 
proteins important for TLR signal transduction (Harte et al., 2003). The hepatitis C 
virus (HCV) expresses a serine protease, NS3/4A, which is able to disrupt the 
poly(I:C)-activated TLR3 pathway by cleavage of the adaptor protein TRIF (Li et al., 
2005). 
 
TLR4  
Lipopolysaccharide (LPS or endotoxin) constitutes the major surface component of the 
outer membrane of Gram-negative bacteria (Rietschel and Wesphal, 1999). In 
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mammals, LPS induces a severe and generalized inflammation leading to a life-
threatening condition called endotoxin or septic shock. It is defined as a collapse of the 
circulatory and respiratory systems, which is caused by the overwhelming secretion of 
cytokines as a result of an uncontrolled systemic bacterial infection. LPS is recognized 
by TLR4 in a complex manner that requires several accessory molecules.  
 
The first identified molecule involved in LPS signaling was the LPS-binding protein 
(LBP), a 60 kDa acute-phase protein produced by the liver (Tobias et al., 1986; Tobias 
et al., 1988; Ramadori et al., 1990; Grube et al., 1994) and secreted into the plasma. 
Although constitutively expressed, LBP is produced in greater amounts after LPS 
challenge (reviewed in Beutler and Rietschel, 2003). The LBP in the serum 
concentrates LPS and recruits it to an additional, concomitantly identified receptor, 
CD14 (Wright et al., 1989; Schumann et al., 1990). This high-affinity LPS receptor 
CD14 is either expressed as a glycophosphoinositol (GPI)-linked protein on the 
surface of cells from the myeloid-lineage (mCD14) (Wright et al., 1990), or exits as 
soluble protein (sCD14) in the serum. The latter one is either directly secreted by the 
CD14-expressing cells or derived from protease-dependent shedding of the membrane-
bound molecules (Bazil and Strominger, 1991; Bufler et al., 1995). sCD14 competes 
with mCD14 for LPS binding and is able to neutralize LPS-induced responses in vitro 
and in vivo (Schutt et al., 1992; Haziot et al., 1994; Haziot et al., 1995). Additionally, 
sCD14 mediates the LPS-induced activation of non-CD14-expressing cells (Haziot et 
al., 1993; Pugin et al., 1993). However, cells derived from CD14-deficient mice 
respond to LPS as well as to live Gram-negative bacteria, although only at very high 
concentrations of LPS or bacteria (Haziot et al., 1996). These findings and the fact that 
mCD14 lacks a cytoplasmic domain for triggering activation signals inside the cell, 
suggested the existence of other receptors involved in LPS signaling that are able to 
transmit the information across the cell membrane.  
 
Already in the late 1970’s, the mouse strain C3H/HeJ was known to be insensitive to 
endotoxin and the responsible gene was conferred as Lps gene (O'Brien et al., 1980). It 
took until 1998 to discover that TLR4 is the Lps gene product. The unresponsiveness 
to LPS in this mouse strain is due to a missense point mutation in the Tlr4 gene, 
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leading to the exchange of a stringently conserved prolin to a histidine residue within 
the TIR (Toll/interleukin-1-receptor) domain of the cytoplasmic tail of the receptor, 
thereby abrogating downstream signaling (Poltorak et al., 1998b; Poltorak et al., 
1998a; Qureshi et al., 1999). Studies using Tlr4 knockout mice (C57BL/10ScCr mice 
lack TLR4 entirely) confirmed that TLR4 functions as the signal-transduction receptor 
for LPS (Hoshino et al., 1999). However, transfection of TLR4 alone does not confer 
LPS responsiveness on a recipient cell line, suggesting the requirement for at least one 
other factor for LPS signaling (Wright, 1999). The missing molecule was identified as 
MD-2, a small glycoprotein that lacks a transmembrane region and is either secreted as 
a soluble, active protein (Visintin et al., 2001a) or expressed on the cell surface in 
physical association with the extracellular domain of TLR4 (Shimazu et al., 1999; 
Schromm et al., 2001). Moreover, formation of an active TLR4:MD-2 complex in the 
Golgi apparatus is essential for TLR4 distribution and TLR4 is not able to reach the 
plasma membrane in MD-2 deficient cells (Nagai et al., 2002a). Thus, activation of the 
TLR4 signaling complex requires the coordinated interplay of LBP, CD14, MD-2, and 
TLR4. 
 
For quite a while, yet another protein was thought to cooperate with TLR4 in LPS 
recognition, at least in B cells: RP105 is a B-cell surface molecule (CD180) and was 
the first mammalian toll-like protein described. It was found to be involved in immune 
responses to LPS, since B cells lacking RP105 show hyporesponsiveness to LPS 
(Ogata et al., 2000). Structurally similar to the TLR4:MD-2-complex, RP105 
associates with a soluble extracellular molecule, MD-1. MD-1 is important for RP105 
with respect to B-cell surface expression and LPS recognition and signaling (Miyake 
et al., 1998; Nagai et al., 2002b).  
However, very recently, the role of RP105 was redefined as negative regulator of 
TLR4 signaling (Divanovic et al., 2005b). Although the extracellular portion of RP105 
resembles that of other TLRs, it does not have a cytoplasmic TIR domain required for 
TLR signaling. RP105 mostly resembles TLR4, not only in the requirement of an 
accessory molecule, but also in the amino-acid sequence. Moreover, Divanovic et al. 
demonstrated that RP105 is expressed by the same subset of human peripheral blood 
mononuclear cells and possesses the same expression pattern as TLR4. However, 
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RP105 is not able to trigger LPS signaling. Instead, expression of RP105:MD1 in a 
transfection model specifically inhibited the TLR4:MD2-mediated response to LPS. 
The inhibition does not involve RP105 signaling but interaction between RP105 and 
TLR4 mediated through MD1-MD2 interaction. In RP105 deficient mice, stimulation 
with LPS but not with other TLR ligands resulted in significantly increased immune 
responses, and these mice suffered a more severe endotoxicity after LPS challenge 
than did wild-type mice.  
 
TLR4 is not only a pattern-recognition receptor for LPS, but has also been shown to be 
required for the cell activating signals induced by the heat-shock proteins Hsp60, 
Hsp70 and Gp96 (Vabulas et al., 2001; Asea et al., 2000; Asea et al., 2002; Vabulas et 
al., 2002b). Furthermore, TLR4 was demonstrated to be involved in the recognition of 
lipoteichoic acids (LTA) from Gram-positive bacteria (Takeuchi et al., 1999). 
Moreover, defensins, small antimicrobial peptides produced by the innate immune 
system upon microbial infection, have been shown to trigger DC maturation via TLR4 
(Biragyn et al., 2002). 
 
Also structural proteins of the outer viral coat are recognized by TLR4: the fusion 
protein of respiratory syncytial virus (RSV), an important respiratory pathogen of 
humans, activates cells in a TLR4- and CD14-dependent manner. The virus persists 
longer in the lungs of infected TLR4-deficient mice compared to wild-type mice 
(Kurt-Jones et al., 2000). It is not yet clear whether the F protein of RSV represents an 
example of a viral PAMP, in that some conserved feature of the F protein is shared 
with fusion proteins of other viruses. Although TLR4 was demonstrated in TLR4-
deficient mouse models to act in viral clearance (Haynes et al., 2001), an alternative 
possibility is that RSV developed the ability to stimulate TLR4 for its own benefit 
(Monick et al., 2003). Vaccinia virus evolved a mechanism to interfere with TLR 
signaling suggesting an important role of TLR-mediated antiviral immunity. Two 
ORFs (open reading frames) of the vaccinia virus genome share amino acid sequence 
homology with the TIR domain of TLRs. Expression of the corresponding cytoplasmic 
proteins in infected mammalian cells interferes with IL-1, IL18 and TLR4 signaling 
but has no effect on MyD88-independent pathways (Bowie et al., 2000). However, as 
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mentioned for TLR2, the current understanding of the role of TLRs in responses to 
viruses is still incomplete. 
 
TLR5 
Flagellin is the main component of the bacterial flagella and is recognized by the 
innate immune defense of organisms as diverse as plants, flies and mammals (Hayashi 
et al., 2001). Recently, mammalian TLR5 was identified as PPR for bacterial flagellin 
from both Gram-positive and Gram-negative bacteria. Expression of flagellin in non-
flagellated bacteria conferred the ability to activate cells via TLR5, whereas deletion 
of the flagellin genes from flagellated bacteria strains abrogated the TLR5-stimulating 
activity (Hayashi et al., 2001). 
Flagellin is an unusual PAMP in that it is a protein, and proteins are notoriously easy 
to mutate in response to selection, and it does not undergo any posttranslational 
modification that would distinguish it from host cellular proteins. However, the C- and 
the N-terminus as well as the three-dimensional structure of flagellin are extremely 
conserved (Samatey et al., 2001). Additionally, flagellin as motor of mobility is vital 
for the bacteria. These aspects render flagellin interesting as a PAMP. Actually, TLR5 
recognizes the same motif in flagellin that is also necessary for propulsion, which is 
required for successful propagation of the bacteria (Reichhart, 2003), thereby 
precluding its mutation in response to evolutionary pressure by the host immune 
system. The recognition site comprises a cluster of 13 amino acid residues and is 
buried in the flagellar filament. Thus, monomeric flagellin, but not the filamentous 
molecules, activates TLR5 (Smith et al., 2003). Insufficient TLR5 signaling in 
response to flagellin has been linked to diseases such as Legionnaires’ disease. A 
common stop codon polymorphism in the extracellular domain abolishes TLR5-
mediated flagellin signaling and is associated with susceptibility to pneumonia caused 
by Legionella pneumophila (Hawn et al., 2003). Helicobacter pylori, which colonizes 
the human gastric mucosa and is associated with gastritis, peptic ulcers, gastric 
adenocarcinomas and gastric mucosa-associated lymphoid type (MALT) B-cell 
lymphomas, seems to evade detection by TLR5 thereby escaping immune clearance. 
Unlike other Gram-negative microbes, it does not release flagellin upon invading the 
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host, and recombinant H. pylori flagellin is significantly less potent in activating 
TLR5-mediated immune responses than flagellin of other species (Gewirtz et al., 
2004). 
 
TLR7 and TLR8 
Genomic structure and sequence similarities suggest that with TLR7 and TLR8 form a 
subfamily with TLR9. Natural ligands for TLR7 and TLR8 were not known until 
recently, but synthetic products with potent anti-viral and anti-tumor properties, such 
as the imidazoquinoline compounds Imiquimod and R-848, stimulate humoral and 
cellular immune responses via these receptors (Hemmi et al., 2002; Jurk et al., 2002; 
Lee et al., 2003a; Heil et al., 2003). These compounds are structurally similar to 
nucleic acids, and subsequently, it was proposed that TLR7 and TLR8 mediate the 
immunostimulating capacities of stabilized RNA (Scheel et al., 2004). Moreover, it 
was demonstrated lately that uracil-rich, single stranded RNAs (ssRNAs) found in 
many viruses are physiological ligands for TLR7 and TLR8. A sequence from the U5 
region of HIV-1 RNA, which is rich in guanosine and uracil, stimulates dendritic cells 
to produce antiviral and proinflammatory cytokines. Cells from TLR7-deficient mice 
are unresponsive to the viral ssRNA, but mice lacking TLR8 responded normally. In 
contrast, analysis of human TLR8 suggests that this TLR may sense viral ssRNA, 
pointing to species differences among the TLRs (Heil et al., 2004): while the human 
TLR8 is a functional receptor for R-848, mouse TLR8 might be nonfunctional 
(Hemmi et al., 2002; Jurk et al., 2002). Concomitantly, it was shown, that mice lacking 
TLR7 fail to activate dendritic cells in response to genomic ssRNA from influenza 
virus and synthetic polyU RNA. Recognition of these PAMPs by TLR7 depends on 
endocytosis and endosomal maturation. It is proposed that during infection, 
phagocytes and dendritic cells take up virus-infected apoptotic cells, and subsequently, 
viral particles are degraded by endosomal proteases in phagosomes exposing the viral 
RNAs (Diebold et al., 2004). Accordingly, TLR7 and TLR3, both of which are 
receptors for viral RNAs, are localized in intracellular acidic compartments and are 
delivered to phagosomes after particle uptake (Matsumoto et al., 2003; Lee et al., 
2003a). The intracellular distribution of TLR7 is mediated by a targeting sequence 
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within its transmembrane domain, whereas targeting of TLR3 to the same intracellular 
compartments is achieved by a short 23 amino acid sequence present in the linker 
region between the transmembrane domain and the TIR domain (Funami et al., 2004; 
Nishiya et al., 2005). TLR8 as well localizes intracellularly, but with a small fraction 
on the cell surface (Nishiya and DeFranco, 2004). Nevertheless, mainly TLR8 and also 
TLR7 detect RNA of the human parechovirus 1, a ssRNA virus, in endosomal 
compartments (Triantafilou et al., 2005). Although, TLR7 and TLR8 are structurally 
and functionally closely related, TLR agonist studies revealed that TLR7 and TLR8 
agonists differ in their target cell selectivity and cytokine induction profile (Gorden et 
al., 2005). TLR ligands mimicking PAMPs are intensively studied for their therapeutic 
use against different diseases as well as vaccine adjuvants. These include the above 
mentioned synthetic TLR7 and TLR8 ligands Imiquimod and R-848, as well as the 
TLR9-stimulating CpG oligonucelotides (as described in more detail below for TLR9) 
(Weeratna et al., 2005). Recently, it was shown that using imiquimod as adjuvant for 
immunization of mice with a CTL epitope is highly effective in activating T cells 
(Rechtsteiner et al., 2005). This strategy provides a basis for vaccine development 
against cancer or virus-associated diseases. 
 
TLR9 
Another PAMP of bacteria is hidden in their DNA structure as unmethylated double-
stranded cytosine-phosphate-guanine (CpG) motif. In vertebrate DNA, the CpG 
sequence motifs are highly suppressed and occur only at about one fifth of the 
randomly expected frequency. And, if present, vertebrate CpG sequences are most 
likely to be methylated at the cytosine residues, whereas bacterial CpG sequences lack 
equivalent cytosine methylation.  
Unmethylated CpG motifs in bacterial, plasmid or viral DNA (Sato et al., 1996; 
Roman et al., 1997) and synthetic oligodeoxynucleotides (CpG ODN) (Krieg et al., 
1995) are potent stimulants for immune cells including B cells (Krieg et al., 1995), 
macrophages (Stacey et al., 1996) and dendritic cells (Sparwasser et al., 1998) to 
support expression of co-stimulatory molecules and production of TH1-type and pro-
inflammatory cytokines (Jakob et al., 1998; Hartmann et al., 1999; Hacker et al., 
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1999).  In 2000, TLR9 was identified as receptor recognizing CpG motifs by using 
Tlr9-knockout mice (Hemmi et al., 2000). In humans, functional TLR9 expression is 
predominantly seen in B cells and plasmacytoid DCs (pDCs) (Krug et al., 2001; 
Hornung et al., 2002). Unlike the TLR4/MD2 complex, TLR9 is not localized at the 
cell surface but is expressed in the endoplasmic reticulum (ER). In line with this, CpG-
DNA- but not LPS-induced cell activation requires endocytosis and endosomal 
maturation (Ahmad-Nejad et al., 2002). Fluorescently tagged CpG-DNA was observed 
to traffic to early endosomes and subsequently moves to a tubular lysosomal 
compartment. Concurrently, TLR9 redistributes from the ER to the CpG-DNA-
containing structures in the endosome (which also accumulate MyD88), where TLR9 
binds to CpG-DNA and initiates signaling (Leifer et al., 2004; Latz et al., 2004b). 
 
Distinct classes of synthetic CpG ODNs have been described that are capable of 
stimulating cells that express human TLR9 (Verthelyi et al., 2001). TLR9 seems to 
recognize CpG DNA directly, since it can distinguish between different 
immunostimulatory CpG motifs: human TLR9 and mouse TLR9 are optimally 
stimulated by different CpG motifs, which vary only slightly in the flanking sequences 
of the CpG dinucleotides (Bauer et al., 2001). These species differences probably 
reflect sequence differences in TLR9. However, it was shown recently that this 
sequence specificity is restricted to phosphorothioate (PS)-modified ODN and is not 
observed when a natural phosphodiester (PO) backbone is used (Roberts et al., 2005). 
Lately, ligand-binding studies revealed that (PO)-CpG DNA directly binds to TLR9. 
Interestingly, this binding is CG sequence-independent and stimulatory as well as 
nonstimulatory CpG DNA sequences are able to bind to TLR9, indicating that each 
construct might be able to modulate inflammatory responses. Indeed, it was shown, 
that nonstimulatory CpG DNA potently inhibits TLR9 signaling (Latz et al., 2004b).  
 
Interestingly, CpG-DNA provides a survival signal to DCs by activating two different 
pathways, the NF-kappaB and PI3K/Akt pathways. This CpG-driven cell survival 
might be one of the mechanisms by which bacterial DNA stimulates and maintains the 
innate immune responses (Park et al., 2002; Yi and Krieg, 1998). Additionally, the 
DNA-dependent protein kinase (DNA-PK), an enzyme activated by DNA and 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
46 
involved in DNA repair of double strand breaks, is also necessary for cell activation by 
CpG-DNA (Chu et al., 2000). Quite recently, DNA-PK was found to trigger CpG-
DNA responses by activating the nuclear factor Akt for translocation into the nucleus, 
whereas TLR9 is not involved in this pathway (Dragoi et al., 2005). This raises the 
question about the relationship between TRL9 and DNA-PK in regard to CpG 
signaling.  
 
TLR10 
Human TLR10 was first described in 2001. It contains 811 amino acid residues and is 
most closely related to TLR1 and TLR6 in regard to the overall amino acid identity 
(Chuang and Ulevitch, 2001). Furthermore, the TLR10 gene lies in a locus that also 
contains TLR1 and TLR6, both of which function as co-receptors for TLR2. But until 
now, no specific ligand for TLR10 has been identified. However, TLR10 was 
demonstrated to directly associate with MyD88, the common TLR adapter protein 
(Hasan et al., 2005). The murine TLR10 gene is nonfunctional and disrupted by a 
retroviral insertion (Hasan et al., 2005). 
 
TLR11  
Murine TLR11 was identified during the search for sequence homologies to the TIR 
domain of TLR4.  Further analysis revealed that TLR11 is particularly abundant in the 
mouse kidney and bladder. When infected with uropathogenic baceria, mice lacking 
TLR11 harbored 10,000 times as many bacteria in their kidneys as normal mice 
(Zhang et al., 2004). Humans only have a truncated form of TLR11, which is probably 
not functional. This might be why humans are predisposed to urinary tract infections. 
For mice, TLR11 was shown, very recently, to play a role in innate responses to 
parasite infections. A first hint for TLR engagement was the requirement of the TLR 
adaptor molecule MyD88 for the host resistance to Toxoplama gondii (Scanga et al., 
2002; Del Rio et al., 2004).  Subsequently, the protein profilin and TLR11 were 
identified as new ligand:TLR pair. The profilin-TLR11 interaction confers resistance 
to infection with T. gondii and moreover, TLR11-deficient mice survived acute 
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infection with this parasite (Yarovinsky et al., 2005). It is assumable that profilin 
homologues from other related parasites are also recognized by TLR11 thereby 
inducing protective responses.  
 
TLR12 and TLR13 
Mouse TLR12 and TLR13 were identified through database search based on TIR 
domain homology, but up to now, no specific ligands have been found. Humans only 
have a tlr12 pseudogene in the orthologous position and also lack a TLR13 ortholog 
(Tabeta et al., 2004). 
 
In summary, a set of different TLRs recognize quite a number of diverse conserved 
patterns from all kinds of pathogens – ranging from DNA structures to cell membrane 
or cell wall components, with a growing list of newly identified TLR ligands and 
receptors interacting with each other. This quite simple strategy enables the innate 
immune system to effectively fight against invading pathogens. Moreover, TLRs are 
able to tailor the innate responses to pathogens by engaging different signaling 
pathways involving specific usage of adaptor and regulative molecules by the different 
TLRs. 
 
TLR signaling pathways 
TLR signaling cascade 
The TLRs belong to a superfamily that includes the interleukin-1 receptors, based on 
the considerable homology in the cytoplasmic region: TLRs and IL-1Rs have a 
conserved region of about 200 amino acids in their cytoplasmic tails, which is known 
as the Toll/IL-1 (TIR) domain (Slack et al., 2000). Within the TIR domain, three 
conserved, highly homologous boxes are crucial for signaling. By contrast, the 
extracellular regions of the IL-1Rs and the TLRs differ noticeable. The extracellular 
region of IL-1Rs contains three immunoglobulin-like domains, the extracellular region 
of TLRs contains 19 to 25 tandem copies of leucin-rich repeat (LRR) motifs, each 
repeat consisting of 24 to 29 amino acids (Bell et al., 2003).  
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Upon ligand binding TLRs/IL-1Rs dimerize, thereby undergoing conformational 
changes required for the recruitment (Figure 2) of the adaptor molecule MyD88 
(myeloid differentiation primary-response protein 88). MyD88 consists of a C-terminal 
TIR domain, which interacts with the TIR domain of the receptor, and a N-terminal 
death domain (DD), which interacts homophilic with the DD of a serin/threonin 
protein kinase, IRAK4 (IL-1R-associated kinase 4) (Muzio et al., 1997; Wesche et al., 
1997; Burns et al., 1998). Binding to MyD88 enables IRAK4 to phosphorylate the 
subsequently recruited IRAK1, thereby inducing the activation of its kinase activity 
(Li et al., 2002; Suzuki et al., 2002). Autophosphorylation of IRAK1 then allows 
TRAF6 (tumor-necrosis factor (TNF)-receptor-associated factor 6) to bind to this 
complex (Ye et al., 2002). Subsequently, the IRAK1-TRAF6 complex disengages 
from the receptor and interacts at the plasma membrane with another preformed 
complex consisting of TAK1 (transforming growth factor-β(TGF-β)-activated kinase), 
TAB1, and TAB2 or TAB3 (TAK1-binding proteins). This interaction induces 
phosphorylation of TAB2/TAB3 and TAK1, leading to their translocation to the 
cytoplasm together with TRAF6 and TAB1, whereas IRAK1 is degraded at the plasma 
membrane. In the cytoplasm, TAK1 is then activated, resulting in the activation of 
IKKs (IκB kinases), which then phosphorylate the IκBs. This phosphorylation allows 
ubiquitylation and subsequent degradation of IκB, thereby releasing NF-κB (nuclear 
factor-κB). NF-κB is consequently free to translocate into the nucleus and induce the 
expression of its target genes. 
 
Activation of TAK1 also results in the activation of the MAP (mitogen-associated 
protein)-kinases ERK (extracellular-regulated kinase) and p38 as well as the SAP 
(stress-associated protein)-kinase JNK/SAPK (JNK for JUN N-terminal kinase), 
finally leading to the phosphorylation and activation of Jun and Fos, which together 
form the AP-1 (activator protein 1) transcription factor (reviewed in Akira and Takeda, 
2004). 
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MyD88-dependent and -independent pathways  
In MyD88-knockout mice (MyD88-/-), cell activation in response to most TLR-
mediated stimuli is completely abolished (Kawai et al., 1999). Thus, MyD88-/--mice do 
not produce TNF or IL-6 when exposed to IL-1 or microbial components which are 
recognized by TLR2, TRL4, TRL5, TLR7 or TLR9 (Adachi et al., 1998; Takeda et al., 
2003). However, LPS stimulation of MyD88-/- macrophages still results in the 
activation of NF-κB and MAPK, although with delayed kinetics (Kawai et al., 1999). 
Moreover, co-stimulatory molecules such as CD40, CD80 and CD86 are upregulated, 
and proliferation of T cells is induced in MyD88-/-- but not in TLR4-/--derived BMDCs 
upon LPS treatment (Kaisho et al., 2001). These observations suggested the existence 
of a TLR4-dependent but MyD88-independent signaling pathway.  
 
Recently, additional receptor-proximal adaptor proteins, all of which have TIR 
domains, have been described: TIRAP (TIR-domain containing adaptor protein, also 
known as MyD88-adaptor-like protein, MAL) (Horng et al., 2001; Fitzgerald et al., 
2001), TRIF (TIR-domain-containing adaptor protein inducing IFN-β; also known as 
TIR-domain-containing molecule 1; TICAM1) (Yamamoto et al., 2002b; Oshiumi et 
al., 2003a) and TRAM (TRIF-related adaptor molecule, also known as TIR-domain-
containing molecule 2; TICAM2) (Bin et al., 2003; Oshiumi et al., 2003b; Yamamoto 
et al., 2003b; Yamamoto et al., 2003b; Fitzgerald et al., 2003). 
TIRAP is involved in signaling of TLR2, TLR4, TLR6 and TLR1 (Horng et al., 2002) 
and is required for cytokine production upon stimulation via these TLRs but only in 
the presence of MyD88 (Yamamoto et al., 2002a). These results indicate that TIRAP is 
essential for MyD88-dependent signaling initiated by TLR2 and TLR4, but does not 
participate in the MyD88-independent pathway.  
TRIF mediates MyD88-independent signaling via TLR3, but is also partially involved 
in TLR4-signaling (Hoebe et al., 2003; Yamamoto et al., 2003a): TRIF is essential for 
TLR4-mediated activation of the MyD88-independent pathway leading to the 
production of type I interferons (IFN-/β), whereas the TLR4-mediated production of 
inflammatory cytokines requires both, MyD88-dependent and MyD88-
independent/TRIF-dependent signals. In the TRIF-dependent pathway involved in 
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TLR3 and TLR4-signal transduction, the IRF family of transcription factors plays a 
role. 
Interestingly, TRAM participates specifically in the activation of the MyD88-
independent/TRIF-dependent signaling pathway through TLR4 but not TLR3 
(Fitzgerald et al., 2003; Oshiumi et al., 2003b), and both, TRAM and TRIF are 
required for the TLR4-mediated induction of inflammatory cytokines although the 
precise mechanisms remain to be determined (Yamamoto et al., 2003b). An exiting 
recent finding demonstrates, that for the MyD88-independent LPS signaling via 
activation of the TRIF-TRAM pathway CD14 – formerly thought to simply 
concentrate the LPS signal via TLR4 – is absolutely required (Jiang et al., 2005).  
In conclusion, the process of NF-κB activation downstream of TLR4 ligation is rather 
complex, with the early response involving MyD88 and TIRAP, leading to the 
production of inflammatory cytokines, and the later response involving TRAM and 
TRIF, allowing the induction of an additional set of genes, including antiviral genes, 
such as interferon-α and -β. 
 
Altogether, MyD88 is the most universal adaptor protein, since it triggers signals from 
all known TLRs and from the IL-1 and IL-18 receptors. Bone-marrow derived 
dendritic cells from MyD88-/- mice reveal a markedly reduced cytokine secretion in 
response to most PAMPs (Kawai et al., 1999) which emphasizes the importance of 
MyD88 in TLR signaling. 
 
Other molecules involved in TLR signaling  
Additionally to the described molecules, other intracellular proteins seem to be 
involved in TLR-signaling pathways. TOLLIP (Toll-interacting protein), for example, 
is able to bind to the TIR domain of IL-1Rs, TLR2 and TLR4, once the receptors are 
activated. In the non-activated situation, TOLLIP suppresses the onset of the TLR-
signaling cascade: by forming a complex with IRAK1, it blocks the kinase activity of 
IRAK1 thereby preventing the NF-κB activation. Upon ligand binding to the TLR, the 
TOLLIP-IRAK1 complex is recruited to the receptor, finally leading to the 
dissociation of TOLLIP (Burns et al., 2000; Zhang and Ghosh, 2002).  
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Pellino was first identified in Drosophila, were it binds to the IRAK-homologue, Pelle 
(Grosshans et al., 1999). In mammalians, Pellino forms a complex with IRAK1 after 
TLR/IL-1R stimulation (Yu et al., 2002). However, Pellino lacks any domain capable 
of enzymatic activity, and is therefore thought to function as a scaffolding protein 
facilitating the release of phosphorylated IRAK from the receptor (Akira and Takeda, 
2004). Among the other molecules potentially involved in TLR-signaling pathways are 
phosphatidylinositol 3-kinase (PI3K) (Koyasu, 2003; Li et al., 2003), evolutionarily 
conserved signaling intermediate in Toll pathways (ECSIT) (Kopp et al., 1999; Xiao et 
al., 2003), SRC-familiy tyrosine kinases (Jefferies et al., 2003; Meng and Lowell, 
1997) and MPKKKs  (Dumitru et al., 2000; Huang et al., 2004).  
The way, how a given PAMP elicits and modulates the immune response is obviously 
quite complex. Not only different pathways are involved upon ligation of a specific 
TLR, but also different TLRs are known to act together to provoke immune responses. 
The list of the described signaling molecules is by no means complete and it certainly 
remains exciting which insights in the orchestrating of “specialized proteins” will be 
discovered. 
 
Negative regulation of TLR signaling 
Although inflammatory responses are critical to control the growth of pathogens 
(Hagberg et al., 1984; Shahin et al., 1987; Eden et al., 1988; Cross et al., 1995), 
excessive production of inflammatory cytokines as a result of TLR signaling causes 
live-threatening systemic disorders (Beutler et al., 1985; Danner et al., 1991), such as 
endotoxic shock, which can be induced by the TLR4 ligand LPS. Organisms therefore 
evolved strategies to modulate their TLR-mediated responses. Chronically repeated 
exposure to endotoxin or LPS transiently increases the tolerance against a endotoxin 
challenge (Beeson and With the Technical Assistance of Elizabeth Roberts, 1947; 
Greisman et al., 1966; Ziegler-Heitbrock, 1995) and preexposure to LPS in vivo and in 
vitro results in a transient state of hyporesponsiveness to subsequent stimulation with 
LPS (Munoz et al., 1991; Setrakian et al., 1994). This endotoxin (LPS) tolerance is a 
negative feedback mechanism to protect from endotoxic shock (Henricson et al., 1990; 
Gustafson et al., 1995; Salkowski et al., 1998). During this process, TLR4 is 
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downregulated (Nomura et al., 2000) and NF-κB activation is decreased (Goldring et 
al., 1998; Kastenbauer and Ziegler-Heitbrock, 1999). So far, several cytoplasmic 
molecules are known to negatively regulate TLR signaling.  
An alternative spliced truncated form of MyD88, termed MyD88s, is induced upon 
LPS treatment and lacks a short intermediate domain separating the DD and TIR 
domains (Janssens et al., 2002). MyD88s is unable to bind to IRAK4 and to promote 
IRAK1 phosphorylation leading to the shutdown of LPS-induced NF-κB activation 
(Burns et al., 2003). Another negative regulator is IRAK-M (Kobayashi et al., 2002) 
which is expressed in monocytes and macrophages following stimulation with various 
TLR ligands. IRAK-M, which lacks kinase activity, prevents the dissociation of the 
IRAK1-IRAK4 complex from MyD88, thereby preventing the formation of the IRAK-
TRAF6 complex (reviewed in Janssens and Beyaert, 2003 and Akira and Takeda, 
2004). Proteins of the SOCS (suppressor of cytokine signaling) family are induced by 
cytokines and negatively regulate their signaling pathways (Yasukawa et al., 2000). 
Although the exact mechanism is unknown, SOCS1 is thought to directly 
downmodulate TLR-signaling pathways by interacting with IRAK1 (Stoiber et al., 
1999; Dalpke et al., 2001; Kinjyo et al., 2002; Nakagawa et al., 2002). Interestingly, 
also membrane-bound molecules that contain TIR domains have recently been shown 
to negatively regulate TLR signaling. SIGIRR (single immunoglobulin IL-1R-related 
molecule) transiently interacts with TLR4, IRAK1 and TRAF6, and SIGIRR-deficient 
mice are hypersensitive to LPS-induced endotoxic shock (Wald et al., 2003). ST2 
associates with MyD88 and TIRAP, and overexpression of ST2 inhibits NF-κB 
activation. ST2-deficient mice show an increased secretion of inflammatory cytokines 
upon LPS stimulation and are unable to induce LPS tolerance.   
Altogether, LPS tolerance is of great benefit by preventing exaggerated inflammatory 
responses and shock syndrome. But it can also cause major problems in the treatment 
of patients that recover from septic shock. Here, hyporesponsiveness to LPS leads to a 
severely reduced host defence during opportunistic infections leading to high mortality 
(Docke et al., 1997). 
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The role of another signaling adaptor molecule, DAP12 (KARAP), containing an 
immunoreceptor tyrosine-based activation motif (ITAM) is discussed controversially. 
Hamerman et al. observed enhanced TLR responses in the absence of DAP12. DAP12-
deficient macrophages produced increased amounts of inflammatory cytokines in 
response to a variety of TLR ligands and DAP12-deficient mice were more susceptible 
to endotoxic shock and showed enhanced resistance to bacterial infections (Hamerman 
et al., 2005). However, Turnbull et al. found that DAP12-/--mice have improved 
survival from endotoxemia as well as from septic peritonitis and decreased acute phase 
responses during sepsis arguing that DAP12 signaling increases the response to 
microbial products leading to higher mortality rates (Turnbull et al., 2005).  
 
Recently, TRIAD3A, a RING-finger E3 ligase, has been shown to promote 
ubiquitylation of TLR4 and TLR9, targeting these TLRs for degradation and thereby 
negatively regulating the intensity and duration of TLR signaling (Chuang and 
Ulevitch, 2004). 
RP105 (radioprotective 105) joins the list of direct negative regulators of TLR 
signaling, but it is unique in its specificity for TLR4. RP105 is a TLR4 homologue and 
like TLR4 whose surface expression and signaling depends upon co-expression of the 
secreted protein MD-2, surface expression of RP105 is dependent upon co-expression 
of the MD-2 homologue, MD-1. Moreover, the expression pattern of RP105 correlates 
with that of TLR4. However, RP105 lacks a signaling domain. The RP105:MD-1 
complex was shown to directly interact with the TLR4:MD-2 signaling complex, 
thereby inhibiting the ability of the latter one to bind its ligands. Additionally, RP105 
regulated responses to endotoxin in vivo emphasizing its role as physiological negative 
regulator of TLR4 responses (Divanovic et al., 2005b; Divanovic et al., 2005a). 
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TLRs and cross-presentation  
As discussed earlier, cross-presentation enables exogenous antigens to be routed for 
presentation on MHC class I molecules allowing their recognition by CD8+ T cells and 
is therefore important for the development of CD8+ CTL responses against tumors and 
infectious pathogens that do not directly infect APCs. Activation of TLRs on APC 
induces upregulation of co-stimulatory molecules and cytokine production, thereby 
shaping an adaptive immune response. For, when present during their priming, TLR 
ligands increase proliferation and cytotoxicity of CTLs responding to foreign antigens 
(Schwarz et al., 2003; Reis e Sousa, 2004). Moreover, TLRs seem to play a role in 
mediating cross-priming by DCs. In an in vitro cross-presentation model, TLR3 and 
TLR9 ligands enhanced cross-presentation by mature DCs (Datta et al., 2003). In vivo, 
immunization experiments of mice with virus-infected cells or cells containing 
synthetic dsRNA revealed the role of TLR3 in promoting cross-priming of CTLs 
against viruses (Schulz et al., 2005). Triggering of TLR9 by immunostimulatory CpG 
DNA is able to induce in vivo CTL responses in the absence of CD4+ T cell help (Cho 
et al., 2000; Horner et al., 2001). The TLR involvement appears to replace the CD40-
CD40L interaction between APCs and CD4+ T cells that is necessary for cross-
presentation (Bennett et al., 1997; Schoenberger et al., 1998; Albert et al., 2001). But 
still, the mechanisms underlying TLR-induced cross-presentation are not fully 
understood. It is independent of endosomal acidification and involves the cytosolic 
antigen processing machinery, including TAP (transporter associated with antigen 
processing) (Cho et al., 2002). Covalent linkage of antigen to immunostimulatory CpG 
DNA reveals that TLR9 has no impact on the observed enhanced antigen-uptake of 
these conjugates, but is required for APC activation and maturation downstream of 
endocytosis and subsequent cross-priming of CD8+ T cells. Wildtype but not TLR9-
deficient DCs were able to upregulate CD40 and CD80 and to secrete inflammatory 
cytokines upon uptake of the CpG-antigen conjugates, and wildtype but not TLR9-
deficient mice generated specific CTL responses to the conjugates (Heit et al., 2003). 
Further investigation emphasizes the involvement of TLR ligands in CTL cross-
priming by showing that the TLR signaling adaptor molecule MyD88 is required for 
cross-priming (Palliser et al., 2004). Recently, immature DCs were demonstrated to 
present processed antigen from captured purified protein in association with class I 
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MHC molecules in the presence of poly(I:C), but not of LPS. Thus, priming of 
antigen-specific CD8+ CTLs with purified viral protein in vivo is dependent on the use 
of an appropriate stimulus or involvement of an appropriate TLR, respectively 
(Fujimoto et al., 2004).   
 
The ability of TLR ligands as non-specific stimuli to mediate cross-presentation by 
DCs bears the risk of ‘innate autoimmunity’, whereby non-specific stimuli break 
cross-tolerance to self-antigens by converting tolerogenic DCs presenting peripheral 
self antigens into autoimmunogenic DCs (Vella et al., 1995; Vezys and Lefrancois, 
2002; Walker and Abbas, 2002; Beutler, 2004); described in TLR and disease section). 
However, this scenario is discussed very controversially (Hamilton-Williams et al., 
2005), for maintenance of self-tolerance is one of the basic concerns of both, the innate 
and the adaptive immune system. 
 
TLRs and human diseases 
Toll-like receptors play a critical role in both innate and adaptive immune responses. It 
is therefore not surprising that TLR functions also affect human diseases. For example, 
septic shock is caused by the overwhelming secretion of inflammatory cytokines as a 
result of LPS triggered TLR4 responses upon uncontrolled systemic bacterial 
infection. On the other hand, TLR polymorphisms can lead to insufficient TLR 
functions and increased risk of bacterial infections as observed for altered TLR4 and 
TLR2 (reviewed in Cook et al., 2004). The same is true for mutations in TLR signaling 
molecules that result in impaired TLR signaling (Picard et al., 2003).  
Surprisingly, TLR4 has been put in the context of atherosclerosis. Abundant TLR4 
mRNA and protein were found in atherosclerotic plaques compared to unaffected 
vessels (Xu et al., 2001). And a role for TLR4 in DC-mediated lesion progression is 
suggested by the finding that mouse DCs loaded with a heart-specific peptide can 
induce myocarditis in a TLR-dependent manner (Eriksson et al., 2003). Accelerated 
atherosclerosis, which is frequently observed in systemic lupus erythematosus (SLE), 
seems to be mediated through modified endogenous lipoproteins that involve TLR 
triggering. Minimally modified-LDL (MM-LDL) induces activation of macrophages 
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and endothelial cells via TLR4 (Miller et al., 2003; Walton et al., 2003), and saturated 
but not polyunsaturated fatty acids can activate macrophages through TLR4 (Lee et al., 
2003b).  
Polymorphism of TLR4 is additionally linked to asthma, although the underlying 
mechanisms are not fully understood and may involve regulatory T cells (Caramalho 
et al., 2003; Higgins et al., 2003). Paradoxically, exposure to LPS and other TLR 
ligands in early childhood decreases the incidence of asthma later in life (Braun-
Fahrlander et al., 2002; Gehring et al., 2002; Braun-Fahrlander, 2003). 
 
TLRs are also discussed to play a role in breaking cross-tolerance to self-antigens 
(Figure 3). In such a scenario, lymphocytes with low affinity for self antigen may 
overcome their state of ignorance in some circumstances upon action of a strong 
stimulus. This stimulation can occur if self structures are recognized by TLRs during 
alterations in the overall body composition such as infection or hormonal changes. 
Triggering by TLRs provides the co-stimulation that is necessary for the activation of 
autoreactive lymphocytes but missing under normal conditions. One example is the 
unmethylated CpG motif in DNA recognized by TLR9. Although much more common 
in bacterial DNA, it can be enriched in activated mammalian cells with substantial 
DNA demethylation. Extensive cell death coupled with insufficient clearance of 
apoptotic bodies drives B lymphocytes specific for DNA to internalize the CpG DNA 
present in these immune complexes via their BCR and to accumulate it in the 
endosomal compartment. Here, it encounters TLR9 which is then activated by a 
sufficient concentration of CpG. This activation signal together with the signal 
provided by the BCR finally activates the previously ignorant B cells to secrete 
antibodies directed against self (Leadbetter et al., 2002; Viglianti et al., 2003).  
 
Although genetical susceptibility must be considered, this pathway is thought to 
explain systemic autoimmunity that commonly implies DNA-related autoantigens. An 
example might be systemic lupus erythematosus (SLE), in which chromatin and DNA 
enriched in guanine/cytosine content (Sano and Morimoto, 1982) are the major targets 
of autoreactive lymphocytes in these patients.  
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However, the high risk of ‘innate autoimmunity’ questions the discussed (Walker and 
Abbas, 2002; Vezys and Lefrancois, 2002; Beutler, 2004) ability of TLR ligands as 
non-specific stimuli to convert tolerongenic DCs presenting peripheral self antigens 
into autoimmunogenic DCs. It would imply that cross-tolerance is regularly converted 
into autoimmunity by infections with pathogens capable to signal via TLRs or from 
the use of TLR-ligands as vaccine adjuvants. Instead, self-tolerance is a rather robust 
state with multiple checkpoints (Arnold et al., 1993; Andre et al., 1996; Heath and 
Carbone, 2001; Hamilton-Williams et al., 2005). Moreover, it was demonstrated very 
recently that DC activation by TLR ligands is not sufficient to break peripheral cross-
tolerance in the absence of antigen-specific CD4+ T cell help. Without such help, 
Figure 3. Schematic representation of a possible mechanism of TLRs breaking ignorance 
to self-antigens. In ignorant B cells, BCR signaling upon encounter of CpG containing dsDNA 
autoantigen is unsufficient to trigger activation. In a situation of autoimmunity, the BCR is 
thought to shuttle and accumulate the autoantigen into an intracellular, TLR9 habouring 
compartment, thus promoting recognition of the CpG motif by TLR9 leading to TLR9 signaling 
via a MyD88-dependent pathway. Only the interplay of both, TLR9 signaling and BCR 
signaling, activates the B cell thereby subverting the ignorate state toward autoimmunity. 
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autoreactive CTLs are deleted despite of persisting self antigen presence. 
Autoimmunity only occurred by stimulating the early effector phase of autoreactive 
CTLs when their precursor frequency was unphysiologically high (Hamilton-Williams 
et al., 2005). 
In contrast, the ability of TLRs to directly activate DCs makes them promising 
candidates for their use in vaccine design and in the development of novel adjuvants 
for vaccine therapy. Thus, linking the polysaccharide of Haemophilus influenzae type 
b (Hib) to a Hib outer membrane protein complex elicits protective immunity 
(Donnelly et al., 1990) by the direct engagement of TLR2 (Latz et al., 2004a). In 
regard to the development of novel adjuvants, the adjuvant effect of LPS could be 
addressed to its lipid A structure, and equivalent derivatives, such as monophosphoryl 
lipid A (MLA), are far less toxic but still trigger via TLR4 maintaining their 
immunomodulatory capacity (reviewed in Persing et al., 2002). Furthermore, CpG 
DNAs, known to trigger TLR9, are under intensive investigation for their use as 
adjuvants: in a recent clinical study, CpG DNA was shown to enhance the 
immunogenicity when added to a hepatitis B vaccine (Cooper et al., 2004). Thus, a 
detailed understanding of TLR involvement in the development of human diseases 
enables promising immunotherapeutic strategies for treatment or even prevention of 
diseases.  
Other pattern recognition receptors 
Besides the TLR, the innate immune system uses a broad range of pattern recognition 
receptors. These comprise not only proteins that are expressed on the cell-surface but 
also cytosolic proteins and even secreted ones. Mannan-binding lectin (MBL), C-
reactive protein (CRP) and serum amyloid protein (SAP) are such soluble PRRs. They 
are produced by the liver and belong to the acute phase proteins, which are released 
into the blood stream early during infection. These receptors recognize cell wall 
compounds of pathogens, such as the phosphocholine portion of certain bacterial and 
fungal cell-wall lipopolysaccharides in the case of CRP or terminal mannose residues 
on the surface of many bacteria and some viruses, including the human 
immunodeficiency virus (HIV). Binding of the equivalent PAMP results in its 
opsonization as well as in the activation of the complement cascade.  
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
60 
Among the secreted PRR are LBP (Lipopolysaccharide binding protein) and CD14, 
both of which are involved in the recognition of LPS. CD14 not only exists in the 
soluble form, but is rather anchored in the cell membrane. The class of cell surface 
PRRs comprises further more the macrophage mannose receptor (Fraser et al., 1998) 
and dectin-1 (Brown et al., 2002), that recognize bacterial and yeast surface 
carbohydrates. MARCO (macrophage receptor with collagenous structure) binds to 
bacterial cell walls. Macrophage scavenger receptors (MSR) show a broad binding 
specificity for polyanions including LPS, dsRNA, oxidized LDL and lipoteichonic 
acid. Mice deficient in MSR have an increased susceptibility to bacterial and viral 
infections (Suzuki et al., 1997) suggesting a role for MSRs in host defense against 
pathogens. 
In the cytosol, several PRRs are known to be involved in antiviral responses. Inside the 
cell, viruses use the host’s cell machinery for their replication. At some point during 
the replication cycle of most viruses, double stranded RNA is produced, which is 
recognized by PKR (IFN-inducible dsRNA-dependent protein kinase) (reviewed in 
Clemens and Elia, 1997). Activated PKR inhibits the eukaryotic translation initiation 
factor EIF-2 by phosphorylation and thereby blocks further viral replication. 
Additionally, the induction of type I interferons (IFN-α/β) is partly dependent on PKR 
(Diebold et al., 2003). These antiviral effector molecules interfere with viral 
replication, thereby blocking the spread of viruses to uninfected cells. 
Intracellular recognition of bacteria involves the cytosolic proteins NOD1 and NOD2 
(Nucleotide-binding oligomerization domain proteins), which bind to distinct 
structures derived from peptidoglycan which are not ligands for TLRs (reviewed in 
Ulevitch, 2004). NOD proteins initiate cell activation through a multi-protein complex 
called inflammasome (Martinon and Tschopp, 2004), finally leading to the activation 
of NF-κB. 
The list of above mentioned PPRs is not exhaustive, and even more PPRs are certain to 
be discovered, now, the field of innate immune recognition gained new interest with 
the discovery and characterization of the Toll-like receptors. 
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Links between innate and adaptive immunity  
For a long time, the immune system was thought to function by discriminating 
between self and nonself. Burnet’s original self-nonself (SNS) model (Burnet, 1959) 
suggested that this discrimination is exclusively performed by cells of the adaptive 
immune system. Lymphocytes recognize foreign structures by their single-specific 
surface receptor, leading to their activation and to the initiation of an immune 
response. The finding that nonidentical cattle twins are mutually tolerant of each 
other’s blood cells (Owen, 1945) led to the conclusion that lymphocytes learn the 
definition of self early in life. This model was supported by Medawar’s experiments, 
in which adult mice accept foreign skin grafts if they had been injected as babies with 
cells from the donors (Billingham et al., 1953). However, it had to be modified due to 
the findings that for both B and T lymphocytes, the recognition of their specific 
antigen is not sufficient for activation. Instead, B lymphocytes die upon antigen 
recognition (signal one) unless they are rescued by help (signal two) (Bretscher and 
Cohn, 1970), a trick which eliminates potential autoreactive B cells. This help was 
later found to be provided by T helper cells. In 1975, Lafferty and Cunningham 
proposed that T helper cells as well need a “signal two” for activation (Lafferty and 
Cunningham, 1975). They receive this co-stimulatory signal from stimulator cells, 
today known as antigen-presenting cells (APC). APCs provide the co-stimulatory 
signal through the specific interaction of their co-stimulatory surface molecules, such 
as CD80 or CD86, with the equivalent receptors on the T cells, such as CD28 
(Schwartz, 1990; Jenkins et al., 1991; Harding et al., 1992). Upon this interaction, T 
cells express the IL-2 receptor and produce IL-2, and the autocrine action of this 
cytokine leads to proliferation and differentiation of the activated T cells into armed 
effector T cells. 
However, APCs themselves need to be activated in order to be able to deliver co-
stimulation to naïve T cells (Krieger et al., 1986). They ingest all sorts of self and 
foreign substances at infection sites and then upregulate co-stimulatory signals on 
activation through innate immune receptors, the pattern recognition receptors (PRR) 
that recognize conserved pathogen-associated molecular patterns (PAMPs). Thus, the 
induction of an adaptive immune response is dependent on innate immune 
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mechanisms, which do not show diversified antigen-specificity and, consequently, are 
not able to distinguish between all kinds of self and nonself. In 1989, Janeway 
therefore proposed in the infectious-nonself (INS) model that APCs discriminate 
between “infectious-nonself” and “non-infectious-self” (Janeway, Jr., 1989) via the 
limited set of PRRs. The activation status of the antigen-presenting cell has a key 
function for the decision whether an antigen specific T cell becomes activated or 
anergic. The role of adaptive and innate immunity had to be reconceived and the 
dichotomy separating both had to be overtaken: the ancient innate immune system is a 
prerequisite for the triggering of the sophisticated adaptive immune system. 
 
In an orchestrated interplay, the PRRs, such as TLRs, link innate and adaptive immune 
responses: innate recognition of PAMPs through TLRs initiates an inflammatory 
response leading to the recruitment of cells to the infection sites. Activation of TLRs 
induces the expression of diffusible chemotactic factors and cell surface adhesion 
molecules attracting innate immune cells, such as monocytes, neutrophils, basophils, 
eosinophils and NK cells as well as adaptive immune cells, and facilitating their 
migration to the inflamed tissue (Huang et al., 2001). Monocytes express a variety of 
TLRs, and upon activation the infiltrating monocytes can differentiate into either tissue 
macrophages or DCs that contribute to the generation of adaptive immunity. TLR 
triggered activation of DCs having captured microbial antigens leads not only to the 
upregulation of co-stimulatory and MHC molecules but also to a switch in chemokine 
receptor expression and to the secretion of cytokines and chemokines finally resulting 
in the generation of effector responses including T helper cell and CTL responses. In 
this process, different DC populations respond only to the pathogens they have 
appropriate TLRs for. And even when triggered by the same ligand, the outcome of the 
TLR stimulation can differ dependent on the DC subtype: stimulation with synthetic 
TLR7 agonists or with certain synthetic oligonucleotides containing CpG motifs 
induces pDCs to secrete IFN-α and mDCs to secrete IL-12 (Ito et al., 2002; Hemmi et 
al., 2003). This impressively shows how DC-mediated control of T cell activation is 
dependent on innate PRRs (reviewed in Iwasaki and Medzhitov, 2004). The finding 
that TLRs play a role in cross-presentation by dendritic cells and concomitant cross-
priming of cytotoxic T cells further supports the idea that adaptive immune responses 
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are mediated or shaped by innate PRRs able to discriminate between infectious non-
self and non-infectious self.  
 
But in 1994, Matzinger changed the points of view and introduced her danger model: 
the primary driving force for the immune system is the need to detect and protect 
against danger (Matzinger, 1994). Danger signals not only arise exogenously by 
pathogens, but also endogenously by nonforeign alarm signals that derive from cells 
and tissues which are stressed, virally infected or killed necrotically, but not by healthy 
cells or those dying apoptotically (Gallucci and Matzinger, 2001). These endogenous 
danger signals include heat-shock proteins, mammalian DNA (Ishii et al., 2001) or 
RNA released by necrotic cells, type-I interferons produced by virus-infected cells, 
CD40L on the surface of activated T cells, reactive oxygen intermediates, 
neuromediators, hyaluron and other extracellular-matrix breakdown products after 
vessel damage (Gallucci et al., 1999). In the danger model, the PRRs from the 
Janeway INS models are considered as sensors for exogenous danger signals. But 
additionally, the danger model is able to explain situation of dangerous self, caused for 
example by some mutations, and harmless foreign, including, e.g., fetuses. Moreover, 
it also tries to explain autoimmunity by suggesting that at least some autoimmune 
diseases may arise by mutations in genes changing for example the normal clearance 
processes, or by pathogens or toxins causing cellular stress or death. In these 
circumstances the immune system is doing its job by responding to alarm signals, but 
to the harm of the host (Matzinger, 2002).  
 
Although the necessity for co-stimulation largely controls the adaptive immune 
system, a small subset of T cells powerfully contributes additionally to the regulation 
of adaptive immune responses. They were originally termed suppressor T cells in the 
early 1970s as being able to suppress autoimmune responses (Gershon, 1975; Gershon 
et al., 1972). Today, these CD4+ CD25+ cells are more accurately conferred to as 
regulatory T cells according to their function in the control of immunopathological 
responses directed against self or foreign antigens (Maloy and Powrie, 2001). Until 
now it is not fully understood how regulatory T cells act on and how they affect their 
target cells to dampen responsiveness. They are able to prevent autoimmune disease in 
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vivo, and can suppress T-cell proliferation in response to a specific antigen or to 
allogeneic stimulator cells in vitro. Suppression seems to be mediated by multiple 
mechanisms including direct cell-cell contact between regulatory T cells and the target 
cells as well as indirect action through soluble factors. Regulatory T cells secrete the 
anti-inflammatory cytokines IL-10 and TGF-β, which inhibit T-cell proliferation and 
render dendritic cells unable to promote T-cell activation (Janeway, Immunobiology, 
6th edition). However, it has been reported recently that TLR signals can influence 
adaptive response by blocking the suppressive effect of regulatory T cells on effector 
T cells. This mechanism is independent of co-stimulation and is instead mediated by 
IL-6 and at least one other soluble factor secreted by the activated APCs in responses 
to TLR activation. In vivo, the blockage of regulatory T cell function requires TLR 
activation on DCs, and other modes of DC activation such as inflammatory cytokines 
cannot substitute for this TLR-dependent signal (Pasare and Medzhitov, 2003; Yang et 
al., 2004). In contrast, Kubo et al. propose that the effect of proinflammatory cytokines 
produced by TLR-activated mature DCs is to reverse the state of anergy of regulatory 
T cells rather than to overcome regulatory T cell suppression (Kubo et al., 2004). 
Conversely, pathogens are known to trigger Toll-like receptor pathways to modulate 
regulator T cell responses toward their own benefits (Higgins et al., 2003; Netea et al., 
2004). On the other hand, regulatory T cells themselves express different Toll-like 
receptors, such as TLR4, 5, 7, and 8. Without the aid of any APCs, they can be 
activated by LPS which even increases their suppressive activity on CD4+ T cells in 
vitro (Caramalho et al., 2003). 
 
The ideas of Janeway and Matzinger that innate immune recognition is a prerequisite 
as well as a control for adaptive immunity have proven true by the exciting discoveries 
of the nexus of TLR-mediated activation and T cell function. But still, there are many 
secrets to be discovered! 
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Outline of this Thesis 
In the past years, the knowledge in the exciting field of Toll-like receptors (TLR) and 
the understanding of how these proteins link innate and adaptive immunity grew 
dramatically.  
When the work on this thesis started in 2001, the controversial discussion about the 
involvement of TLR2 and TLR4-pathways in response to the bacterial cell wall 
component lipopolysaccharid (LPS) seemed to be resolved and it was commonly 
accepted that TLR2 recognizes LPS of Gram-positive bacteria and TLR4 that of 
Gram-negative bacteria. However, this rule seemed to be proven by exceptions. 
Therefore, one focus of interest of this thesis was the characterization of the receptor 
involved in the recognition of LPS species, which are regarded to be structurally 
and/or functionally atypical. The interesting observation that LPS from the Gram-
negative bacteria Legionella pneumophila as well as the bacteria as a whole signal via 
TLR2 and depend on CD14 is presented in Chapter 2.  
Another aim of this thesis was to elucidate a possible role of Toll-like receptors in the 
immune surveillance of invasive aspergillosis. The finding that antigens of the 
causative agent, Aspergillus fumigatus, use different TLRs to differentially induce the 
secretion of pro-inflammatory cytokines by dendritic cells (Chapter 3) emphasizes the 
complex role of TLRs in controlling adaptive immune responses. 
Other goals of this thesis were the characterization of the molecular basis by which 
heat shock protein Gp96:peptide complexes confer protective immunity against tumors 
or pathogens the peptide had derived from. The remarkable finding that Gp96-
mediated dendritic cell activation is triggered by TLRs (Chapter 4) and finally results 
in a CD8-biased T cell response (Chapter 5) revealed the importance of innate immune 
recognition for adaptive immune responses. To further address the issue of TLRs 
linking innate and adaptive immunity, we analyzed the contribution of TLR-mediated 
innate immune recognition to priming of cytotoxic T lymphocytes during the response 
against viral and minor H antigens. The promising results obtained are presented in 
Chapter 6.  
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In this study, we analyzed the activation of bone marrow-derived dendritic cells 
(BMDCs) from mice lacking the cd14-gene with purified Legionella pneumophila 
lipopolysaccharide and with viable or formalin-killed L. pneumophila. We found that 
low concentrations of LPS and doses of L. pneumophila that are relevant to infection 
are dependent on CD14 to activate BMDCs. Higher concentrations of LPS are able to 
overcome the lack of CD14 indicating that other receptors are involved. We, therefore, 
included studies using BMDCs from mice lacking functional TLR2 and/or TLR4 
molecules. We found that purified L. pneumophila LPS as well as L. pneumophila 
either viable or formalin-killed are able to activate BMDCs from TLR4-deficient 
C3H/HeJ mice but fail to activate BMDCs from TLR2-knockout mice. Our data show 
that not only purified LPS from L. pneumophila but also the micro-organism itself 
stimulate BMDCs via TLR2 and that this stimulation is dependent on CD14 in this 
mouse model. 
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Introduction 
Legionella pneumophila, the causative agent of Legionnaires’ disease, is an 
intracellular pathogen of alveolar macrophages. Pneumonia primarily occurs in 
immunocompromized hosts suffering from malignancies associated with monocyte 
dysfunction as well as in patients who receive immunosuppressive drugs. The 
mechanism by which L. pneumophila infection of the lung is controlled is not yet 
clear. L. pneumophila is relatively resistant to innate and humoral immune response. 
The protective effect of antibody production and polymorphonuclear cells is limited 
(Ciesielski et al., 1986; Conlan and Ashworth, 1986; Weeratna et al., 1994) and 
activation of complement does not result in inactivation or killing of the bacteria 
(Horwitz and Silverstein, 1981). Instead, cell-mediated immunity seems to be 
important for infection control. Initial investigations have demonstrated that 
lymphocytes from convalescents undergo proliferation and release cytokine activity 
into the cell culture supernatant after in vitro contact with formalin-inactivated 
legionellae (Plouffe and Baird, 1981; Plouffe and Baird, 1982; Horwitz, 1983; 
Friedman et al., 1984a; Friedman et al., 1984b). 
The induction of cell-mediated immunity crucially depends on the participation of 
dendritic cells (DCs) as professional antigen-presenting cells (APCs) which are able to 
display processed antigens on MHC molecules. This was shown recently also for the 
presentation of L. pneumophila derived antigens (Neild and Roy, 2003). In addition, 
upon first encounter with the pathogen, DCs are stimulated to mature and thereby to 
secrete pro-inflammatory cytokines. This is initiated by the recognition of conserved 
structures of the pathogen, the PAMPs (pathogen associates molecular patterns) by a 
set of pathogen recognition receptors (PRR) such as Toll-like receptors (TLRs).  
In this way, lipopolysaccharide (LPS) from the cell wall of Gram-negative bacteria 
triggers innate effector functions. Several molecules on the surface of innate immune 
cells are involved in this process. They include the LPS-binding protein (LBP) (Antal-
Szalmas, 2000), which interacts with the GPI-anchored cell surface protein CD14 
(Wright et al., 1990; Golenbock et al., 1993), the signal transducing molecule TLR4 
(Poltorak et al., 1998a) and the accessory molecule MD-2 (Shimazu et al., 1999). 
CD14 exists in two isoforms, the glycoxylphosphatidylinositol (GPI) anchored 
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membrane protein and the soluble serum protein (Ulevitch and Tobias, 1994) and both 
froms of CD14 can be involved in LPS signalling (Antal-Szalmas, 2000).  
So far, the requirement for TLR4 is observed for all LPS types derived from bacteria 
belonging to the Enterobacteriaceae. However, recent studies have also shown that the 
LPS of some Gram-negative bacteria like Rhizobium and Legionella require TLR2 
rather than TLR4 (Girard et al., 2003). In comparison to other Gram-negative bacteria, 
the lipopolysaccharide (LPS) of L. pneumophila exhibits unusual structural features 
(Zahringer et al., 1995; Helbig et al., 1995) which are predicted to be responsible for 
the interaction with TLR2 rather than with TLR4 molecules (Horwitz, 1983) and for 
the strongly reduced interaction with CD14 molecules on human monocytes 
(Neumeister et al., 1998). The latter study revealed that about 1000-fold higher 
concentrations of L. pneumophila LPS (LPS-Lp) as compared to Escherichia coli 
(LPS-Ec) or Salmonella enterica serovar Minnesota-derived LPS (LPS-Sm) had to be 
used in order to achieve comparable cytokine production. This difference correlated 
with the inability of LPS-Lp to compete with LPS-Ec for the binding to membrane 
bound-CD14 and to interact with soluble CD14 molecules. Since competition and 
binding experiments are limited to a certain range of LPS concentrations that can be 
used, it remained to be determined whether or not weak and, therefore, so far 
undetectable interactions with CD14 molecules still take place and contribute to the 
LPS-Lp-mediated activation of cells of the innate immune system.  
We, therefore, examined the contribution of CD14 and TLR molecules to the 
stimulation of bone marrow-derived dendritic cells (BMDCs) by purified LPS-Lp as 
well as by viable or formalin-killed L. pneumophila using mice lacking CD14 
molecules and different TLRs. Since LPS is the major pro-inflammatory constituent of 
the Gram-negative bacterial cell wall and is recognized by the host as main PAMP, we 
wondered whether intact bacteria are recognized by the same molecules as the purified 
LPS-Lp or if different TLRs are involved. We found for both purified LPS-Lp and 
intact bacteria that signal transduction involves CD14 molecules and strictly depends 
on TLR2 in our mouse model. 
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Materials and Methods 
Reagents and antibodies 
LPS from Salmonella typhimurium (LPS-Stm) was purchased from Sigma-Aldrich 
(Taufkirchen, Germany). LPS from L. pneumophila serogroup 1 (LPS-Lp) was 
extracted according to Moll et al. Phosphothioate-stabilized CpG oligonucleotide 1668 
(TCC-ATC-ACG-TTC-CTG-ATG-C) (ODN) was obtained from TIB MOLBIOL 
(Berlin, Germany). Palmitoyl-3-Cys-Ser-(Lys)4 (Pam3Cys) was obtained from EMC 
microcollections GmbH (Tübingen, Germany). 
 
Bacteria 
L. pneumophila serogroup 1 strain Pontiac (isolated from a patient with severe 
Legionella pneumonia and passaged less than three times on BCYE α-agar) was 
kindly provided by Prof. Dr. G Ruckdeschel (Munich, Germany).  
 
Generation of mouse dendritic cells 
Mouse immature DCs were generated from bone marrow of C3H/HeN, C3H/HeJ 
(Tularic Inc., South San Fransisco, CA, USA), BALB/c (Charles River, Sulzfeld, 
Germany) and C3H/HeJ/TLR2-/-, TLR2-/-, CD14-/- mice as previously reported 
(Vabulas et al., 2002b). C3H/HeJ/TLR2-/- and TL2-/- mice were generously provided 
by H. Wagner/K. Kirschning (Munich, Germany). CD14-/- mice were a kind gift from 
C. Schütt (Greifswald, Germany). For the generation of mouse bone marrow-derived 
DCs, Iscove’s Modified Dulbecco’s Medium (IMDM; BioWhittaker, Verviers, 
Belgium) was used supplemented with 2 mM L-glutamine (GibcoBRL Life 
Technologies, Paisley, UK), 100 IU/ml penicillin/streptomycin (GibcoBRL), 10% 
FCS (PAA, Linz, Austria) and 150 U/ml GM-CSF. Bone marrow cells from two mice 
were pooled and incubated in GM-CSF containing medium for 6-7 days and fresh 
medium with GM-CSF was replaced every 2 days. The obtained DCs were CD11c 
positive and CD14 negative.  
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Pre-treatment of mouse DCs prior stimulation 
Immature DCs (6-7days) derived from CD14-/- and B6 mice were washed three times 
with serum-free medium and were then stimulated either in the presence or absence of 
serum.  
For stimulation with bacteria, bone marrow cells were washed on day 4 with 
antibiotic-free medium; for all further steps, antibiotic free medium was used. 
 
Stimulation of mouse DCs 
Immature DCs were stimulated by addition of L. pneumophila LPS, S.typhimurium 
LPS, Pam3Cys or 1668 ODN in appropriate concentrations. For infection with L. 
pneumophila, the bacteria-to-cell ratio was adjusted to 10:1 and 1:1, respectively, 
using a 96-well tissue culture plate (Greiner, Frickenhausen, Germany). After 2 h of 
co-incubation at 37°C and 5% CO2, non-phagocytosed bacteria were killed by the 
addition of 75 µg/ml of gentamicin (Invitrogen, Eggenstein, Germany). After an 
additional incubation time of 20 h, supernatants were removed for detection of 
secreted cytokines. 
 
Detection of mouse cytokines 
Twenty hours after stimulation of mouse DCs, IL-6 and IL-12 (p40) concentrations in 
the cell culture supernatants were determined using standard sandwich ELISA 
protocols. Antibodies and recombinant cytokine standards were obtained from Becton 
Dickinson (Heidelberg, Germany). The capture antibody was bound to the ELISA 
plate (MaxiSorbTM, Nunc, Roskilde, Denmark), the biotinylated detection antibody 
was visualized by streptavidin-conjugated horseradish peroxidase and TMB substrate 
(Sigma) and the assay was read at 405 nm.  
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Results  
BMDC activation by L. pneumophila LPS requires CD14 
To investigate the role of CD14 during L. pneumophila LPS-induced activation, 
BMDCs derived from CD14 knockout mice and from BALB/c wild-type mice were 
stimulated with purified LPS from L. pneumophila in the presence or absence of FCS  
- which naturally contains soluble CD14 and LBP (Wright et al., 1990) and cell culture 
supernatants were analyzed for the secretion of IL-6 (Fig. 1) and IL-12 (data not 
shown).  
Low concentrations of L. pneumophila LPS (e.g. < 1 µg/ml) activated BMDCs in a 
CD14-dependent manner. Only higher concentrations of L. pneumophila LPS (10 
µg/ml) activated BMDCs via a CD14-independent way. In the presence of FCS, 
BMDCs derived from CD14 knockout mice were more susceptible to activation by L. 
pneumophila LPS; however, at 100 ng/ml, BMDCs from CD14 knockout mice 
produced also reduced amounts of IL-6 (Fig. 1B). As a control for a CD14-dependent 
stimulation, LPS from S. typhimurium was used. As CD14-independent stimuli, 
Pam3Cys and poly(I:C) were added to BMDCs.  
L. pneumophila interacts with CD14 
To analyze the effect of CD14 under more physiological conditions and to elucidate 
whether additional CD14-independent stimuli play a role in BMDC activation, we 
used viable and formalin-killed bacteria instead of purified LPS. Both, viable and 
formalin-killed Legionella bacteria were able to stimulate BMDCs derived from wild-
type mice to secrete IL-12 (Fig. 2) and IL-6 (data not shown). 
This stimulation was clearly CD14-dependent, since under serum-free condition the 
ability of BMDCs derived from CD14 knockout mice to respond to L. pneumophila is 
drastically reduced. Addition of serum reconstitutes the ability of BMDCs to secrete 
cytokines partially. The controls were used as describe above. 
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Figure 1. Role of CD14 in L. pneumophila LPS-mediated IL-6 production. Bone marrow-
derived dendritic cells from the indicated mice strains were cultured with L.pneumophila LPS (10 
µg/ml, 1 µg/ml or 100 ng/ml) in the presence and the absence of FCS – LPS of S. typhimurium (1 
µg/ml, 100 ng/ml or 10 ng/ml) was used as CD14-dependent control and Pam3Cys (2.5 µg/ml) and 
poly I:C as CD14-independent control. After 20 h, the IL-6 concentration in the cell culture 
supernatant was measured by ELISA. (A) In the absence of FCS, BMDCs derived from CD14 
knockout mice produced significantly less IL-6 in response to 100 ng/ml and 1 µg/ml of L. 
pneumophila LPS compared to the wild-type. (B) In the presence of FCS, the defect of CD14 is 
restored at concentrations higher than 1µg/ml. The experiment was performed three times. The error 
bar represents the deviation of triplicates of one experiment.  
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Figure 2. Role of CD14 on IL-12 secretion by BMDCs in response to L. pneumophila. In the 
presence and the absence of FCS, bone marrow-derived dendritic cells from BALB/c and CD14 
knockout mice were co-cultured with L. pneumophila in bacteria-to-cell ratios of 10:1 and 1:1. 
Non-phagocytosed bacteria were killed 2 h post-infection by addition of gentamicin. LPS of S. 
typhimurium (1µg/ml, 100 ng/ml or 10 ng/ml) was used as CD14-dependent and Pam3Cys (2.5 
µg/ml) and poly I:C as CD14-independent control. After 20 h, the supernatant was analysed for 
secretion of IL-12. (A) In the absence of FCS, the ability of BMDCs derived from CD14 knockout 
mice to secrete IL-12 in response to infection by viable or fixed L. pneumophila is impaired. (B) 
Addition of FCS to the cell culture restores the ability of BMDCs derived from CD14 knockout 
mice to secrete IL-12 in response to infection by viable or fixed L. pneumophila. The mean value 
of triplicates is shown together with the standard deviation from one of three independent 
experiments. 
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L. pneumophila LPS triggers activation of BMDCs via TLR2 but not via TLR4 
Since activation of BMDC by L. pneumophila LPS and Legionella bacteria requires 
the presence of CD14, we investigated whether Toll-like receptors (TLRs) are 
involved. To determine the role of TLRs, L. pneumophila LPS-mediated activation of 
BMDCs from mice lacking functional TLR2 and/or TLR4 molecules was studied. We 
investigated the secretion of the pro-inflammatory cytokine IL-12 (Fig. 3) and IL-6 
(data not shown) in response to L. pneumophila LPS, S. typhimurium LPS, Pam3Cys 
and CpG-ODN. BMDCs from C3H/HeN and C3H/HeJ (a TLR4-deficient mouse) but 
not from TLR2-/- and C3H/HeJ/TLR2-/- responded to the L. pneumophila LPS stimulus 
by secretion of IL-12. CpG-ODN induced IL-12 secretion in all cultures, Pam3Cys-
mediated activation was abrogated in BMDCs from TLR2-/- mice and S. typhimurium 
LPS was impaired in BMDCs from C3H/HeJ mice, in line with previous reports.  
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Figure 3. L. pneumophila LPS-induced IL-12 production by dendritic cells is TLR2 
dependent. Bone marrow-derived dendritic cells from indicated mice strains were stimulated with 
L. pneumophila LPS (10 µg/ml, 1 µg/ml or 100 ng/ml), S. typhimurium LPS (100 ng/ml, 10 ng/ml 
or 1 ng/ml), Pam3Cys (2.5 µg/ml) and Oligonucleotide 1668 (2.5 µM).  After 20 h, the IL-12 
concentration in cell culture supernatant was measured by sandwich ELISA. Only BMDCs from 
C3H/HeN and C3H/HeJ mice secrete IL-12 in response to L. pneumophila LPS, BMDCs from 
TLR2-/- and C3H/HeJ/TLR2-/- mice do not. The mean value of triplicates from one of three 
indeependnt experiments is shown. Error bars represent standard deviation. 
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BMDCs derived from TLR2 knockout mice do not respond to L. pneumophila 
Since activation of BMDCs by L. pneumophila LPS was strictely dependent on TLR2 
(Fig. 3), we wanted to investigate if the activation of BMDCs by whole bacteria 
follows the same pathway.  
We, therefore, infected the above used BMDCs with viable and formalin-killed L. 
pneumophila and determined the secretion of IL-12. As shown in Figure 4, BMDCs 
from wild-type mice (C3H/H3N) as well as from TLR4-deficient mice (C3H/HeJ) 
secreted IL-12 in response to the stimulation with L. pneumophila. In contrast, 
BMDCs from mice lacking TLR2 molecules (TLR2-/- and C3H/HeJ/TLR2-/-) did not 
respond to the stimulation with L. pneumophila by secretion of IL-12. Oligonucleotide 
induced IL-12 secretion in all cultures, S. typhimurium LPS triggered activation via 
TLR4 (impaired activation in BMDCs from C3H/HeJ and C3H/HeJ/TLR2-/- mice) and 
Pam3Cys via TLR2 (impaired activation in BMDCs from TLR2-/- and  
C3H/HeJ/TLR2- /- mice), in line with previous reports. Interestingly, the fixation of L. 
pneumophila by 1% PFA seemed to be required to induce a strong activation of 
BMDCs. 
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Figure 4. L. pneumophila activates dendritic cells to produce IL-12 via TLR2. L. pneumophila 
either viable or fixed by 1% PFA were added to the culture of BMDCs from the indicated mice 
strains in bacteria-to-cell ratios of 10:1 and 1:1. Two hours later, non-phagocytosed bacteria were 
killed by gentamicin. LPS from S. typhimurium (100 ng/ml), Pam3Cys (0.5 µg/ml) and 
oligonucleotide 1668 (0.5 µM) were used as controls. Cell culture supernatant after 20 h was 
analysed for the secretion of IL-12 by sandwich ELISA. BMDCs from C3H/HeN and C3H/HeJ 
mice are stimulated by both viable and fixed L. pneumophila to secrete IL-12. BMDCs from 
TLR2-/- and C3H/HeJ/TLR2-/- mice are not able to secrete IL-12 in response to neither viable nor 
fixed L. pneumophila. The mean value of triplicates from one of three independent experiments is 
shown. Error bars represent standard deviation.  
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Discussion  
It was assumed in the past that the LPS of enterobacteria is restricted to the use of 
TLR4 as a signal transducing molecule, whereas TLR2 is involved in the recognition 
of Gram-positive bacteria and Mycobacteria (Yoshimura et al., 1999; Flo et al., 2000). 
However, it was recently demonstrated that even though Porphyromonas gingivalis 
(Hirschfeld et al., 2001), Leptospira interrogans (Werts et al., 2001) and L. 
pneumphila (Girard et al., 2003) are Gram-negative bacteria, they activate cells of the 
immune system via a TLR2-dependent mechanism. Previous studies have also 
demonstrated that TLR4 was not involved in host defense against pulmonary L. 
pneumophila infection (Lettinga et al., 2002). Whereas TLR4-mediated responses to 
LPS require the presence of LBP and CD14 molecules, efficient TLR2-mediated 
signalling can also be observed in the absence of CD14 (Chow et al., 1999; Netea et 
al., 2002a). We, therefore, analyzed the contribution of TLR2, TLR4 and CD14 to the 
signaling pathways triggered by intact L. pneumophila and by its most abundant cell 
surface molecule LPS. For this purpose, we used BMDCs from mice lacking CD14 as 
well as mice with defects in TLR2 and TLR4. We found that both CD14 and TLR2 
molecules are involved in the L. pneumophila LPS-induced secretion of pro-
inflammatory cytokines by mouse BMDCs.  
Although it has been recently demonstrated that the LPS of L. pneumophila does not 
interact with CD14 expressed by human monocytes (Neumeister et al., 1998), we 
obtained first evidence that CD14 might be involved in the activation of antigen-
presenting cells by L. pneumophila LPS in a functional assay using BMDCs from 
CD14-knockout mice. Cytokine secretion induced by a low dose of LPS (1 µg/ml) was 
reduced in BMDCs from CD14-knockout mice, while high concentrations of LPS 
triggered BMDC activation also in the absence of CD14 (Fig. 1A). The addition of 
serum containing sCD14 (Bazil et al., 1986) increased the ability of LPS to activate 
BMDCs even at low concentrations (Fig. 1B).  
The involvement of CD14 in the activation of APCs became clearly visible using live 
and fixed bacteria as a stimulus. At an infectious dose of 10:1 bacteria per cell BMDC, 
we observed a drastically reduced cytokine secretion in CD14 knockout mice 
compared to wild-type mice (Fig. 2A). It was not possible to test whether increased 
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numbers of bacteria would provide a CD14-independent stimulus as observed for L. 
pneumophila LPS because increasing the bacteria to cell ratio killed the BMDCs as 
observed previously (Husmann and Johnson, 1994). 
As observed for purified L. pneumophila LPS, addition of serum induced a better 
cytokine secretion by BMDCs when intact bacteria were used for stimulation (Fig. 
2B). In this case, BMDCs from CD14 knockout mice secreted the same amount of 
cytokines as the BMDCs from wild-type mice. However, in the absence of FCS, the 
ability of BMDCs from CD14-knockout mice to secrete cytokines is reduced 
compared to wild-type BMDCs (Fig. 2A).  
We next investigated the role of TLRs in the activation of dendritic cells by L. 
pneumophila LPS and intact bacteria. Using BMDCs from C3H/HeJ, C3H/HeJ/  
TLR2-/- and TLR2-/- mice, we found that Legionella LPS triggered activation of 
BMDCs exclusively via TLR2 whereas TLR4 was not involved (Fig. 3). This finding 
was in line with the results obtained by Girard and colleagues who described a TLR2-
mediated CD14 expression in bone marrow derived granulocytes as a measurement for 
activation (Girard et al., 2003) and Kikuchi and colleagues reporting a TLR4-
independent signaling of L. pneumophila LPS (Kikuchi et al., 2004). Our experiments 
extended this observation to intact bacteria: only TLR2 appeared to be involved in the 
Legionella-mediated activation of BMDCs without a detectable contribution of TLR4 
(Fig. 4). This absolute requirement for TLR2 in BMDC activation by whole bacteria 
was surprising since a redundant recognition of several different PAMPs (soluble or 
membrane bound) of a given pathogen was expected. However, our results strongly 
argue that LPS is the main structure for the recognition of L. pneumophila by the 
innate immune system. We can not finally rule out that other pathogen structures of L. 
pneumophila activate the immune system in a similar TLR2- and CD14-dependent 
manner although this might be quite unlikely. This finding is in contrast to the 
stimulation of innate immune responses by other bacteria like the Gram-positive group 
B streptococci (GBS). Here, a so far unknown secreted GBS factor stimulates 
macrophages in a CD14/TLR2/TLR6-dependent manner but GBS stimulate cells 
without the contribution of these molecules (Henneke et al., 2002).  
Nevertheless, additional molecules might also influence the interaction of intact L. 
pneumophila with BMDCs. When we compared viable bacteria with bacteria killed by 
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1% PFA we found that the latter were much more potent in activating BMDCs and 
inducing the secretion of cytokines (Fig. 4) as reported recently (Kikuchi et al., 2004). 
This increase in BMDC activation is not due to the fixation procedure since irradiated 
bacteria behave like fixed bacteria (data not shown). Whether or not soluble factors 
secreted by live L. pneumophila which suppress the activation of cells of the innate 
immune system are involved remains to be determined. 
 
Conclusions 
These results provide strong evidence that L. pneumophila LPS is the main PAMP 
recognized on the surface of L. pneumophila and that CD14 contributes to the TLR2 
mediated activation.  
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Invasive aspergillosis (IA) is a leading cause of mortality in hematological patients. 
Appropriate activation of the innate immune system is crucial for the successful 
clearance of IA. Therefore, we studied the Aspergillus fumigatus-mediated activation 
of human granulocytes and monocyte-derived immature dendritic cells (DCs), as well 
as murine bone marrow-derived DCs (BMDCs) from wild-type, toll-like receptor 
(TLR)4-deficient, TLR2 knockout., and TLR2/TLR4 double-deficient  mice. Aspergillus 
fumigatus antigens induced the activation and maturation of immature DCs as 
characterized by CD83 expression, upregulation of major histocompatibility complex 
and co-stimulatory molecules. Moreover, fungal antigens enhanced the phagocytosis 
and production of interleukin (IL)-8 in granulocytes. The release of IL-12 by BMDCs 
in response to A. fumigatus antigens was dependent on the expression of TLR2, 
whereas the release of IL-6 was dependent on the expression of functional TLR4 
molecules. The protein precipitate of A. fumigatus supernatant provided strong 
stimulation of DCs and granulocytes, indicating that a factor secreted by A. fumigatus 
might activate innate immune cells. In conclusion, A. fumigatus antigens induced the 
activation of DCs and granulocytes. Our results indicated that, this activation was 
mediated via TLR2 and TLR4. Future studies are needed to assess the clinical impact 
of these findings in patients at high risk for IA. 
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Introduction 
Invasive aspergillosis (IA) has become a major cause of infection-related mortality in 
patients with haematological malignancies, especially after allogeneic stem cell 
transplantation (SCT) (Wald et al., 1997). Proven risk factors in humans are defects in 
phagocyte function (Morgenstern et al., 1997), steroid-induced suppression of 
macrophage conidiocidal activity (Schaffner et al., 1982; Palmer et al., 1991), and 
chemotherapy-induced neutropenia (Gerson et al., 1984). Patients with a previous 
history of IA (Offner et al., 1998) and patients colonized in the lower respiratory tract 
without signs of tissue-invasive disease (Einsele et al., 1998) have been found to have 
an increased risk for recurrence of IA during a subsequent episode of neutropenia or 
immunosuppression (Offner et al., 1998). These observations implicate local cellular 
defects in the immune effector mechanisms as major predisposing factors of the host 
to IA (Schaffner et al., 1982; Romani, 1997; Cenci et al., 1998). 
In Drosophila, toll participates in the defence against fungi by the induction of 
drosomycin secretion as an early form of an innate immune response (Lemaitre et al., 
1996). In mammals, toll-like receptors (TLRs) are involved in the response to 
pathogens by the recognition of so-called pathogen-associated molecular patterns 
(PAMPs). These include lipopolysaccharide (LPS), peptidoglycans, lipoproteins and 
bacterial CpG-DNA, which are recognized by TLR4, TLR2 and TLR9, respectively 
(Aderem and Ulevitch, 2000; Hemmi et al., 2000).  
Toll-like receptors have been demonstrated to induce tumour necrosis factor α (TNF-
α) release in murine peritoneal macrophages and transfected human cell lines after 
stimulation with different biological forms of Aspergillus fumigatus (Mambula et al., 
2002) and preliminary data indicate a potential role of TLRs in the A. fumigatus-
induced activation of human monocytes (Wang et al., 2001).  
More recently, a critical role of T-helper (TH) cell responses in the control of IA has 
been reported in murine models (Clerici and Shearer, 1994; Cenci et al., 1997; Cenci 
et al., 1998; Cenci et al., 1999; Cenci et al., 2000; Mehrad et al., 1999; Clemons et al., 
2000) and in patients with haematological malignancies and allogeneic SCT recipients 
(Hebart et al., 2002). Dendritic cells (DCs) are recognized as the initiators of specific 
immune responses to pathogens (Banchereau and Steinman, 1998). In the murine 
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model, pulmonary DCs were found to internalise Aspergillus conidia and hyphae, to 
undergo functional maturation upon migration to the draining lymph nodes and spleen 
and to induce T cell priming of CD4+ T lymphocytes (Bozza et al., 2002). In vitro, 
DCs were found to restore Aspergillus-specific lymphoproliferation in haematological 
patients (Grazziutti et al., 2001). 
In the current study, we assessed the A. fumigatus-induced activation of granulocytes 
and DCs. 
 
Materials and Methods 
Reagents, antibodies and plasmids  
Lipopolysaccharide from Pseudomonas aeruginosa (kindly provided by T. Schröder, 
Tübingen) was used or LPS from Salmonella typhimurium was purchased from Sigma-
Aldrich (Taufkirchen, Germany). Phosphothioate-stabilized CpG oligonucleotide 1668 
(TCC-ATC-ACG-TTC-CTG-ATG-C) was purchased from TIB MOLBIOL (Berlin, 
Germany). Palmitoyl-3-Cys-Ser-(Lys)4 (Pam3Cys) was obtained from EMC 
microcollections GmbH (Tübingen, Germany). 
Cell staining was performed using fluorescein isothiocyanate (FITC)- or phycoerythrin 
(PE)-conjugated mouse monoclonal antibodies against CD86, CD40, CD11b 
(purchased from Pharmingen, Hamburg, Germany); CD80, HLA-DR, CD14 (all 
purchased from Becton Dickinson, Heidelberg, Germany); CD66b or CD83 (all from 
Coulter-Immunotech Diagnostics, Hamburg, Germany), and CD1a (OKT6; Ortho 
Diagnostic Systems, Neckargemund, Germany), and mouse immunoglobulin (Ig)G 
isotype controls (Becton Dickinson). Samples were analysed on a FACScalibur 
(Becton Dickinson). 
  
Aspergillus fumigatus antigens 
Conidia of A. fumigatus (strain CBS 144-89) were inoculated in 150-ml Erlenmeyer 
flasks containing Sabouraud liquid medium (2% [w/v] glucose, 1% [w/v] 
mycopeptone). Flasks were shaken for 24 h at 37°C and 200 rpm. Two-liter fermenters 
(LSL Biolafitte, Saint Germain en Laye, France) containing 1.2 liters of Sabourau
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medium were inoculated with the shaken flask cultures. The 18 h-culture conditions 
were as follows: inoculum 8% (v/v); temperature, 26°C; aeration, 50 l of air per 
minute; agitation, 500 rpm. The mycelial mat recovered by filtration was extensively 
washed with water. Mycelium was disrupted in a glass bead cell homogeniser in 50 
mmol/l Tris-HCl buffer pH 7.5 and the water-soluble cellular extracts (EC SAB) were 
recovered after centrifugation. The ethanol precipitate (PP SAB) of A. fumigatus was 
prepared by precipitating the culture filtrate with 4 volumes of ethanol after 18 h of 
culture and stored at 4°C. Protein content was measured by the BioRad technique 
(Bio-Rad, Marne La Coquette, France) according to the manufacturer’s instructions 
and estimated in milligram equivalent BSA per millilitre. EC SAB and PP SAB were 
tested endotoxin free (< 0.1 endotoxin units/µg protein) by limulus amebocyte lysate 
assay (BioWhittaker, Verviers, Belgium). 
To generate hyphae, conidia (106 colony forming units/ml) were harvested after 3 d of 
culture on Sabouraud glucose agar, filtered through sterile gauze and then incubated in 
yeast nitrogen base for 18 h at 37°C, followed by a centrifugation for 10 min at 3000 
g. Mycelia were washed twice and, for sterilization, incubated in ethanol-posphate-
buffered saline (ethanol-PBS; 70%) for 24 h at 4°C.  
 
Preparation and culture of human cells 
Polymorphonuclear neutrophils (PMN) were separated from heparinized blood of 
healthy volunteer donors by dextran sedimentation using Polymorphprep (Nycomed, 
Oslo, Norway) according to the manufacturer’s instructions and as described 
previously (Radsak et al., 2003). Contaminating red blood cells were removed by an 
in-house lysis buffer [150 mmol/l ammonium chloride, 1 mmol/l potassium 
bicarbonate, 0.1 mmol/l ethylene diamine tetra acetate (all from Sigma, St Louis, MO, 
USA) in distilled water, pH 7.3]. The purity of cell preparation was assessed by flow 
cytometry with CD66b as marker for PMN. Usually, 95-98 % of cells were CD66b 
positive. For stimulation of PMN, cells were suspended in a concentration of 2 x 106 
cells/ml in Roswell Park Memorial Institue (RPMI) 1640 (PAN Biotech, Aidenbach, 
Germany) with 3 % (v/v) heat inactivated (30 min at 56°C) fetal bovine serum (FBS; 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
86 
PAN Biotech) and cultivated at 37°C with 7.5 % CO2 in air in the presence of various 
stimuli diluted in medium as indicated.  
Human DCs were generated from heparinized blood of healthy donors as reported 
previously (Grigoleit et al., 2002). Briefly, peripheral blood mononuclear cells 
(PBMCs) were isolated using a Ficoll density gradient (LINARIS, Bettingen am Main, 
Germany), washed twice in sterile calcium- and magnesium-free Hanks’ balanced salt 
solution (GIBCO BRL, Karlsruhe, Germany) and re-suspended in RPMI 1640 medium 
supplemented with Glutamax-I, 25 mmol/l HEPES buffer (GIBCO BRL), 200 µg/ml 
Gentamicinsulfate (Refobacin® 80 mg; Merck, Darmstadt, Germany), and 10% fetal 
calf serum (FCS; Sigma). PBMCs were plated at a density of 10 x 106 cells/well for 2 
h at 37 °C and non-adherent cells were removed by washing with PBS. Adherent 
monocytes were cultured for 6 d in RP10 medium supplemented with 1000 IU/ml 
interleukin-4 (IL-4; R&D Systems, Minneapolis, MN, USA) and 100 ng/ml 
granulocyte-macrophage colony-stimulating factor (GM-CSF; Leukomax, Novartis 
Pharma GmbH, Nürnberg, Germany). The differentiation state of DCs was examined 
by flow cytometry.  
 
Generation of mouse DCs 
Mouse immature DCs were generated from bone marrow of C3H/HeN and C3H/HeJ 
(Tularic Inc., South San Fransisco, CA, USA).  C3H/HeJ / TLR2-/-, and TLR2-/- mice 
were generously provided by H. Wagner/K. Kirschning (Munich, Germany). For the 
generation of mouse bone marrow-derived DCs (BMDCs) Iscove‘s modified 
Dulbecco‘s medium (IMDM; BioWhittaker, Verviers, Belgium) was used 
supplemented with 2 mmol/l L-glutamine (GibcoBRL Life Technologies, Paisley, 
GB), 100 IU/ml penicillin/streptomycin (GibcoBRL), 10% FS (PAA, Linz, Austria) 
and 200 U/ml GM-CSF (Peprotec, Rocky Hill, NJ, USA). Bone marrow cells were 
incubated in GM-CSF containing medium for 6-8 d and fresh medium with GM-CSF 
was replaced every 2 d. The obtained DCs were CD11c positive and CD14 negative. 
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Phagocytosis 
For analysis of phagocytic activity, ingestion of PE-labeled polystyrene microspheres 
(diameter 1 µm, Fluoresbrite Plain Microspheres PCRed; Polysciences, Warrington, 
PA; USA) was evaluated as described previously (Lehmann et al., 2000; Radsak et al., 
2003). Briefly, aliquots of 2 x 105 freshly purified PMN were incubated in the presence 
of stimuli as indicated and 5 x 106 microbeads [effector:target (E:T) ratio 1:25] for 60 
min at 37 °C, then kept on ice, washed twice in fluorescence-activated cell sorting 
buffer (FACS) and fixed in 1 % paraformaldehyde in PBS. Analysis was performed by 
FACS.  
 
Detection of human and mouse cytokines 
For analysis for cytokines by enzyme-linked immunosorbent assay (ELISA), 
supernatants were derived from stimulation with purified human PMN or mouse DCs 
and frozen at -20 °C until required.  
Supernatants of PMN were analysed by ELISA for IL-8 (OptEIA from Pharmingen, 
Hamburg) according to the manufacturer’s instructions. 
Supernatants derived from mouse DCs were analysed using commercial IL-6 and IL-
12 specific ELISA (BD Pharmingen) as described previously (Vabulas et al., 2002b). 
 
Quantifiable reverse transciption polymerase chain reaction (RT-PCR) 
Total RNA was extracted using RNeasy spin columns (Qiagen, Hilden, Germany) 
followed by cDNA synthesis using the first strand cDNA synthesis kit based on avian 
myeloblastosis virus (AMV) reverse transcriptase (Roche, Mannheim, Germany). 
Quantifiable PCR assays were performed by real-time PCR with the LightCyclerTM 
instrument as reported previously (Loeffler et al., 2003). This technique is based on the 
fluorescence resonance energy transfer (FRET). The samples were quantified by 
defined external standards, ranging from 109 to 101 CFU/ml. Primers were specific for 
TNF- and IL-12 (5’-). The probes consisted of two parts: one part had been labelled 
at the 5’-end with the Light Cycler- Red 640 fluorophore (5’-), the other at the 3’-
end with fluorescein (5’-; Tibmolbiol, Berlin, Germany). 
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Statistics 
The statistical significance of the data was analysed using a non-parametric Mann-
Witney U-test for comparison between two groups. For multivariate analyses, the data 
were analysed by two-way analysis of variance (ANOVA). For all analyses, P < 0.05 
was considered statistically significant. 
 
Results  
Aspergillus fumigatus antigens activate human immature monocyte-derived 
dendritic cells 
This study was intended to analyse the effects of A. fumigatus antigens on immature 
DCs. Therefore, monocyte-derived immature DCs were stimulated overnight with 
different antigen preparations from A. fumigatus including hyphae, a cellular extract 
(EC SAB) and the ethanol precipitate of the culture supernatant of A. fumigatus       
(PP SAB) and analysed for the surface expression of CD83, co-stimulatory and major 
histocompatibility complex (MHC) molecules as well as for the expression of           
IL-12p40 and TNF-α by quantifiable RT-PCR. Aspergillus fumigatus antigens were 
found to activate immature DCs as demonstrated by an increased expression of co-
stimulatory molecules and HLA-DR, and to induce maturation of immature DCs   
(Fig. 1). Moreover, stimulation of immature DCs with A. fumigatus antigen 
preparations induced a strong expression of IL-12p40 (up to 1000-fold) and TNF-α 
RNA (up to 100-fold) (data not shown). PP SAB was found to provide the strongest 
stimulation, but high input of hyphae yielded comparable result indicating that this 
effect might result from a higher concentration of TLR ligands in the PP SAB 
preparation. As PP SAB and EC SAB were found to stimulate immature DCs as 
effectively as Aspergillus hyphae, all further experiments were performed with         
EC SAB and PP SAB. 
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Aspergillus antigens stimulate effector functions of human neutrophils 
Polymorphonuclear neutrophils play an important part in the first line of defence 
against microbial pathogens by contributing substantially to the innate host defence 
with their ability to rapidly extravasate into inflamed tissue and their employment of 
potent effector mechanisms, i.e. phagocytosis, production of reactive oxygen species, 
and release of mediators and antimicrobial substances (Van Furth et al., 1973; Lloyd 
and Oppenheim, 1992; Ben Baruch et al., 1995; Greenberg and Grinstein, 2002).  
Therefore, we studied whether PP SAB and EC SAB could also mediate activation of 
human PMN. In a first set of experiments, we investigated the ingestion of 
unopsonized fluorochrome-labelled polystyrene beads as measure for unspecific 
phagocytosis as described previously (Radsak et al., 2003). The phagocytic activity of 
PMN was markedly enhanced by PP SAB, but not by EC SAB (Table I). The 
Figure 1: Aspergillus fumigatus hyphae induce activation and maturation of monocyte-
derived human immature dendritic cells (DCs). The figure shows the result of one 
representative experiment. Overnight stimulation with A. fumigatus hyphae (one hyphae/DC) 
induces activation (upregulation of CD40, CD80, CD86, HLA-DR) and maturation (increased 
expression of CD83) of immature DCs. CD14 expression was unchanged. Isotype control, dotted 
line; negative control, thin line; A. fumigatus stimulated DCs, thick line. 
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activation was insensitive to the presence of polymyxin B (not shown) indicating that 
the observed activation was not due to potential contaminations by bacterial 
endotoxins.  
 
 
 
Stimulus  
 fold 
dilution 
mean (n=8 experiments)  SD P-value 
Medium   267,0 136.2  
10 935,0 383.8 <0,001 PP SAB  
 30 744,3 202.6 <0,001 
10 385,5 334.5 ns EC SAB  
 30 256,0 215.0 ns 
 
 
 
 
 
 
 
In addition, Aspergillus antigens stimulated the release of IL-8 in purified PMN, as 
shown in Fig. 2. In a similar way, Aspergillus antigens mediated degranulation in 
PMN, analysed by upregulation of surface expression of CD66b and Mac-1 (CD11b) 
indicating mobilization of specific and gelatinase granules (not shown).  
These results suggest that these Aspergillus antigens present potent stimuli for the 
activation of innate immune cells. 
 
 
 
 
PMN, polymorphonuclear neutrophil; ns, not significant. 
Purified PMN (2 x 105) were incubated with the indicated stimuli in the presence of 5 x 106 
fluorochrome-labelled microspheres as described in Materials and Methods. Cells were washed 
and fixed in 1% paraformaldehyde. Fluorescence intensity was evaluated by FACS. The 
summarised results of eight independent experiments with different donors are shown as mean 
with standard deviation (SD). Statistical analysis was performed by Mann-Witney U-test 
comparing the stimulated cells to the medium control. 
Table I. Aspergillus antigen PP SAB, but not EC SAB, enhances phagocytic activity of 
PMN.  
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Aspergillus fumigatus mediates DC activation via TLR2 and TLR4  
To analyse a potential role of TLR2 and TLR4 in the A. fumigatus antigen-mediated 
activation of innate immune cells, we investigated this interaction in detail in bone 
marrow-derived DCs (BMDCs) from wild-type mice and mice lacking functional 
TLR2 or TLR4 molecules. In the first set of experiments, we analysed the secretion of 
the pro-inflammatory cytokines IL-12 and IL-6 in response to EC SAB and PP SAB or 
LPS, Pam3Cys and CpG-DNA as control stimuli. Upon stimulation BMDCs derived 
from TLR4 deficient mice and wild-type mice produced comparable amounts of IL-12 
in response to EC SAB and PP SAB (Fig. 3). In contrast, BMDCs from TLR2 
knockout mice were still activated by PP SAB but not by EC SAB, suggesting that 
activation by EC SAB is strictly dependent on TLR2.  
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Figure 2. Release of IL-8 by polymorphonuclear neutrophils (PMN) after stimulation 
with Aspergillus antigens. Freshly purified PMN (4 x 105) were incubated in presence of 
the indicated Aspergillus antigens PP SAB (grey bars), EC SAB (open bars), or controls 
(medium alone or Lipopolysaccharide 1 µg/ml; black bars). Culture supernatants were 
harvested after 6 h and assayed for IL-8 by ELISA. All samples were assayed in triplicates 
and are depicted as mean and standard deviation. The representative results from one of 
three independent experiments are shown. 
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In order to look at this more closely, a second set of experiments was performed using  
also BMDCs from TLR2 and 4 double-deficient mice. As shown in Fig. 4A, BMDCs 
from wild-type mice (C3H/HeN) and TLR4-deficient mice (C3H/HeJ) again gave a 
comparable IL-12 response to PP SAB and EC SAB (Fig. 3). However, BMDCs from 
the TLR2/4 double-deficient mice were did not respond to the PP SAB stimulus. As 
expected, BMDCs from TLR2/4 double-deficient mice did not respond to the TLR2-
dependent IL-12 release induced by EC SAB. Analysing the production of IL-6 only 
showed a strong response to PP SAB in the wild-type BMDCs, but not to EC SAB 
(Fig 4B). Interestingly and unlike the production of IL-12, PP SAB-induced secretion 
of IL-6 was also affected in TLR4-deficient mice. 
These results clearly demonstrate that the activation of BMDCs by EC SAB is 
exclusively dependent on TLR2. The situation is more complex for PP SAB. In the 
case of IL-12 production induced by PP SAB, TLR2 and TLR4 can fully compensate 
for each other. However, IL-6 production in TLR4-deficient mice can not be 
compensated by TLR2. 
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Figure 3. EC SAB-induced IL-12 production by DCs is TLR2 dependent. Bone marrow-
derived dendritic cells (BMDCs) from the indicated mice strains were cultured in the presence of 
EC SAB (200-fold dilution), PP SAB (200-fold dilution), LPS (2.5 µg/ml), CpG ODN 1668        
(2 µM) or Pam3Cys (2 µg/ml). After 20 h IL-12 concentration in cell culture supernatant was 
measured by sandwich ELISA. BMDCs derived from C3H/HeN mice and C3H/HeJ mice 
produced comparable amounts of IL-12 in response to EC SAB and PP SAB. In contrast, TLR2 
knockout mice-derived DCs responded to PP SAB but not to EC SAB regarding IL-12 production. 
The mean and standard deviation of triplicate wells is shown. The differences shown are 
statistically significant (P < 0.05 by two-way ANOVA).  
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Figure 4. Aspergillus fumigatus mediates dendritic cell (DC) activation via TLR2 and TLR4.  
Bone marrow-derived dendritic cells (BMDCs) from the indicated mice strains were stimulated 
with EC SAB, PP SAB (indicated dilution), LPS (10 ng/ml), CpG ODN 1668 (5 µmol/l) or 
Pam3Cys (1 µg/ml). Cell culture supernatants were harvested after 20 h and analysed for IL-12 
and IL-6 secretion by sandwich ELISA. (A) BMDCs from C3H/HeN mice and C3H/HeJ mice 
secreted comparable amounts of IL-12 in response to EC SAB and PP SAB. C3H/HeJ/TLR2-/- 
mice did not respond to either fungal preparation. (B) BMDCs from C3H/HeN produced 
significant amounts of IL-6 in response to PP SAB, but not to EC SAB. The IL-6 release upon 
stimulation with PP SAB was more dependent on TLR4 compared with the release of IL-12. The 
mean and standard deviation of triplicate wells is shown. The differences shown are statistically 
significant (P < 0.05 by two-way ANOVA).  
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Discussion 
In this report, we demonstrated that antigen preparations derived from A. fumigatus 
were potent activators of human immature monocyte-derived DCs, as demonstrated by 
the upregulation of MHC and co-stimulatory molecules, and an increased TNF-α and 
IL-12p40 mRNA concentration. The presence of these pro-inflammatory cytokines can 
be expected to contribute to the development of a TH1-dominated immune response, 
which was found to be associated with control of IA. Moreover, CD83 was 
upregulated, indicating differentiation into mature DCs. In line with these results, the 
adoptive transfer of DCs pulsed with conidia and DCs transfected with conidial RNA 
were found to induce TH1-dependent antifungal resistance in allogeneic bone marrow 
transplanted mice (Bozza et al., 2003). 
The precipitate of the culture supernatant (PP SAB) was found to induce the strongest 
stimulation of immature DCs in comparison to hyphae and the cellular extract of A. 
fumigatus (EC SAB). However, the high input of hyphae yielded comparable results, 
indicating that this effect might result from a higher concentration of TLR ligands in 
the PP SAB preparation. Whereas the cytokine release of DCs from TLR4- and TLR2-
deficient mice was only slightly reduced upon stimulation with PP SAB, a complete 
blockade of the cytokine release was observed in DCs from TLR2 and TLR4 double-
deficient mice (Fig. 4). For signals mediated by PP SAB, TLR2 and TLR4 could fully 
compensate for each other if one was deficient, but deficiency of both, TLR2 and 
TLR4, could not be compensated for, demonstrating that TLRs are responsible for PP 
SAB-mediated cell activation. In contrast, signalling induced by the cellular extract of 
A. fumigatus EC SAB was found to be strictly TLR2 dependent, which is in line with 
data describing a TLR2 dependence of TNF-α release in murine peritoneal 
macrophages after stimulation with Aspergillus conidia and hyphae (Mambula et al., 
2002). More recently, A. fumigatus-induced activation of murine peritoneal 
macrophages has been described to be dependent on the expression of TLR2 and 
TLR4 (Meier et al., 2003). 
Interestingly, PP SAB but not EC SAB was found to strongly induce IL-6 release in 
culture supernatants of murine immature DCs. This finding is of special interest as IL-
6 release by DCs has recently been described as essential for blocking the suppressive 
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effects of regulatory CD4+CD25+ T cells on the initiation of pathogen-specific 
adaptive immune responses (Pasare and Medzhitov, 2003). The characterisation of 
regulatory T cells has opened exciting opportunities to induce tolerance after 
transplantation and to prevent graft versus host disease after allogeneic SCT; however, 
these cells might induce potentially detrimental effects by down-regulation of 
immunity to infections and also to tumours (Wood and Sakaguchi, 2003). The 
characterisation of the PP SAB-derived TLR ligand responsible for IL-6 release in 
DCs is thus of potential interest for the development of Aspergillus-directed 
immunotherapy protocols.  
PP SAB-induced IL-6 release was dependent on the expression of functional TLR4 
molecules whereas IL-12 release was TLR2 dependent. This suggests that various 
pattern recognition receptors might be involved in the complex interaction of microbes 
and DCs. Recently, the use of different TLRs to differentially induce the release of 
pro-inflammatory cytokines and chemokines has been described for the interaction of 
Candida albicans and DCs (Netea et al., 2002b). Thus, differences in antigen 
preparations, cytokines analysed and cell types under study are likely to have a major 
impact on the results in the study of cell pathogen interactions and to explain differing 
results, as reported recently for TLR-usage in the A. fumigatus-mediated cell activation 
(Wang et al., 2001; Mambula et al., 2002). Moreover, TLR4-mediated but not TLR2-
mediated cytokine signals were found to be lost upon Aspergillus germination to 
hyphae indicating that phenotypic switching during germination might counteract host 
immune defence mechanisms (Netea et al., 2003).   
Our findings obtained with mouse- and human-derived DCs are complemented by the 
experiments performed with human neutrophils. This cell type has been shown to 
express high levels of TLR2 and low levels of TLR4 on the surface (Kurt-Jones et al., 
2002). In line with the results observed in DCs, PP SAB and EC SAB, although to a 
lesser extent, were found to augment neutrophil function as assessed by the release of 
IL-8, phagocytosis and degranulation. Thus, factors stimulated by A. fumigatus 
directly activate anti-Aspergillus effector functions of neutrophils and induce the 
release of IL-8 to attract further effector cells to the site of infection.  
In conclusion, our results clearly indicate that A. fumigatus antigens induce the 
activation of immature DCs and granulocytes. According to our results, this activation 
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is mediated via TLR2 and TLR4. Future studies are needed to assess the clinical 
impact of these findings in patients at high risk for IA, such as recipients of an 
allogeneic SCT.  
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The heat shock protein Gp96 has been shown to induce specific immune responses. On 
one hand, this phenomenon is based on the specific interaction with CD91 that 
mediates endocytosis and results in major histocompatibility complex class I-restricted 
representation of the Gp96-associated peptides. On the other hand, Gp96 induces 
activation of professional antigen-presenting cells, resulting in the production of pro-
inflammatory cytokines and up-regulation of costimulatory molecules by unknown 
mechanisms. In this study, we have analyzed the consequences of Gp96 interaction 
with cells expressing different toll-like receptors (TLR) and with bone marrow-derived 
dendritic cells from mice lacking functional TLR2 and/or TLR4 molecules. We find 
that the Gp96-TLR2/4 interaction results in activation of nuclear factor κB-driven 
reporter genes and mitogen- and stress-activated protein kinases and induces IκBα 
degradation. Bone marrow-derived dendritic cells of C3H/HeJ and more pronounced 
C3H/HeJ / TLR2-/- mice fail to respond to Gp96. Interestingly, activation of bone 
marrow-derived dendritic cells depends on endocytosis of Gp96 molecules. Our 
results provide, for the first time, the molecular basis for understanding the Gp96-
mediated activation of antigen-presenting cells by describing the simultaneous 
stimulation of the innate and adaptive immune system. This feature explains the 
remarkable ability of Gp96 to induce specific immune responses against tumors and 
pathogens. 
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Introduction 
The immunogenic potential of heat shock proteins (HSPs) is a well-established 
phenomenon first observed by Srivastava during the immunotherapy of mouse tumors 
(reviewed in Srivastava, 1991). Specificity of the immune response is based on 
peptides that associate with HSPs as a consequence of their function as molecular 
chaperones (Srivastava et al., 1998; Schild et al., 1999). Tumor-specific protection is 
mediated by CD8+ T cells as shown by in vivo cell depletion studies (Udono et al., 
1994) and by the ability to generate cytotoxic T lymphocyte cell lines specific for a 
variety of antigens from mice immunized with HSP molecules (Blachere et al., 1993; 
Arnold et al., 1995; Suto and Srivastava, 1995). The HSPs that mediated this effect 
include the cytosolic HSP70 and HSP90 and the endoplasmic reticulum-resident 
chaperones calreticulin and Gp96 (Basu et al., 2001; Udono and Srivastava, 1994). 
Furthermore, Gp96 molecules have been shown to induce cytotoxic T lymphocyte 
cross-priming against viral and minor histocompatibility antigens, supporting the 
hypothesis that Gp96 molecules are associated with a large repertoire of peptides not 
influenced by the cellular major histocompatibility complex expression (Arnold et al., 
1995; Suto and Srivastava, 1995). HSP molecules can also provide an immunogenic 
context to synthetic peptides complexed to HSP70 or Gp96 molecules in vitro 
(Blachere et al., 1997; Rock et al., 1990). Because of this, HSP molecules have been 
called adjuvants of mammalian origin (Srivastava et al., 1998). Recently, progress has 
been made in understanding the mechanisms that contribute to the efficient induction 
of immune responses against HSP-associated peptides.  
A receptor responsible for the uptake of HSP-peptide complexes has been identified as 
the α2-macroglobulin receptor CD91, expressed on professional antigen-presenting 
cells (APCs) (Binder et al., 2000b; Basu et al., 2001). Only receptor-mediated 
endocytosis has been shown to result in the representation of HSP-associated peptides 
by MHC class I molecules, thus explaining the high efficiency of this process (Singh-
Jasuja et al., 2000b). However, the ideal adjuvant should not only target the antigen to 
professional APCs, it also should induce APC activation to provide the proper 
costimuli required for efficient induction of the immune response. For HSPs, 
especially HSP70, HSP90 and Gp96, this ability has been demonstrated recently. The 
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exposure of macrophages or DCs to HSPs resulted in the upregulation of major 
histocompatibility complex class II and costimulatory molecules as well as in tumor 
necrosis factor α and IL-12 secretion (Asea et al., 2000; Singh-Jasuja et al., 2000a; 
Basu et al., 2000). The contribution of this mechanism in situations of physiological 
relevance is supported by the observation that necrotic but not apoptotic cell death 
leads to the release of HSPs (Basu et al., 2000; Berwin et al., 2001), thus activating the 
innate arm of the immune system to attract cells equipped with antigen specific 
receptors. 
The molecular basis for this process, however, has not been understood thus far. 
Studies investigating the stimulatory effect of HSP60 on epithelial cells and HSP60 
and HSP70 on macrophages demonstrated the involvement of CD14 molecules, 
suggesting the participation of Toll-like receptors (TLRs) (Chen et al., 1999). In 
Drosophila, Toll participates, in addition to the induction (coordination) of dorsal-
ventral patterning during embryogenesis, in the defense against fungi by the induction 
of drosomycin secretion as an early form of innate immune responses against infection 
(Lemaitre et al., 1996). In mammals, TLRs are involved in the response to pathogens 
by the recognition of so-called pathogen-associated molecular patterns. These include 
lipopolysaccharide (LPS), peptidoglycans, and lipoproteins and bacterial CpG-DNA, 
which are recognized by TLR4, TLR2, and TLR9, respectively (Aderem and Ulevitch, 
2000; Hemmi et al., 2000). The TLR signaling pathway shares most components with 
the IL-1 receptor signaling pathway responsible for activation of the innate immune 
system (Aderem and Ulevitch, 2000). 
Recently, HSPs have been linked to TLRs by the observation that HSP60 failed to 
activate TLR4 defective macrophages from C3H/HeJ mice (Ohashi et al., 2000). 
Subsequently, it was shown that genetic complementation of nonresponder cells with 
TLR4 or TLR2 restores responsiveness (gain of function) to HSP60 while TLR2-/- or 
TLR4 deficient cells exhibit a “loss of function”. Surprisingly, macrophage activation 
was equally well induced by bacterial and endogenous mammalian HSP60. Thus, the 
presence of molecular patterns that interact with members of the TLR family is not 
limited to pathogen-derived molecules. Because of this, HSP60 has been proposed to 
serve as a danger signal for the innate immune system (Chen et al., 1999). HSP60 is 
not associated with antigenic peptides (Arnold-Schild and Schild, unpublished 
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observation) and is found much earlier in phylogeny, as are the TLR and IL-1 receptor 
families. Therefore, it remains unclear whether the HSP/TLR pathway is used solely 
by the innate immune system to fight pathogens by unspecific mechanisms or whether 
HSPs with peptide binding ability, such as Gp96, also use this mechanism to link 
nonspecific immunostimulatory capacities with their specific, peptide-based features 
with the activation of the adaptive immune system. 
In this study, we decided to analyze the functional consequences of the interaction of 
Gp96 with members of the TLR family.  
 
Materials and Methods 
Reagents, antibodies, and plasmids 
Gp96 and FITC-labeled Gp96 were provided by Immatics Biotechnologies (Tübingen, 
Germany). LPS from Salmonella minnesota RE 595, monodansylcadaverine (MDC), 
and anisomycin were purchased from Sigma-Aldrich. Phosphothioate stabilized CpG 
oligonucleotide 1668 (TCCATCACGTTCCTGATGC) was purchased from TIB 
MOLBIOL (Berlin, Germany). 
Antibodies to ERK1/2 were obtained from Upstate Biotechnology (Lake Placid, NY), 
and other antibodies used in cell signaling studies, including anti-phospho-JNK1/2 
(Thr183/Tyr185), anti JNK1/2, anti-phospho-p38 (Thr180/Tyr182), anti-p38, anti-IκB-α, 
anti-phospho-ERK1/2 (Thr202/Tyr204), anti-ERK1/2, anti-phospho-STAT1 (Tyr701) and 
anti-STAT1, were from New Engalnd Biolabs (Frankfurt, Germany). Antibodies for 
fluorescence-activated cell-sorting analysis were purchased from BD PharMingen. 
The expression vectors for the NH2 terminus of human FLAG-tagged TLR2 and TLR4 
were gifts from Tularik, Inc. (South San Francisco, CA). The human MD2 expression 
vector was kindly provided by K. Miyake (Sage Medical School, Nabeshima, Japan). 
The luciferase reporter driven by a synthetic enhancer harboring six NF-κB binding 
consensus sites was a gift from P. Baeuerle (München, Germany).  
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Analysis of signaling pathways in RAW264.7 cells 
The mouse macrophage cell line RAW264.7 (purchased from American Type Culture 
Collection, Manassas, VA) was grown in VLE-RPMI medium (Biochrom KG, Berlin, 
Germany) supplemented with 100 IU/ml penicillin/streptomycin (Biochrom KG) and 
10% fetal calf serum (Biochrom KG). Before stimulation, cells were incubated with 
serum-free medium for 2-4 h. Stimulation was performed for the indicated time period 
by the addition of 10 or 100 nM Gp96, 100 nM Gp96 pretreated at 95°C for 20 min or 
2 µM CpG oligonucleotide 1668. 
Cells were then lysed in lysis buffer containing 25 mM HEPES pH 7.5, 150 mM NaCl, 
1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Trition X-100, 10 mM pyrophosphate, 
20 mM β-glycerophosphate, 1 mM orthovanadate, 10 mM sodium fluoride, 10 µg/ml 
leupeptin, 1 mM phenylmethylsulfonyl fluoride. Lysates were boiled in SDS sample 
buffer, sonicated, and centrifuged at 10,000 x g for 10 min. Electrophoresis of the 
lysates was carried out by 10% SDS-PAGE and Western blotting was performed using 
Protran nitrocellulose membranes (Schleicher & Schuell). The membranes were 
blocked in 5% skim milk solution, probed with the indicated antibodies and visualized 
using Renaissance Chemiluminescence Reagent (PerkinElmer Life Sciences). 
When indicated 100 µM MDC was added 20 minutes before stimulation. All following 
steps were performed as described above. 
 
Luciferase reporter assay in 293T human embryonic kidney fibroblasts 
293T human embryonic kidney fibroblasts were cultured in Dulbecco’s modified 
Eagle’s medium (Biochrom KG) supplemented with 100 IU/ml penicillin/streptomycin 
(Biochrom KG) and 10% fetal calf serum (Biochrom KG). For luciferase reporter 
assays, 5-10 x 106 cells were transfected with 1 ng 6x NF-κB luciferase reporter and 
10 ng TLR2 or 10 ng TLR4 plus 10 ng MD2 plasmid DNA. The overall amount of 
plasmid DNA was held constant at 20 µg/electroporation by the addition of empty 
expression vector. Cells were electroporated in a final volume of 400 µl (RPMI-25% 
fetal calf serum) at 200 V and 960 microfarads (Gene Pulser, Bio-Rad). After 
electroporation, cells were washed and cultured in 6-well plates. Cells were 
subsequently stimulated with 100 nM Gp96, 500 nM Gp96, 500 nM Gp96 pre-treated 
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at 95°C for 20 min, or 100 ng/ml LPS overnight in serum-free medium. Cell lysis and 
measurement of luciferase activity in extracts was performed with the Luciferase 
Assay System Kit from Promega (Mannheim, Germany) according to manufacturer‘s 
instructions.  
 
Generation of mouse dendritic cells 
Mouse immature DCs were generated from bone marrow of C3H/HeN, C3H/HeJ, 
C3H/HeJ/TLR2-/-, 129Sv/C57BL/6 and TLR2-/- mice. TLR2-/- mice were obtained 
from Tularic Inc. (South San Fransisco, CA). All other mice were obtained from 
Charles River (Sulzfeld, Germany). For the generation of mouse bone marrow-derived 
DCs, we used Iscove’s modified Dulbecco’s medium (BioWhittaker, Verviers, 
Belgium) supplemented with 2 mM L-glutamine (Invitrogen), 100 IU/ml 
penicillin/streptomycin (Invitrogen), 10% fetal calf serum (PAA, Linz, Austria) and 
200 U/ml granulocyte macrophage colony-stimulating factor. Bone marrow cells were 
incubated in granulocyte macrophage colony-stimulating factor-containing medium 
for 6-8 days, and medium was replaced with fresh granulocyte macrophage colony-
stimulating factor-containing medium every 2 days. The obtained DCs were CD11c-
positive and CD14-negative. 
 
Generation of human dendritic cells 
Human DCs were prepared from freshly drawn blood from healthy donors. Peripheral 
blood mononuclear cells were isolated using a Ficoll density gradient (Lymphoprep; 
Nycomed, Oslo, Norway). The obtained cells were washed twice with phosphate-
buffered saline and resuspended in X-Vivo 15 medium (Bio-Whittaker, Walkersville, 
MD, USA) supplemented with 2 mM L-glutamine, 50 U/ml penicillin and 50 µg/ml 
streptomycin. Peripheral blood mononuclear cells were plated at a density of 20x106 
cells/well. After 2 h at 37 °C, nonadherent cells were removed by washing with 
phosphate-buffered saline. Adherent monocytes were cultured for 6 days in medium 
supplemented with 1% (v/v) human serum (Peel-Freez, Brown Deer, WI, USA), 1000 
U/ml IL-4 (R&D Systems, Minneapolis, USA) and 20 ng/ml granulocyte macrophage 
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colony-stimulating factor (Leukomax; Novartis Pharma GmbH, Nürnberg, Germany). 
The differentiation state of DCs was examined by flow cytometry. Only immature 
DCs that were CD1a+, CD14-, CD83- and CD86low were used for activation 
experiments. The fraction of activated DCs analyzed by CD83 expression was always 
<5 %. 
 
Stimulation of DCs 
Mouse DCs were stimulated by the addition of 1 µM Gp96, 1 µM heat pre-treated 
Gp96, or 2 µg/ml LPS. After 24 h, IL-12 (p40) and IL-10 concentrations in the 
supernatants were measured using standard sandwich enzyme-linked immunosorbent 
assay protocols. Antibodies and recombinant standards of both cytokines were 
obtained from BD PharMingen (Heidelberg, Germany). The capture antibody was 
bound to the enzyme-linked immunosorbent assay plate (MaxiSorbTM; Nunc, 
Roskilde, Denmark), the biotinylated detection antibody was revealed by streptavidin-
conjugated horseradish peroxidase and 2,2’-azino-bis-(3-ethylbenzthiazoline-6-
sulfonic acid) substrate (Sigma), and the assay read at 405 nm. Furthermore, on day 2 
after activation, expression of the costimulatory molecule CD86 was measured by flow 
cytometry (FACSCalibur™; BD PharMingen). Isotype controls of antibodies were 
used in all experiments to determine the appropriate background fluorescence. 
For experiments in the presence of MDC, human monocyte-derived immature 
dendritic cells (day 7) were incubated with 0.5 µM or 1.0 µM Gp96, 1.0 µM Gp96 
heat-inactivated at 95°C for 20 min, or 2 µg/ml LPS in 0.5% Me2SO ±  
250 µM MDC for 16 h. Supernatants were assayed for tumor necrosis factor α and IL-
12 by sandwich enzyme-linked immunosorbent assay as described above. 
 
Confocal microscopy 
Human monocyte-derived dendritic cells (day 7) were seeded on cover slips. The DCs 
were precooled and incubated for 30 min on ice with Iscove’s modified Dulbeccos’s 
medium containing 10% fetal calf serum and 100 µg/ml Gp96 -FITC („pulse“) in 
0.5% Me2SO ± 250 µM monodansylcadaverine (MDC). The coverslips were washed 
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twice and fixed immediately or incubated in Iscove’s modified Dulbeccos’s medium 
for 15 min at 37°C („chase“). Fixation was done in methanol/acetone (ratio, 1:1) at –
20°C. For confocal microscopy, a Zeiss LSM 510 laser scanning microscope was used. 
Thickness of the optical plane was adjusted by the pinhole to be < 1 µm. 
 
Results 
Gp96 interacts with TLR2 and TLR4 
Among the members of the TLR family, the ligands for TLR2, TLR4 and TLR9 have 
been studied in considerable detail. Interestingly, HSP60 has been shown to activate 
macrophages via TLR4 (Ohashi et al., 2000). Inspired by these observations, we 
investigated the potential of these TLRs to trigger Gp96-mediated APC activation 
(Singh-Jasuja et al., 2000b; Basu et al., 2000). For this purpose, we incubated 293T 
human embryonic kidney fibroblast transiently transfected with different TLRs and the 
luciferase reporter driven by synthetic enhancer containing NF-κB binding consensus 
sites with Gp96 or LPS as a control. As shown in Fig. 1, the expression of TLR2 and 
also TLR4/MD-2 conferred responsiveness to the Gp96 stimulus in a dose-dependent 
manner. Boiling of Gp96 abolished the induction of luciferase activity, thus 
demonstrating that possible endotoxin contaminations in the Gp96 preparation were 
not responsible for the observed effect. Likewise, the presence of polymyxin B (an 
LPS inhibitor) did not interfere with Gp96-mediated activation (data not shown).  
TLR4-mediated Gp96 activation is dependent on the presence of MD2 as transfection 
with TLR4 or MD2 alone did not result in the induction of luciferase activity (Fig. 1). 
LPS mediates NF-κB-driven luciferase induction via TLR2 and TLR4. This finding is 
in line with previous reports showing that in addition to TLR4-mediated activation by 
LPS, other endotoxin contaminations present in commercially available LPS also 
mediate APC activation via TLR2 (Hirschfeld et al., 2000). Transfection of TLR3, 
TLR7, TRL8, and TLR9 did not confer responsiveness to the Gp96 stimulus 
(stimulation indices between 1.2 and 1.5; data not shown). 
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Gp96 mediates DC activation via TLR4 and TLR2 
To analyze the contribution of TLR2 and TLR4 under more physiological situations, 
we studied the Gp96-mediated activation of bone marrow-derived DCs (BMDCs) from 
mice lacking functional TLR2 or TLR4 molecules or both. In the first set of 
experiments, we investigated the secretion of the pro-inflammatory cytokine IL-12 in 
response to Gp96, LPS, and CpG DNA. As shown in Fig. 2, BMDCs from C3H/HeN, 
TLR2-/-, and TLR2 wild-type but not C3H/HeJ (a TLR4 deficient mouse) and 
C3H/HeJ/TLR2-/- (TLR2-/-/TLR4-deficient) mice responded to the Gp96 stimulus by 
secretion of IL-12. CpG DNA induced IL-12 secretion in all cultures, and LPS-
mediated activation was impaired in BMDCs from C3H/HeJ and C3H/HeJ/TLR2-/- 
mice, in line with previous reports. Again, boiled Gp96 did not induce any stimulation. 
The lack of TLR2 did not affect Gp96-mediated IL-12 secretion from BMDCs. 
 
 
Figure 1. Gp96 activates cells via TRL2 and TLR4. 293T human embryonic kidney 
fibroblasts were transiently transfected with the indicated Toll-like receptors. At the same time, 
they were cotransfected with luciferase reporter driven by a synthetic enhancer harboring NF-
κB binding consensus sites. Luciferase activity was measured after stimulation by Gp96, boiled 
Gp96, and LPS. Only cells transfected with TLR2 or TLR4 plus MD2 respond to Gp96 
activation; cells without Toll-like receptor transfection did not respond to Gp96 activation. 
Each error bar represents the deviation of duplicates. The results are representative of three 
independent experiments. In some cases, the fold induction of luciferase activity relative to the 
unstimulated cells is indicated. 
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During Gp96-mediated DC activation, secretion of IL-12 is accompanied by the up-
regulation of the costimulatory molecule CD86 (Singh-Jasuja et al., 2000b; Basu et al., 
2000). Therefore, CD86 expression in mice lacking TLR2 and/or TLR4 molecules was 
investigated. As observed for the secretion of IL-12, BMDCs from C3H/HeN, TLR2-/-, 
and TLR2 wild-type mice but not from C3H/HeJ and C3H/HeJ/TLR2-/- mice up-
regulated CD86 molecules after 48 h coculture with Gp96. 
Fig. 3A shows CD86 up-regulation for one C3H/HeN mouse and one C3H/HeJ mouse; 
Fig. 3B represents mean values of CD86 up-regulation of three individual mice. This 
effect was again heat-sensitive. CpG-DNA induced CD86 up-regulation on all 
BMDCs, whereas LPS was impaired in BMDCs from C3H/HeJ and TLR2/4-/- mice. A 
minimal up-regulation of CD86 molecules in C3H/HeJ mice compared with TLR2/4-/- 
mice was observed in three independent experiments and might be caused by the 
interaction of Gp96 with TLR2 as observed for the NF-κB driven luciferase induction 
reported in Fig. 1. In TLR2-/- mice, this effect can obviously be compensated by TLR4. 
 
 
Figure 2. Gp96 -induced IL-12 production by dendritic cells is TLR4-dependent. Bone 
marrow-derived dendritic cells from the indicated mouse strains were cultured in the presence 
of Gp96 (1 µM), boiled Gp96, CpG (oligonucleotide 1668, 2 µM), or LPS (2 µg/ml). After 
20 h, IL-12 concentration in cell culture supernatant was measured by sandwich enzyme-
linked immunosorbent assay. The mean value of triplicates is shown, and error bars represent 
standard deviation.  
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Gp96 activates classical signaling cascades 
The interaction of Gp96 with TLR2 and TLR4 suggests that the activation of APCs 
involves the classical signaling cascades described for other TLR2 and TLR4 ligands 
(Hemmi et al., 2000; Kaisho and Akira, 2001).To analyze this issue, the macrophage 
cell line RAW264.7 was incubated with different concentrations of Gp96 and probed 
for the phosphorylation of JNK1/2, stress-activated protein kinase (SAPK) p38, the 
mitogen-activated protein kinase (MAPK) extracellular signal-regulated kinase 1/2 
(ERK1/2) and the degradation of IκB-α as an indication for the activation of the NF-
κB pathway. Fig. 4 shows that all kinases tested were activated. The Gp96 effect was 
again heat sensitive. CpG-DNA was used as a positive control. 
 
Figure 3. Gp96 mediates DC activation via TLR4 and 
TLR2. Bone marrow-derived dendritic cells were 
stimulated with Gp96, CpG, or LPS (using the same 
concentrations as described in the Fig. 2 legend). After 2 
days, surface expression of CD86 was evaluated. 
Appropriate isotype control stainings were included. (A) 
CD86 surface expression by BMDCs from C3H/HeJ and 
C3H/HeN control mice is shown. C3H/HeJ-derived 
dendritic cells do not up-regulate CD86 in response to 
Gp96, whereas CpG activation is not affected, and LPS 
activation is only partially affected. (B) The percentage 
of CD86high cells of triplicates was evaluated. Mean 
values were corrected by the percentage of CD86-
positive cells in control samples (20%, as shown in (A)). 
Error bars represent standard deviation of mean of the 
mean. Gp96-induced DC maturation is impaired in 
C3H/HeJ mice and impaired even more in 
C3H/HeJ/TLR2-/- mice. In contrast, mice missing only 
TLR2 are not affected, suggesting that the function of 
TLR2 can be compensated by TLR4 in these cells. 
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DC activation requires endocytosis of Gp96 
Because major histocompatibility complex class I-restricted representation of HSP70- 
as well as Gp96-associated peptides depends on receptor-mediated, clathrin-dependent 
endocytosis of these molecules and subsequent transport to multivesicular 
compartments (Arnold-Schild et al., 1999; Singh-Jasuja et al., 2000b), we investigated 
whether endocytosis of Gp96 might be a prerequisite for DC activation. MDC is an 
inhibitor of the membrane-bound transglutaminase and interferes with clathrin- 
mediated receptor trafficking as demonstrated for the α2-macroglobulin receptor, 
CD91 (Davies et al., 1980). Interestingly, CD91 has been shown to be responsible for 
Gp96 uptake and representation of the associated peptides (Basu et al., 2001; Binder et 
al., 2000b) after receptor-mediated endocytosis (Singh-Jasuja et al., 2000b). 
 
Figure 4. Gp96 triggers classical 
signaling cascades. RAW267.4 
macrophages were incubated with 
different concentrations of Gp96 for 60 
or 90 min and with 2 µg/ml CpG-DNA 
as a positive control for 30 min. Cells 
were lysed and the amount of phospho-
JNK, phospho-p38, phospho-ERK and  
was determined by western blot. In 
addition, the total amount of JNK, p38 
and ERK in lysates was determined. 
JNK1/2, p38 and ERK1/2 were activated 
upon stimulation with Gp96 in a time 
and concentration dependent manner. At 
the same time, the NF-κB pathway was 
triggered as indicated by the degradation 
of IκB-α. The stimulatory effect of Gp96 
was heat sensitive. 
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Indeed, MDC was found to inhibit the endocytosis of FITC-labeled Gp96 molecules 
by DCs (Fig. 5). The presence of 0.5% Me2SO did not influence Gp96 uptake 
compared with medium control lacking Me2SO (data not shown). Therefore, the 
accumulation of Gp96-FITC at the cell membrane is due to the effect of MDC. 
The lack of Gp96 endocytosis in the presence of MDC is accompanied by the lack of 
tumor necrosis factor α secretion (Fig. 6). As a control, LPS-mediated DC activation is 
not inhibited by MDC. These results also argue against an endotoxin contamination in 
the Gp96 preparation being responsible for the observed effect. Similar results were 
obtained for the Gp96-induced secretion of IL-12 (data not shown).  
We next analyzed the effect of MDC on the signal transduction pathways and found 
that it also interfered with the phosphorylation of JNK1/2 (Fig. 7). The inhibitory 
effect of MDC was dose-dependent (data not shown) and did not influence the 
anisomycin-mediated phosphorylation of JNK1/2 (used as control). Thus, Gp96 
mediates activation of DCs via TLR2 and TLR4 using the SAPK, MAPK, and NF-kB 
pathways in a process that requires endocytosis. 
 
 
 
 
 
 
 
Figure 5. Monodansylcadaverine 
inhibits receptor-mediated endo-
cytosis of Gp96. Human monocyte-
derived immature dendritic cells were 
incubated with Gp96-FITC at 4°C and 
washed and fixed (no endocytosis) or 
treated at 37°C for an additional 15 
min (endocytosis) and fixed with 
methanol/acetone. The confocal 
micrographs show an overlay of the 
transmission and fluorescence 
channels. In the presence of MDC, 
uptake of Gp96-FITC was substantially 
inhibited. MDC is an inhibitor of 
transglutaminase and has been shown 
to abrogate clathrin-dependent 
receptor-mediated endocytosis. 
Viability of cells (tested by trypan blue 
staining) in 0.5% Me2SO and 250 µM 
MDC was approximately 95% and 
90%, respectively. Representative 
sections are shown. Identical results 
were obtained in at least four 
independent experiments. 
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Figure 6. Receptor-mediated endocytosis is required for Gp96-mediated DC activation. 
Human monocyte-derived immature dendritic cells were activated by Gp96 and LPS in the 
presence and absence of 250 µM MDC. Boiled Gp96 was used as a control to exclude the 
possibility of endotoxin contaminations in the Gp96 preparation. MDC specifically inhibited 
Gp96-mediated DC activation, whereas the activity of LPS was unchanged in the presence of 
MDC. This demonstrates that receptor-mediated endocytosis is required for Gp96-mediated 
activation of dendritic cells. Error bars represent S.E. 
 
Figure 7. Endocytosis of Gp96 is required for activation of JNK. RAW267.4 macrophages 
were stimulated with different concentrations of Gp96 for 60 or 90 min or with 0.2 µg 
anisomycine for 10 min. Cells were incubated in either standard medium, medium containing 
100 µM MDC, or medium containing Me2SO matching the amount used for solvation of 
MDC. The assay of JNK was performed as described in Fig. 4. The stimulatory capacity of 
Gp96 is abrogated upon inhibition of endocytosis by MDC. Stimulation by anisomycine was 
unaffected by MDC treatment. The overall amount of JNK remained the same in all samples.  
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Discussion 
We identified the molecular mechanism of APC activation by the endoplasmic 
reticulum-resident chaperone Gp96. We find that TLR2 and TLR4 mediate NF-κB-
driven luciferase induction (Fig. 1) and that mainly TLR4 and, to a small extent, TLR2 
are responsible for the up-regulation of CD86 and the secretion of IL-12 and tumor 
necrosis factor α (Figs. 2 and 3). IL-10 was not detectable (<1.5 ng/ml; data not 
shown), which is in line with the previously reported secretion of only pro-
inflammatory cytokines (Singh-Jasuja et al., 2000b; Basu et al., 2000). TLR3, TLR7, 
TLR8, and TLR9 molecules appear not to be involved in Gp96-mediated signaling 
(data not shown). Expression of CD86 and cytokine secretion is preceded by the NF-
κB pathway and activation of the SAPKs JNK1/2 and p38 as well as the mitogen-
activated protein kinase ERK1/2 (Fig. 4). DC activation is inhibited by MDC, which 
interferes with receptor-mediated endocytosis (Figs. 5-7). 
Despite the fact that Gp96 and LPS are very different molecules, they both mediate 
DC activation via TLR4 and TLR2. The nature of the pathogen-associated molecular 
pattern of HSPs that allows their specific interaction with TLR2 and TLR4 is 
unknown. We are currently investigating the possibility that Gp96 and microbial 
components interfere with each others in binding to both TLRs. However, regardless 
of their shared interaction with TLR2 and TLR4 molecules, several differences in their 
mode of action are apparent. The most striking observation is that the Gp96-mediated 
DC activation strictly depends on the endocytosis of Gp96, whereas LPS-mediated DC 
activation does not require endocytosis and thus functions in the presence of the 
endocytosis inhibitor MDC. As a consequence, Gp96 - but not LPS-mediated secretion 
of cytokines is impaired in the presence of MDC (Fig. 6). This, together with the 
observed sensitivity of Gp96-mediated DC activation to heat denaturation, also 
demonstrates that an endotoxin contamination in the Gp96 preparation does not 
account for the observed effects. 
This is further supported by the observation that cells expressing Gp96 molecules 
targeted to their surface induce efficient DC maturation upon cell-to-cell contact 
(Zheng et al., 2001). Internalization of TLR2 during the activation of macrophages has 
been observed previously (Underhill et al., 1999). In this series of experiments, TLR2 
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was found to accumulate in phagosomes of macrophages activated with the yeast cell 
wall particle zymosan. Whether or not endocytosis was a prerequisite for activation 
was not investigated. Our results obtained with Gp96 as an agonist for TLR2 and 
TLR4 suggest this to be the case.  
The importance of HSP endocytosis for macrophage activation has very recently been 
reported for the HSP60/TLR2/4-mediated activation of macrophages (Vabulas et al., 
2001). Here, we observe the same effect for the new TLR2 and TLR4 ligand, Gp96, 
and extent. Our finding parallels the need for Gp96 endocytosis during receptor-
mediated uptake and representation of Gp96-associated peptides (Arnold-Schild et al., 
1999; Singh-Jasuja et al., 2000b) that is mediated through the interaction of Gp96  
with CD91, the receptor for α2-macroglobulin (Basu et al., 2001; Binder et al., 2000b). 
Interestingly, MDC has been first described as an inhibitor of endocytosis of the α2-
macroglobulin receptor (Davies et al., 1980). 
An interesting scenario can be postulated from the above findings: similar to the 
proposed requirement of LPS-mediated activation for CD14 and LPS-binding protein 
on the cell surface (reviewed in Golenbock and Fenton, 2001), Gp96-mediated DC 
activation might depend on the presence of CD91 molecules that endocytose bound 
Gp96 molecules and subsequently mediate their transport to endocytic vesicles, as 
described previously (Arnold-Schild et al., 1999). This process will increase the local 
concentration of Gp96, now able to trigger signaling through TLR2 and TLR4 present 
in these vesicles (Wagner, 2001) by the recruitment of cytosolic MyD88 to the outer 
membrane of endocytic vesicles.  
The contribution of TLR2 to Gp96-mediated DC activation is not clear. Whereas 
transfection of TLR2 induces NF-κB-driven luciferase activity (Fig. 1), TLR2-/- mice 
show normal Gp96-mediated DC activation profiles (Fig. 2 and Fig. 3b). On the other 
hand, Gp96-mediated DC activation in C3H/HeJ mice is always stronger than in 
TLR2-/-/TLR4-deficient mice, which are not able to respond to a Gp96 stimulus at all. 
This observation suggests a minor contribution of TLR2. In TLR2-/- mice, the lack of 
TLR2 signaling can apparently be completely compensated by TLR4, but TLR2 can 
induce only minimal activation when TLR4 is not functional, as observed for BMDCs 
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from C3H/HeJ mice. One explanation could be an imbalance in the expression of 
TLR2 and TLR4 on BMDCs, favoring effects mediated by TLR4.  
However, the interaction of both TLR molecules with Gp96 is strongly supported by 
the recent finding that the interaction of TLR2 and TLR4 with Gp96 inside the 
endoplasmic reticulum is crucial for the expression of these receptors on the cell 
surface (Randow and Seed, 2001). 
Thus far, TLRs have been described as sensors for pathogen-associated molecular 
patterns crucial for the initiation of an innate immune response. These mechanisms 
were developed long before the adaptive immune system. One of the newest additions 
to the list of TLR ligands identified is HSP60. Interestingly, not only bacterial but also 
human HSP60 cross-react with TLRs (Vabulas et al., 2001). Our results now 
demonstrate that the exclusive association of TLRs with pathogen-associated 
molecular patterns is obsolete. Gp96 is not expressed in bacteria or fungi and provides 
the first example of a non-pathogen derived ligand of TLRs. More importantly, our 
results show for the first time how the innate and adaptive immune system can be 
stimulated simultaneously by the same molecule that is released under physiological 
situations from necrotic cells (Basu et al., 2000; Berwin et al., 2001). The importance 
of these TLR-mediated stimuli for the induction of T helper type 1-dominated immune 
responses has been observed recently using MyD88-/- mice (Schnare et al., 2001). 
Gp96 has kept the ability (probably HSP60-derived) to stimulate APCs nonspecifically 
via TLRs but added a new function: to act as a carrier for antigenic peptides and to 
promote receptor-mediated uptake by professional APCs (Arnold-Schild et al., 1999; 
Singh-Jasuja et al., 2000b). The unique combination of both features now allows the 
major histocompatibility complex-restricted presentation of antigenic peptides to cells 
of the adaptive immune system in an immunostimulatory context and enables DCs to 
act as coordinators of innate and adaptive immune responses. Being able to understand 
these mechanisms will make it possible to interfere with the HSP-mediated activation 
of APCs and to rationally modulate immune responses towards either immunity or 
tolerance. 
 
                                                             5 – GP96-ACTIVATED DCS INDUCE CTL RESPONSES 
  115 
5 
 
Sabine Ramirez1,3, Harpreet Singh-Jasuja1,3, Tobias Warger2, 
Sibylla Braedel-Ruoff2, Norbert Hilf1, Katrin Wiemann1, 
Hans-Georg Rammensee1, Hansjörg Schild2 
 
 
GLYCOPROTEIN 96-ACTIVATED DENDRITIC 
CELLS INDUCE A CD8-BIASED T-CELL 
RESPONSE 
 
 
1
 Institute for Cell Biology, Department of Immunology, University of Tübingen, Auf der 
Morgenstelle 15, D-72076 Tübingen, Germany 
2
 Institute for Immunology, University of Mainz, Obere Zahlbacher Str. 67, D-55131 Mainz, Germany 
3
 The first two authors contributed equally 
 
 
 
 
 
 
This chapter has been published in: 
Cell Stress Chaperones 10[3], 221-229 (2005) 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
116 
Heat shock proteins (HSPs) are able to induce protective immune responses against 
pathogens and tumors after injection into immunocompetent hosts. The activation of 
components of the adaptive immune system, including cytotoxic T lymphocytes (CTLs) 
specific for pathogen- or tumor-derived peptides, is crucial for the establishment of 
immunoprotection. HSPs acquire these peptides during intracellular protein 
degradation and when released during necrotic cell death, facilitate their uptake and 
MHC-restricted representation by professional antigen-presenting cells (APCs). In 
addition, the interaction of HSPs with APCs, including the ER-resident chaperone 
Gp96, induces the maturation of these cells by Toll-like receptor (TLR)-mediated 
signalling events. We now provide evidence that in contrast to LPS-mediated DC 
maturation, the interaction of Gp96 with dendritic cells (DCs) leads to the preferential 
expansion of antigen-specific CD8-positive T cells in vitro and in vivo. This CD8 
preference induced by mouse and human DCs did not correlate with enhanced levels 
of IL-12 secretion. Thus, despite the fact that both, LPS and Gp96 activate DCs in a 
TLR4-dependent manner, our experiments clearly demonstrate qualitative differences 
in the outcome of this maturation process which preferentially favours the expansion 
of CD8-positive T cells. 
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Introduction 
Antigenic peptides chaperoned by heat shock proteins have been described as potent 
tumor vaccines in animal models and are currently studied in clinical trials. Recently, a 
considerable number of new functions have been uncovered for particularly one heat 
shock protein, the ER-resident Glycoprotein 96 (Gp96, also known as Glucose-
regulated protein 94, Grp94). Gp96 is not only a peptide carrier but also targets surface 
receptors on antigen-presenting cells, e.g. CD91 for efficient delivery of its peptide 
cargo into the MHC class I antigen processing pathway. This results in the receptor-
mediated cross-presentation of the Gp96-associated peptides on MHC class I 
molecules and activation of cytotoxic T lymphocytes (Arnold-Schild et al., 1999; 
Wassenberg et al., 1999; Singh-Jasuja et al., 2000b; Binder et al., 2000b). 
Furthermore, Gp96 simultaneously activates APCs like dendritic cells in vitro (Singh-
Jasuja et al., 2000a; Basu et al., 2000) and in vivo (Binder et al., 2000a) resulting in 
increased co-stimulatory activity and release of pro-inflammatory cytokines and nitric 
oxide (Panjwani et al., 2002). We have also demonstrated that maturation of dendritic 
cells by Gp96 requires the presence of Toll-like receptor 2 and 4 (Vabulas et al., 
2002b). These results support the speculation that heat shock proteins like Gp96 
function as local danger signals in response to cellular stress. This has been underlined 
by several observations: Gp96 is released during necrotic cell death and viral lysis but 
not after apoptosis (Basu et al., 2000; Berwin et al., 2001). Necrotic lysates from 
primary tumor tissue able to mature dendritic cells have been shown to be enriched of 
HSPs and the amount of HSPs in the lysates was critical for the ability of DC 
maturation (Somersan et al., 2001). At the same time, platelets efficiently bind Gp96, 
neutralizing its ability to activate DCs, a proposed regulatory mechanism confining the 
effective area of activating HSPs to the local tissue (Hilf et al., 2002). The APC-
activating function of Gp96 is presumably an intrinsic capability independent of the 
associated peptides (Baker-LePain et al., 2002). 
Previously, we have shown that dendritic cells activated by Gp96 exhibit an enhanced 
T cell stimulatory capacity demonstrated by in vitro proliferation assays with 
allogeneic T cells (Singh-Jasuja et al., 2000a). Investigating this phenomenon in more 
detail, we now find that human monocyte-derived and mouse bone marrow-derived 
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dendritic cells matured by Gp96 activate CD8+ cytotoxic T cells rather than CD4+ 
helper T cells in vitro as well as in vivo. On the other hand, DC maturation by LPS 
shows a preference for the expansion of CD4+ T cells. We conclude that the interaction 
of Gp96 with DCs induces maturation signals that qualitatively differ from those 
mediated by LPS resulting in the induction of immune responses dominated by CD8+ 
T cells. 
 
Materials and Methods 
Mice 
C57BL/6 (H2b, CD90.2+) mice were obtained from Charles River. Congenic 
C57BL/6J-IghaThy1aGpi1a (H2b, CD90.1+) mice were obtained from Jackson 
Laboratories. OT-I (Hogquist et al., 1994) and OT-II (Barnden et al., 1998) mice 
which have a transgenic T-cell receptor for the H2-Kb-restricted SIINFEKL peptide 
derived from Ovalbumin257-264 or for the H2-Ab-restricted ISQAVHAAHAEINEAGR 
peptide derived from Ovalbumin323-339, respectively, and St42 mice (transgenic T-cell 
receptor for H2-Db-restricted Ad5-E1A234-243 peptide) were obtained from the animal 
facility of the Leiden University Medical Center (The Netherlands) (den Boer et al., 
2001). 
 
Generation of DC 
Mouse immature DCs were generated from bone marrow of C57BL/6 mice according 
to standard protocols (Inaba et al., 1992) in Iscove’s Modified Dulbecco’s Medium 
(IMDM; BioWhittaker, Verviers, Belgium) supplemented with 200 mM L-glutamine 
(GibcoBRL Life Technologies, Paisley, GB), 100 IU/ml penicillin/streptomycin 
(Gibco), 10% FCS (PAA, Linz, Austria) and cytokines as indicated below. Briefly, 
bone marrow cells were incubated with 150 U/ml granulocyte-macrophage colony 
stimulation factor (GM-CSF, PeproTech, London, GB) for 7 days with medium 
renewed every 2 days. Approximately 90-100% of all cells in the FACS gate used for 
monocytes were DCs determined by flow cytometry with antibodies (obtained from 
Pharmingen, San Diego, CA) to be CD11c+, CD14-, CD86low and H2-Ab+. Human 
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immature DCs were prepared from peripheral mononuclear blood cells (PBMC) 
according to Bender et al. (Bender et al., 1996) in X-Vivo 15 medium (Walkersville, 
USA) supplemented with 200 mM
 
L-glutamine, 100 IU/ml penicillin/streptomycin, 
1% human serum (Peel-Freez, Brown Deer, WI, USA) and cytokines as indicated 
below. Briefly, monocytes isolated by Ficoll density gradient (Lymphoprep, Nycomed, 
Oslo, Norway) and plastic adherence were cultured in medium supplemented with    
10 µg/ml interleukin-4 (IL-4, R&D Systems, Minneapolis, USA) and 50 µg/ml GM-
CSF (Leukomax, Novartis Pharma GmbH, Nürnberg, Germany) for 6-8 days. The 
cells generated in this way showed a large number of dendrites up to day 12 and were 
only slightly adherent. They expressed CD1a, low CD14, low CD86, HLA-DR and 
very low CD83 on their surface as determined by different antibodies (from BD 
PharMingen) in flow cytometry (data not shown). All FACS analyses were performed 
on a FACSCalibur® (Becton Dickinson, Mountain View, CA) using Cell Quest 
Software. 
 
Stimulation of DCs 
Mouse BMDCs were stimulated by addition of Gp96 or heat-treated Gp96 (95°C for 
20 min) or LPS (from Salmonella typhimurium, Sigma Chemicals, St. Louis, MO) for 
6 h to 3 days. Gp96 was used at 100 µg/ml and LPS at 100 ng/ml unless indicated 
otherwise. Gp96 (kindly provided by Immatics Biotechnologies, Tübingen, Germany) 
was purified from the IGELa2 mouse cell line (tested mycoplasma-free). Endotoxin 
content in commercial Gp96 preparations was tested using a Limulus Amebocyte 
Lysate Kit (QCL-1000, BioWhittaker) according to the guidelines published by the US 
Food and Drug Administration. The endotoxin content determined in all cases was 
below 0.05 EU/µg Gp96.  
Supernatants were taken after 18-24 h and mouse IL-12 (p40) was measured using 
standard sandwich ELISA protocols (antibodies and standards by BD PharMingen), 
streptavidin-conjugated horseradish peroxidase and 2,2’-azino-bis-(3-ethylbenz-
thiazoline-6-sulfonic acid) (ABTS) substrate (Sigma). Furthermore, on day 3 after 
activation, expression of the co-stimulatory molecule CD86 was measured by flow 
cytometry (data not shown).  
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Human monocyte-derived, immature dendritic cells (day 7) were stimulated by Gp96, 
heat-treated Gp96, LPS or heat-treated LPS. Gp96 was used at 100 µg/ml and LPS at 
100 ng/ml unless indicated otherwise. Supernatants were assayed for TNF- or IL-12 
by sandwich ELISA as described above (data not shown). On day 3 after activation, 
expression of co-stimulatory molecules CD83 and CD86 and MICA/B were measured 
by flow cytometry. 
 
Stimulation of alloreactive T cells 
Human DCs were stimulated with different activators in a 96 well plate for 3 days as 
described above, washed extensively and incubated with PBLs (ratio 1:10) from a 
different donor for 5 days. CD69 and MHC class II (data not shown) expression, both 
markers for human T cell activation, was determined on day 1 or 5, respectively, by 
flow cytometry.  
 
Stimulation of St42 CD8 T cells in vitro 
Immature BMDCs were activated as described above for three days, washed 
extensively and loaded with 1 µg/ml H2-Db-restricted Ad5-E1A234-243 peptide 
(sequence SGPSNTPPEI) for 1.5 h at 37°C. E1A peptide was synthesized on a ABI 
432 A peptide synthesizer (Applied Biosystems) applying Fmoc chemistry. 2x104 
loaded BMDCs were washed four times and incubated with 1x106 CFSE 
(carboxyfluorescein diacetate succinimide ester)-labelled splenocytes from St42 mice. 
4 and 5 days later proliferation and intracellular IFN- production were measured by 
flow cytometry. Cells were labelled with CFSE by incubation with 1 µM CFSE in PBS 
at room temperature for 3 min in the dark and then washed three times with IMDM 
containing 10% FCS. For flow cytometric analysis intracellular IFN- staining was 
performed using the Cytofix/Cytoperm™ kit (BD Pharmingen, San Diego, CA) 
according to the instructions of the manufacturer using a phycoerythrin-labelled anti-
mouse IFN- antibody (BD Pharmingen). 
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Adoptive Transfer 
St42 adoptive transfer: 30x106 CFSE-labelled CD90.1+ heterozygous St42 spleen 
cells were injected i.v. into CD90.2+ homozygous C57BL/6 on day 0. Transferred 
CSFE-labelled cells could be detected by flow cytometry in peripheral blood on day 1. 
On day 2, BMDCs from C57BL/6 mice activated with different stimulators as 
described above were loaded with 100 µg/ml H2-Db-restricted Ad5-E1A234-243 peptide 
or 100 µg/ml H2-Db-restricted Ad5-E1B peptide (sequence VNIRNCCYI) as a 
negative control peptide for 1 h at 37°C and 4x105 peptide-loaded BMDCs were 
injected i.p. into the mice. At days 6 and 8 cells from peripheral blood as well as 
lymph nodes were analyzed by flow cytometry. 
OT-I/OT-II adoptive transfer was performed similar to the adoptive transfer of St42 
mice except for the following changes: 30x106 CFSE-labelled CD90.2+ homozygous 
OT-I or OT-II spleen cells were injected i.v. into CD90.1+ homozygous C57BL/6 mice 
on day 0. BMDCs from C57BL/6 mice were incubated with 100 ng/ml H2-Kb-
restricted Ova257-264 peptide or 10 µg/ml H2-Ab-restricted Ova323-339 peptide for 1 h at 
37°C. 
 
Results 
Dendritic cells are activated by Gp96 
Bone-marrow derived dendritic cells (BMDC) were generated from C57BL/6 mice 
according to established protocols. Incubation of these immature dendritic cells with 
Gp96 for 3 days led to up-regulation of the co-stimulatory molecules CD80 and CD86 
(data not shown, see Singh-Jasuja et al., 2000a) and release of pro-inflammatory 
cytokines like IL-12 and IL-6 (Fig. 1A). As lipopolysaccharides (LPS) from gram-
negative bacteria are also described as potent TLR4-dependent DC stimulators, the 
possibility of LPS contaminations in the Gp96 preparation had to be addressed.  For 
this, the following control experiments were performed: A) Gp96 and LPS were both 
boiled for 20 min prior addition to the cell culture medium. While the activity of Gp96 
was completely lost by the heat treatment, the activity of LPS was not affected (Singh-
Jasuja et al., 2000a). B) The addition of the endocytosis inhibitor 
monodansylcadaverine (MDC) abolished the ability of Gp96 but not of LPS to induce 
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DC activation. Thus, activation of DCs by Gp96 depends upon the endocytosis of 
Gp96 while activation by LPS is endocytosis independent (Vabulas et al., 2002b). C) 
Endotoxin levels in the Gp96 preparations by Limulus lysate assay were determined to 
be below 0.05 E.U./µg. Low amounts of LPS (0.5 ng/ml) which correspond to the 
level of endotoxin detected in Gp96 preparations were not able to mature dendritic 
cells (Fig. 1A). D) Fractions obtained from the chromatographic purification of Gp96 
which contained no Gp96 but similar levels of endotoxin when compared to the Gp96-
containing fraction did not lead to maturation of DCs (Fig. 1A). 
 
Dendritic cells matured by Gp96 show enhanced stimulation of peptide-specific 
CD8 T-cells in vitro 
To study the activation of peptide-specific T-cells, BMDCs from C57BL/6 mice were 
activated by Gp96, boiled Gp96 (both at 100 µg/ml) or LPS at 100 ng/ml.  These 
concentrations were selected because they induce optimal BMDC activation as judged 
by the expression of CD80, CD86 and the production of the pro-inflammatory 
cytokines IL-6, IL-12 and TNF- (data not shown). One day later, the activation status 
of the BMDCs was measured by determining IL-12 levels in the supernatant (Fig. 1D). 
3 days after activation, these DCs were loaded with E1A peptide, washed extensively 
and co-cultured with CFSE-labelled spleen cells from St42 mice expressing transgenic 
T cell receptors specific for E1A peptide bound to H2-Db molecules. The fluorescein-
based dye CFSE is split among daughter cells during cell division, thus emission of 
CFSE-labelled cells is reduced with every round of proliferation (Weston and Parish, 
1990). 4 days after T cell stimulation, proliferation of CD8 T cells was measured by 
determining the level of CFSE (Fig. 1B). On day 5, activation (by determining 
intracellular IFN- production) and proliferation of CD8 T cells in the culture were 
measured simultaneously (Fig. 1C). Thus, DCs matured by Gp96 induce a 
significantly stronger proliferation (Fig. 1B) as well as activation (Fig. 1C) of CD8 T 
cells from St42 mice compared to LPS-matured DCs. This was observed despite the 
fact that LPS-matured DCs produced higher levels of IL-12 (Fig.1D) or IL-6 and 
showed no difference in the expression of co-stimulatory molecules (data not shown).  
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Figure 1. Mouse BMDCs matured by Gp96 induce peptide-specific proliferation and IFN- 
production by CD8 T cells in vitro. (A) Cytokine production by mouse BMDCs matured by Gp96 
or control stimuli for 3 days. (B) Proliferation of St42 CD8 T cells in vitro. BMDCs from C57BL/6 
mice were treated with Gp96 or LPS for 3 days and loaded with Ad5-E1A peptide to be used for co-
culture with CFSE-labelled spleen cells from St42 mice. Proliferation of CD8 T cells was assayed 
by flow cytometric analysis on day 4 after T cell stimulation. (C) IFN- production of St42 CD8 T 
cells in vitro. The graph shows the percentage of intracellular IFN- production of the most 
proliferated CD8 T cells on day 5 (see insert). (D)  IL-12 production of the BMDCs used for the in 
vitro activation of St42 T cells. The results are representative of three independent experiments.  
B A 
C 
D 
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Gp96-matured dendritic cells show enhanced stimulation of CD8 T cells in vivo 
Next, we extended the results obtained for the proliferation of St42 T cells in vitro to 
an in vivo model. For this, CFSE-labelled spleen cells from St42 mice (CD90.1+) were 
injected into the tail vein (i.v.) of CD90.2+ C57BL/6 mice. 24 hours later the injected 
CD90.1+, CFSE-labelled St42 T cells could be detected in the blood of CD90.2+ mice 
and represented approximately 1% of all peripheral blood cells (data not shown). One 
day later, BMDCs matured by Gp96 or LPS for 6 hours or 3 days were loaded with 
E1A peptide or irrelevant E1B control peptide and injected intraperitoneally (i.p.) into 
these mice. 8 days after injection of St42 cells peripheral blood and draining lymph 
nodes were collected to analyze the proliferation of the CFSE-labelled CD90.1+ St42 T 
cells in response to DC immunization. As shown in Fig. 2 in vivo proliferation of St42 
T cells in response to BMDCs matured by Gp96 was significantly stronger compared 
to non-matured or LPS-matured DCs (Fig. 2A, B) although Gp96 and LPS-induced 
maturation of DCs was comparable as judged on the basis of IL-12 (Fig. 2C) or IL-6 
production determined prior to DC injection. No proliferation of St42 T cells was 
observed without injection of DCs (Fig. 2B) or when DCs loaded with an irrelevant 
control peptide were injected (data not shown). 
 
Mouse Gp96-matured DCs preferentially activate CD8 T cells vs. CD4 T cells in 
vivo 
So far, we demonstrated that although Gp96 and LPS were able to mature BMDCs in 
vitro to a similar extent, Gp96-matured DCs induced a stronger CD8 T cell activation 
as LPS-matured DCs. To directly compare the effects of DCs matured by Gp96 or LPS 
on the proliferation of CD8 and CD4 T cells as well, the OT-I and OT-II transgenic 
mouse systems were selected. T cells from OT-I mice express a transgenic T cell 
receptor specific for an ovalbumin-derived MHC class I epitope while OT-II 
transgenic T cells recognize a MHC class II epitope from the same protein. Analogous 
to the experiments above using T cells from St42 mice, CFSE-labelled OT-I or OT-II 
spleen cells (CD90.2+) were injected i.v. into C57BL/6 mice (CD90.1+). 48 hours later 
Gp96- or LPS-matured BMDCs which were loaded with either the MHC class I or 
class II-restricted peptide from ovalbumin were injected i.p. into these mice. On day 8  
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Figure 2.  BMDCs matured by Gp96 induce peptide-specific proliferation of CTLs in vivo. On 
day 0 CFSE-labelled St42 spleen cells (CD90.1) were injected i.v. into C57BL/6 mice (CD90.2). 
BMDCs from C57BL/6 mice were matured by Gp96 or LPS for 6 hours or 3 days and loaded with 
Ad5-E1A peptide or Ad5-E1B peptide as a negative control. BMDCs were injected i.p. into 
C57BL/6 mice previously transferred with St42 splenocytes. On day 8 peripheral blood samples and 
draining lymph nodes were collected. (A) Proliferation of St42 CD8 T cells from lymph nodes 6 
days after immunization with Ad5-E1A peptide-loaded DCs matured by Gp96 or LPS for 3 days. 
(B) Percentage of proliferated St42 CD8 T cells (gate as shown in (A)) after immunization with 
peptide-loaded BMDCs stimulated with Gp96 or LPS for 6 hours or 3 days as indicated. Untreated 
mice received St42 spleen cells only. (C) IL-12 production of BMDCs stimulated with Gp96 or LPS 
and used for immunization. Error bars give SD of triplicates. The results are representative of two 
independent experiments. 
DCs + 
DCs + LPS 
DCs + Gp96 
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peripheral blood and lymph nodes were collected to analyze the proliferation of CFSE-
labelled CD90.2+ OT-I or OT-II cells. Although DCs were activated to similar levels 
by Gp96 or LPS as judged by the production of IL-12 in vitro (Fig. 3D), proliferation 
of the CD8+ OT-I T cells was significantly stronger when Gp96-matured DCs were 
used in comparison to LPS-matured DCs (Fig. 3A, B). On the other hand, proliferation 
of CD4+ OT-II T cells was more pronounced when LPS-matured DCs were used as 
stimulator cells (Fig. 3A, C). No proliferation was observed when DCs loaded with a 
control peptide (Fig. 3A, B, C) or PBS (Fig. 3B, C) were injected. 
 
Human Gp96-matured dendritic cells preferentially stimulate CD8 T cells 
Next, the preference for CD8 T cell activation by Gp96-matured DCs was analyzed 
using human cells. Monocyte-derived human dendritic cells were generated from 
buffy coats according to established protocols by plastic adherence and culturing of the 
purified monocytes with GM-CSF and IL-4 for 7 days. Incubation of these immature 
dendritic cells with Gp96 or LPS for 3 days led to the up-regulation of the co-
stimulatory molecule CD86 and the maturation marker CD83 as well as to the release 
of pro-inflammatory cytokines like IL-12, TNF- and IL-6 (data not shown).  DCs 
activated by Gp96 or LPS at the concentrations indicated were co-cultured with 
allogeneic peripheral blood lymphocytes (PBL). Activation of the T cells was 
determined by the analysis of the activation markers CD69 on day 1 (Fig. 4) and MHC 
class II molecules on day 5 (data not shown) after DC co-culture. As expected, 
significantly less T cells were activated by immature dendritic cells (“Medium”) 
compared to dendritic cells matured by Gp96 or LPS (see also (Singh-Jasuja et al., 
2000a)). When analysing the expansion of CD8+ versus CD4+ T cells we observed that 
Gp96-matured DCs preferentially activated CD8+ T cells. This preference was not 
observed when LPS was used for the maturation of DCs (Fig. 4). Reducing the amount 
of LPS or Gp96 resulted in a reduced overall T cell activation as evident from the 
lower numbers of CD69+ T cells but did not influence the ratio of CD8+ vs. CD4+ T 
cells (Fig. 4 and data not shown).  
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Figure 3. Mouse Gp96-matured DCs preferentially activate CD8 vs. CD4 T cells in vivo. On 
day 0 CFSE labelled OT-I or OT-II spleen cells (CD90.2+) were injected i.v. into C57BL/6 mice 
(CD90.1+). On day 2, BMDCs from C57BL/6 mice matured by Gp96 or LPS for 6 hours were 
loaded with H2-Kb-restricted Ova257-264 peptide or H2-Ab-restricted Ova323-339 peptide and injected 
i.p. into C57BL/6 mice previously injected with OT-I or OT-II spleen cells. On day 8 peripheral 
blood samples and draining lymph nodes were collected.  (A) Proliferation of OT-I or OT-II T 
cells in lymph nodes. (B, C) Summary of the proliferation of OT-I and OT-II T cells in vivo. The 
graphs show the percentage of proliferation present in the gates shown in (A). Untreated mice 
received OT-I or OT-II spleen cells only. (D) IL-12 production of DCs matured by Gp96 and LPS. 
Error bars give SD of triplicates. The results are representative of two independent experiments. 
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Figure 4. Human DCs matured by Gp96 preferentially induce activation of allogeneic 
CD8 T cells. Monocyte-derived human dendritic cells were incubated with Gp96 or LPS at 
the indicated concentrations for 3 days and then co-cultured with allogeneic PBL. The graph 
shows the percentage of CD69 expressing T cells (gray bars) and the CD8/CD4 ratio of 
CD69 positive T cells (black bars) 1 day after stimulation with matured DCs. Results are 
representative of two independent experiments. 
 
Discussion 
Heat shock proteins like Gp96 and Hsp70 have been shown to promote the maturation 
of BMDCs in vivo and in vitro (Singh-Jasuja et al., 2000a; Basu et al., 2000; Todryk et 
al., 1999) and to contribute to CTL activation (Srivastava et al., 1998; Schild et al., 
1999; Schild and Rammensee, 2000a; Srivastava, 2002). This results in the secretion 
of pro-inflammatory cytokines (Fig. 1A) and the up-regulation of co-stimulatory 
molecules in a TLR2/4-dependent fashion (Vabulas et al., 2002a; Vabulas et al., 
2002b; Asea et al., 2002).  
In this work we analyzed whether BMDC activation by Gp96 induces adaptive 
immune responses that differ from those induced by LPS-activated BMDCs. The 
reason to compare these two stimuli is based on the fact that LPS is present during 
infections with gram-negative bacteria which will be controlled predominantly by 
antibody-dominated immune responses. Gp96, on the other hand, is released during 
necrotic cell death, for example as a consequence of viral infections (Berwin et al., 
2001); the elimination of many viruses requires the activation of CTLs. Using BMDCs 
activated with either of the two stimuli we find that Gp96-mediated stimulation 
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promotes predominantly the activation and expansion of antigen-specific CD8+ T cells 
in vitro (Fig. 1B and 1C) and in vivo (Fig. 2 and Fig. 3), whereas LPS-mediated 
stimulation favours the activation and expansion of antigen-specific CD4+ T cells (Fig. 
3). This bias can neither be explained by differences in the production of IL-12 nor IL-
6 nor the expression of MHC nor co-stimulatory molecules (Fig. 1D, Fig. 2C, Fig. 3D; 
data not shown) by Gp96- or LPS-stimulated BMDCs. A similar observation is made 
for the activation of alloreactive CD8+ T cells by human DCs stimulated by Gp96. 
Examining the ratio of activated CD8+ versus CD4+ T cells, we find that Gp96-
activated human DCs unlike LPS-activated DCs preferentially stimulate the activation 
of CD8+ T cells. The reduced activation of CD8+ T cells by LPS-activated DCs does 
not depend on the amount of LPS used for DC activation. Varying the concentration of 
LPS changes only the number of CD69+, activated T cells but does not affect the ratio 
of CD8+ vs. CD4+ T cells (Fig. 4).  
Our findings suggest qualitative differences in the activation of DCs by Gp96 or LPS. 
However, the direct or indirect molecular mechanisms or interactions between Gp96-
matured DCs and T cells responsible for this preference remain to be determined. We 
have compared the secretion of several pro-inflammatory cytokines, the up-regulation 
of various co-stimulatory molecules including CD80, CD86, CD137 (4-1BB ligand), 
the up-regulation of MHC class I vs. class II molecules and the induction of MIC-A/B 
molecules which are known to interact with NKG2D molecules present on the surface 
of CD8+ but not CD4+ T cells (Bauer et al., 1999) (data not shown). All of these 
molecules are not expressed at significantly different levels between Gp96- and LPS-
matured DCs and are therefore unlikely to provide an explanation for our findings. 
The previously reported participation of TLR4 in APC activation by heat shock 
proteins initiated discussions about the contribution of endotoxin contaminations to the 
observed effects. Several arguments for an endotoxin independent activity of HSPs 
have been discussed previously. They include that HSP effects were sensitive to heat 
treatment, the presence of MDC and, in addition, were insensitive to polymyxin B 
(Singh-Jasuja et al., 2000a; Zheng et al., 2001; Baker-LePain et al., 2002). 
Furthermore, a study by Reed et al. (Reed et al., 2003) demonstrated that highly 
purified Gp96 molecules with almost undetectable endotoxin contaminations (< 0.027 
pg/µg Gp96) are still able to promote phosphorylation of ERK which is part of the 
TLRS – LINK BETWEEN INNATE AND ADAPTIVE IMMUNITY   
130 
activation pathway preceding pro-inflammatory cytokine secretion. Nevertheless, 
experiments using recombinant Hsp70 molecules suggested that endotoxin 
contaminations are exclusively responsible for the APC-activating capabilities of these 
HSP (Gao and Tsan, 2003; Bausinger et al., 2002). However, the experiments 
presented in this study provide additional evidence that endotoxin contaminations 
present in the HSP preparations are not exclusively responsible for the activation of 
DCs. One attractive hypothesis that would provide an explanation for this controversy 
is the possibility that LPS interacts with HSPs as shown recently for Gp96 (Reed et al., 
2003) or Hsp60 (Habich et al., 2005) and that this interaction modulates or augments 
the biological effects of low amounts of LPS present in Gp96 preparations which on 
their own might be unable to induce DC activation.  
In summary, our data show that heat shock proteins such as Gp96 are molecules which 
are able to participate in the activation of cells of the innate immune system and 
thereby influence the outcome of adaptive immune responses. 
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Efficient priming of cytotoxic T-lymphocytes requires their interaction with matured 
antigen-presenting cells that express sufficient levels of co-stimulatory molecules and 
secrete pro-inflammatory cytokines. APC maturation is initiated either during the 
interaction with CD4+ T cells in an antigen-specific manner or directly by the 
interaction of conserved pathogen-derived components with members of the Toll-like 
receptor (TLR) family. Using mice deficient in the TLR-associated adaptor protein 
myeloid differentiation factor 88 (MyD88) we now show that each of these two 
signaling pathways is sufficient to achieve priming of human influenza virus A-specific 
CTLs. Only if both pathways are non-functional, is CTL priming impaired. In the case 
of minor H-specific CTL induction both, MyD88-mediated signals as well as CD4+ T 
cells are required. This suggests an important role of TLR signaling even in pathogen-
free settings, for example during tumor rejection. 
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Introduction 
Priming of naive cytotoxic T lymphocytes requires their interaction with professional 
antigen presenting cells, such as dendritic cells (DCs) which are considered to be the 
most potent APCs. For efficient CTL priming, DCs have to develop from an immature 
to a mature state, characterized by upregulation of costimulatory molecules and 
production of pro-inflammatory cytokines (Pulendran et al., 2001). Lack of 
costimulation leads to anergy or apoptosis of naive T cells and therefore to tolerance 
against the presented antigen (Dhodapkar et al., 2001; Steinman et al., 2003). DC 
maturation can be initiated via several distinct ways: Specific CD4+ helper T cells are 
able to trigger DC activation via CD40/CD40 ligand interaction (Cella et al., 1996). 
Apart from this antigen-specific pathway, pathogen-derived molecules can be 
recognized as danger signals by a limited number of germ-line encoded innate immune 
recognition receptors triggering APC activation. The Toll-like receptor (TLR) family 
with at least 11 different members in mammals comprises an important class of this 
receptor type (Bendelac and Medzhitov, 2002). Each TLR recognizes a distinct subset 
of conserved microbial products called PAMPs (pathogen associated molecular 
patterns), such as bacterial LPS or viral double-stranded RNA (Medzhitov, 2001). 
Ligation of TLRs leads to the recruitment of cytosolic adaptor proteins to the receptor, 
and triggers the activation of Jun, Fos and NF-B transcription factors via signal 
kinase cascades (Wesche et al., 1997; Medzhitov et al., 1998; Medzhitov, 2001). 
The adaptor MyD88 is an essential component of the signaling pathways of most 
TLRs (Kawai et al., 1999) and also for the IL-1 and IL-18 receptors (Adachi et al., 
1998). Bone-marrow derived dendritic cells (BMDCs) from MyD88-deficient mice do 
not reveal any cytokine response to most PAMPs. Nevertheless, MyD88-independent 
activation has been described for TLR3 and 4, most probably mediated by the 
alternative adaptor protein TRIF (TIR domain-containing adapter inducing IFN-β) 
(Yamamoto et al., 2002b; Yamamoto et al., 2003a; Hoebe et al., 2003), but at least for 
TLR4 signaling DC activation occurs with delayed kinetics and cytokine production is 
greatly diminished (Kawai et al., 1999; Kaisho et al., 2001). TIRAP (Toll-IL-1 
receptor domain-containing adaptor protein), another TLR adaptor, is involved in 
TLR4 and TLR2 signaling (Fitzgerald et al., 2001; Horng et al., 2001). But TIRAP 
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does not participate in MyD88-independent signaling pathways (Horng et al., 2002; 
Yamamoto et al., 2002a), pointing out again the unique role of MyD88 in TLR-
mediated signaling. 
The role of TLR-mediated stimuli for the induction of CTL responses is still under 
investigation. Priming of CTLs against certain viruses and bacteria has been shown to 
be independent from the presence of CD4+ helper T cells and APC activation signals 
provided by the CD40/CD40L interaction (Larsson et al., 2000; Hamilton et al., 2001). 
In these cases, it was speculated that other signals can promote sufficient maturation of 
dendritic cells. Recent findings that type 1 T helper cell (TH1) responses are impaired 
in MyD88-deficient mice while TH2 responses remain unaffected support the 
assumption that TLR-mediated signals may account for the CD4+ T cell-independent 
priming of CTLs (Schnare et al., 2001; Kaisho et al., 2002). Moreover, it has been 
reported that rejection of minor H-antigen mismatched skin grafts requires MyD88 
signaling (Goldstein et al., 2003). Protective CD8+ T cell responses after infection with 
the bacterial pathogen Listeria monocytogenensis on the other hand are independent of 
MyD88 (Way et al., 2003). Apparently, there are differences in the need for 
TLR/MyD88-mediated signalling during CTL priming that demand further 
investigation. 
As CTL responses play a crucial role in the eradication of virus-infected cells and 
tumors, we analyzed the contribution of innate immune recognition to CTL priming in 
appropriate model systems using MyD88-deficient mice. During priming against 
human influenza virus A either MyD88- or CD4+ T cell-dependent signals are required 
and each can compensate for the lack of the other. Responses to minor H antigens, 
which provide a model for the recognition of cellular antigens, demand the 
contribution of both signaling pathways. Therefore, minor H-specific CTL responses 
depend on activation of the innate immune system by danger signals. These data might 
help to understand impaired CTL responses against many tumors. 
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Materials and Methods 
Mice, Reagents and Antibodies 
C57BL/6 (H2b) and BALB/c (H2d) mice were obtained from Charles River Wiga 
GmbH (Sulzfeld, Germany). BALB.B mice (H2b, minor H antigens almost identical to 
BALB/c) were obtained from Harlan Winkelmann GmbH (Borchen, Germany). MHC 
class II-deficient mice (C57BL/6Tac-ABBtm1) depleted of mature CD4+ T cells were 
obtained from Taconic M&B (Ry, Denmark). Generation of MyD88-/--deficient mice 
(C57BL/6 background, H2b) has been described previously (Adachi et al., 1998). 
Animals were maintained in the animal facilities of the Department of Immunology, 
Institute for Cell Biology, University of Tübingen, Germany or the Institute for 
Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 
Germany. 
Phosphothioate-stabilized CpG deoxyoligonucleotide 1668 (TCC ATG ACG TTC 
CTG ATG CT) was purchased from TIB MOLBIOL (Berlin, Germany). LPS from 
Salmonella typhimurium was obtained from Sigma (Taufkirchen, Germany), poly(I:C) 
from Amersham (Freiburg, Germany) and (S)-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-
N-palmitoyl-(R)-cysteine (Pam3Cys) from EMC microcollections (Tübingen, 
Germany). The peptide ASNENMETM derived from influenza nucleoprotein (366-
374) was synthesized by the peptide chemistry facilities in the Department of 
Immunology (Tübingen, Germany). 
For flow cytometry, phycoerythrin or fluorescein isothiocyanate-conjugated 
monoclonal antibodies to mouse CD4 (GK1.5), CD8 (53-6.7), CD11c, CD14, CD86 
and appropriate isotype controls were obtained from BD Biosciences (Heidelberg, 
Germany). Purified GK1.5 antibody for in vivo CD4+ T cell depletion was a kind gift 
of R. M. Toes (Leiden University Medical Center, The Netherlands). Phycoerythrin-
conjugated tetramers of H2-Db/ASNENMETM were obtained using the standard 
refolding protocol described by Altman et al. (Altman et al., 1996). 
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Immunizations, 51Cr release assay, ex vivo tetramer staining 
500 haemagglutinating units (HAU) of human influenza virus (A/PR/8/34) were 
injected i.p. for the induction of CTL responses against the H2-Db-restricted 
immunodominant CTL epitope ASNENMETM. For priming against minor H antigens, 
1x107 spleen cells were irradiated with 30 Gy and injected subsequently i.p. in a 
volume of 300 µl PBS. Alternatively, 5x106 non-irradiated BMDCs were used. For 
CD4+ T cell depletion, 100 µg of purified CD4-specific antibody were injected i.p. on 
days -5, -3, -1, +1 and +6 referring to the time point of immunization. On days 0 and 9, 
the effectiveness of T helper cell depletion was analyzed by flow cytometry of blood 
lymphocytes. On day 9 after immunization, mice were sacrificed and splenocytes were 
stimulated in vitro for additional 5 days in Modified Eagle’s Medium (alpha 
modification) containing 10 % fetal calf serum, 2 mM L-glutamine, 50 µM 
β-mercaptoethanol and antibiotics. If indicated, T cells were restimulated at weekly 
intervals using medium supplemented with 25 ml supernatant of concanavalin A 
treated rat splenocytes and 25 mM alpha-methylmannoside. 51Cr release assay was 
performed as described previously (Arnold et al., 1997). For generation of T cell 
blasts, mouse spleen cells were cultured for 3 days with 2.5 µg/ml concanavalin A. 
For ex vivo detection of peptide-specific T cells, 1x106 splenocytes were stained with 
phycoerythrin-conjugated H2-Db/ASNENMETM tetramer and fluorescein 
isothiocyanate-conjugated anti-CD8 antibody for 30 min on ice directly after cell 
isolation. Cell fluorescence was measured by flow cytometry on a FACSCalibur™ 
(BD Biosciences). 
 
Generation of mouse dendritic cells 
Mouse immature DCs were generated from bone marrow of C57BL/6 and MyD88-/- 
mice using Iscove‘s Modified Dulbecco‘s Medium (BioWhittaker, Verviers, Belgium) 
supplemented with 2 mM L-glutamine, antibiotics and 10 % fetal calf serum. Bone 
marrow cells were incubated in medium containing 150 U/ml granulocyte-macrophage 
colony-stimulating factor (PeproTech, London, England) for 6-8 days. Medium was 
replaced every 2 days. The DCs obtained were CD11c+ and CD14-. 
  6 – TLR SIGNALING DURING CTL PRIMING 
  137 
Stimulation of BMDCs 
Mouse BMDCs were stimulated by the addition of CpG, LPS, poly(I:C) or Pam3Cys. 
After 24 h, IL-12 (p40) and IL-6 concentrations in the supernatants were measured 
using standard sandwich ELISA protocols. Antibodies and recombinant standards of 
both cytokines were obtained from BD Biosciences. The capture antibody was bound 
to a MaxiSorbTM ELISA plate (Nunc, Roskilde, Denmark), the biotinylated detection 
antibody was revealed by streptavidin-conjugated horseradish peroxidase (BD 
Biosciences) and 2,2’-azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid substrate 
(Sigma). The assay was read at 405 nm. Furthermore, on day 3 after activation, 
expression of the costimulatory molecule CD86 was measured by flow cytometry on a 
FACSCalibur™ (BD Biosciences). Isotype controls of antibodies were included in all 
experiments to determine the appropriate background fluorescence. 
 
Results  
MyD88-dependent signals can compensate for missing CD4+ T cell help during 
priming of influenza-specific CTLs 
To investigate the role of MyD88-mediated signals in the generation of virus-specific 
CTLs, C57BL/6 and MyD88-/- mice were immunized i.p. with 500 HAU human 
influenza virus (A/PR/8/34). CTL activity was analyzed from spleen cell cultures 
stimulated for 5 days with the H2-Db-restricted immunodominant influenza 
nucleoprotein peptide (366-374) using target cells incubated with peptide. As shown in 
Fig. 1, MyD88-/- mice (Fig. 1B) produce an influenza-specific CTL response 
comparable to that of C57BL/6 mice (Fig. 1A), despite the fact that MyD88-/--derived 
BMDCs display a strongly reduced cytokine response, shown here for IL-12 and IL-6, 
to various TLR-ligands including LPS, CpG deoxyoligonucleotides and Pam3Cys 
(Fig.1C,D), as previously reported (Kawai et al., 1999). These results indicate that 
MyD88-mediated stimuli are not necessarily required for CTL priming. 
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Figure 1. CTL activity against human influenza virus is not affected in MyD88-/- mice. 
(A,B) C57BL/6 (A) or MyD88-/- mice (B) were injected i.p. with 500 HAU of human influenza 
virus (). Control mice were left untreated (). After 9 days splenocytes were stimulated in vitro 
with the immunodominant influenza CTL epitope. On day 5, CTL activity against EL-4 target 
cells loaded with peptide (filled symbols) or without (open symbols) was tested in a 51Cr release 
assay. Spontaneous 51Cr release was < 6 %. Experiments were performed with two mice per 
group. Results shown are representative of four independent experiments with similar results. 
(C,D) Immature BMDCs form the immunized mice used in A,B were stimulated with 1 ng/ml 
LPS, 2.5 µM CpG or 2.5 µg/ml Pam3Cys. After 20 h, IL-12 (C) and IL-6 (D) concentrations in the 
culture supernatants were analyzed by ELISA. Mean values of triplicates from C57BL/6 BMDCs 
are shown with filled bars, from MyD88-/- BMDCs with open bars. Error bars represent SE. 
Similar results were obtained from more than 5 different experiments. 
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Figure 2. CTL response against human influenza virus in MyD88-/- mice is dependent on CD4+ T 
helper cells. C57BL/6 and MyD88-/- mice were immunized with human influenza virus and 
splenocytes were stimulated with peptide as described for Fig. 1. CD4+ T cells had been depleted in 
half of the mice by repeated i.p. injection of 100 µg GK1.5 antibody on day -5, -3, -1, +1, +6 before 
and after virus challenge. (A) The efficiency of CD4+ T cell-depletion was tested by flow cytometry 
after staining of blood lymphocytes with fluorochrome-labeled CD8- and CD4-specific monoclonal 
antibodies at the day of virus injection (day 0). Percentages of CD4+ and CD8+ positive cells among 
total lymphocytes are indicated for CD4-depleted (right panels) and control mice (left panels) in the 
upper left and lower right quadrants, respectively. (B,C) CTL activity after 5 d in vitro stimulation 
with peptide was assayed in a 51Cr release for lymphocytes from C57BL/6 (B) and MyD88-/- (C) mice 
( CD4+ T cell-depleted mice;  undepleted control mice). EL-4 target cells loaded with peptide 
(filled symbols) and as specificity control without peptide (open symbols) were used. Spontaneous 
51Cr release was < 5 %. Results shown are representative of two independent experiments. 
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The induction of primary CTL responses against many viruses, including influenza, 
has been shown to take place independently of CD4+ T cells (Buller et al., 1987; 
Rahemtulla et al., 1991; Tripp et al., 1995). We also observe that the depletion of 
CD4+ T cells hardly influences the priming of Influenza-specific CTLs in C57BL/6 
mice (Fig. 2A, B), but strongly reduces CTL induction in MyD88-/- mice (Fig. 2A,C). 
Thus, MyD88- or CD4+ T cell-mediated signals can compensate for each other during 
the priming of influenza virus-specific CTLs. Only if both pathways are missing, CTL 
priming is impaired.  
To determine if the reduced CTL activity in CD4-depleted MyD88-/- mice is due to 
reduced numbers of influenza-specific CTL we performed ex vivo tetramer staining 
after virus immunization. As shown in Fig. 3, CD4 depletion does not effect the 
number of influenza nucleoprotein-specific CTL in C57BL/6 mice but strongly 
reduces the number of T cells reacting with the H2-Db/ASNENMETM tetramer in 
MyD88-/- mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Priming of influenza-specific 
CTL is reduced in CD4-depleted 
MyD88-/- mice. C57BL/6 and MyD88-/- 
mice were immunized with human 
influenza virus as described in Fig. 1. 
CD4+ T cells were depleted by repeated 
i.p. injection of 100 µg GK1.5 antibody 
on days -5, -3, -1, +1, +6 before and after 
virus challenge. The efficiency of CD4+ 
T cell-depletion was tested by flow 
cytometry after staining of blood 
lymphocytes with fluorochrome-labeled 
CD4-specific monoclonal antibodies at 
the day of virus injection (day 0). 
Influenza-specific CTL were detected 9 
days after infection of influenza virus 
with phycoerythrin-conjugated H2-
Db/ASNENMETM tetramers and 
fluorescein isothiocyanate-conjgated 
anti-CD8  anti-CD8 antibody staining. Experiments were performed with three mice per group. Results 
shown are representative of two independent experiments.  
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Priming of minor H-specific CTLs requires MyD88- and CD4+ T cell-mediated 
stimuli 
To investigate the role of MyD88-mediated stimuli in a pathogen-free system, we 
studied the induction of minor H-specific CTLs, which is often used as a model system 
for tumor rejection. CD4+ T cells have been shown to be necessary for the generation 
of minor H-specific CTLs (Schild et al., 1987). As shown in Fig. 4A,B, we observe the 
same CD4+ T cell-dependence for the CTL induction against BALB minor H antigens 
in C57BL/6 mice (H2b): After immunization with BALB.B cells (H2b), no CTL 
activity is detectable in MHC class II-deficient mice which lack mature CD4+ T cells 
(strain C57BL/6Tac-Abbtm1 N5). In contrast, the presence of a functional MyD88 
pathway is not required in host APCs, as MyD88-/- (H2b) and C57BL/6 mice (Fig. 
4A,C) mount comparable minor H CTL responses. Most likely, CTL priming is 
independent of host APCs in this situation and mediated directly by the interaction of 
naïve T cells with donor APCs not defective in the MyD88 pathway.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. CTL responses against BALB minor H antigens require CD4+ T helper cells, but not 
MyD88-dependent signals in host APCs. 1x107 irradiated BALB.B splenocytes were injected i.p. 
into C57BL/6 (A), MHC class II-deficient (B) or MyD88-/- mice (C). 9 days later, mice were 
sacrificed and splenic lymphocytes were stimulated with irradiated spleen cells of BALB.B mice 
and once restimulated after one week. After additional 5 days, cytolytic activity against BALB.B 
(filled symbols) and C57BL/6 (open symbols) derived blasts was evaluated in a 51Cr release assay 
( immunized mice;  untreated controls, not shown in B). Spontaneous 51Cr release was 19 % for 
BALB.B and 24 % for C57BL/6 blasts. Experiments were performed with two mice per group. 
Results shown are representative of two independent experiments.  
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To investigate this possibility, we injected cells from MyD88-/- mice or C57BL/6 mice 
as control into BALB.B hosts in order to induce CTLs against C57BL/6 minor H 
antigens. In contrast to the results obtained by injection of C57BL/6 cells (Fig. 5A), 
we found that the immunization using spleen cells from MyD88-/- mice was unable to 
prime CTLs (Fig. 5B). However, cells from MyD88-/- as well as C57BL/6 mice were 
able to induce the activation of alloreactive CTLs, showing that MyD88-/--derived 
spleen cells are able to stimulate T cells in general (data not shown). Thus, in contrast 
to the induction of influenza-specific CTLs, the priming of minor H-specific CTLs 
requires both the presence of CD4+ T cells and a functional MyD88 pathway in the 
cells used for immunization. 
. 
 
Figure 5. Donor APCs require functional MyD88-dependent signaling pathways to induce 
minor H-specific CTL responses. 1x107 irradiated splenocytes from C57BL/6 (A) or MyD88-/- 
mice (B) were injected i.p. into BALB.B mice. On day 9 after injection, lymphocytes from the 
injected mice () and from untreated controls (, not shown in B) were stimulated in vitro with 
irradiated C57BL/6-derived splenocytes. Cultures were restimulated twice in weekly intervalls. 5 
days after the last restimulation, a 51Cr release assay was performed to analyse CTL activity against 
C57BL/6 minor H antigens. Filled symbols show CTL activity against C57BL/6 blasts (20 % 
spontaneous release), open symbols against BALB.B blasts (13 % spontaneous release). 
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BMDCs from MyD88-/- mice prime minor H-specific CTLs after maturation with 
poly(I:C) 
The inability of MyD88-/- cells to induce minor H-specific CTLs after injection in 
BALB.B mice might be attributed to their defect in the IL-1R/TLR signaling pathway 
preventing maturation of professional APCs, such as DCs. If this is the case, activation 
of MyD88-/--derived BMDCs by MyD88-independent stimuli would overcome this 
defect. BMDCs from both C57BL/6 and MyD88-/- mice were found to respond to 
poly(I:C) stimulation by the secretion of IL-6 (Fig. 6A) and IL-12 (data not shown) 
and by the upregulation of CD86 molecules (Fig. 6B), while the maturation of  
MyD88-/--derived BMDCs in response to CpG deoxyoligonucleotides and Pam3Cys 
was completely abrogated in the same experiment (data not shown). After injection of 
poly(I:C) activated BMDCs from MyD88-/- mice into BALB.B mice, we observed 
priming of minor H-specific CTLs whereas immunization using unstimulated BMDCs 
from MyD88-/- mice was unable to induce minor H-specific CTL activity (Fig. 6C). 
These results indicate that the lack of MyD88 in donor APCs can be overcome by 
MyD88-independent maturation of the cells prior to injection. 
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Figure 6. MyD88-dependent signals during CTL priming against minor H antigens can be 
compensated by MyD88-independent activation of donor APCs. (A and B) Immature BMDCs from 
C57BL/6 () and MyD88-deficient (	) mice were stimulated with the indicated concentrations of 
poly(I:C). (A) After 20 h IL-6 concentrations in the supernatant were analysed by ELISA. Means of 
triplicates are shown with error bars representing SE. Data shown are representative of three 
independent experiments. (B) After 3 days, maturation status of C57BL/6-derived (upper panel) and 
MyD88-/--derived (lower panel) BMDCs was measured by flow cytometry after staining with a 
phycoerythrin-conjugated anti-CD86 antibody (........ unstimulated BMDCs; 

  BMDCs stimulated 
with 100 µg/ml poly(I:C). Percentages of CD86high cells as defined by the indicated marker were 69.7 ± 
1.2 and 69.6 ± 2.3 for C57BL/6 and MyD88-/- mice, respectively (means of triplicates). (C) 5x105 
BMDCs from MyD88-/- ( activated by 100 µg/ml poly(I:C);  unstimulated) were injected i.p. into 
BALB.B mice. 9 days later, mice were sacrificed and splenocytes were stimulated with irradiated 
BALB.B cells. After additional 5 days CTL activity against C57BL/6 (filled symbols) and BALB.B 
blasts (open symbols) was assayed in a 51Cr release assay. Spontaneous 51Cr release was 16 % and 7 % 
for C57BL/6 and BALB.B blasts, respectively. Results shown are representative of two independent 
experiments. 
 
  6 – TLR SIGNALING DURING CTL PRIMING 
  145 
Discussion 
In this study, we analyzed the contribution of MyD88-mediated signals to the priming 
of CTLs specific for influenza virus and minor H antigens. We found that the 
activation of influenza-specific CTLs requires either the presence of CD4+ T cells or a 
functional MyD88 signaling pathway (Fig. 1 and Fig. 2). Only if both components are 
missing, CTL priming is severely impaired but either one of the two is nevertheless 
able to maintain CTL activation. Ex vivo staining of splenocytes of influenza infected 
mice with H2-Db/ASNENMETM tetramers reveals that expansion of virus-specific 
CTL in vivo is strongly reduced in CD4-depleted MyD88-/- but not in C57BL/6 mice 
(Fig.3). This suggests that during a viral challenge in the absence of CD4+ T cell help 
sufficient activation of APCs can be achieved via the MyD88 pathway, probably 
triggered by PAMP - TLR interaction. On the other hand, defects in the MyD88-
dependent pathway can be compensated by CD4+ T cells. 
The activation signal provided by CD4+ helper T cells is most likely mediated through 
CD40/CD40L interactions because this help can be replaced by injection of a 
stimulating anti-CD40 monoclonal antibody (Bennett et al., 1998; Schoenberger et al., 
1998). In addition, CD40-independent DC sensitization and direct lymphokine-
dependent CD4+ - CD8+ T cell communication might contribute to the priming of CTL 
(Lu et al., 2000). 
One of the signals that stimulates the MyD88 pathway in APCs after the injection of 
influenza virus is probably induced by the interaction of viral dsRNA with TLR3 
(Alexopoulou et al., 2001) which occurs as intermediate during the replication cycle of 
RNA viruses. The ability of DCs in particular to respond to dsRNA stimuli was 
reported earlier (Cella et al., 1999) and correlates with the increasing TLR3 expression 
during the development of monocytes into immature DCs (Visintin et al., 2001b; 
Kadowaki et al., 2001). However, the contribution of TLR3-mediated signals derived 
by influenza virus-derived dsRNA remains questionable as they are not able to 
promote efficient CTL priming in CD4-depleted MyD88-/- mice (Fig.2B). Additional 
virus-derived PAMPs might contribute to TLR-mediated APC activation as well. For 
the measles virus, it has recently been reported that the viral hemagglutinin protein 
activates cells via TLR2 (Bieback et al., 2002). TLR4 has been shown to be involved 
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in the innate immune response to respiratory syncytial virus but not to influenza virus 
(Kurt-Jones et al., 2000; Haynes et al., 2001). Especially stimulation of TLR3 and 
TLR4 induces the expression of interferon regulatory factor 3 (IRF-3), an important 
transcriptional regulator of the antiviral response (Doyle et al., 2003)). Interestingly, 
IRF-3 upregulation is mediated MyD88-independently via the TRIF adaptor 
(Yamamoto et al., 2002b). Therefore, the lack of antiviral response in MyD88-/- mice 
after CD4+ T cell depletion cannot be explained by defective IRF-3 activation. 
Nevertheless, our results show that TLR- and MyD88-mediated activation cascades 
are crucially involved during the induction of antiviral CTL responses. 
A different situation is observed for the induction of CTLs against minor H antigens. 
Here, both CD4+ T cells and a functional MyD88 signaling pathway are required in the 
antigen-bearing donor cells (Fig. 4 and Fig. 5). The lack of a functional MyD88 
signaling pathway in APCs from MyD88-/- mice can be compensated by poly(I:C)-
induced maturation of BMDCs prior to their injection (Fig. 6C). The reason for this is 
most likely the TLR3-dependent but MyD88-independent upregulation of CD86 
molecules by poly(I:C) (Fig. 6B), as reported previously (Alexopoulou et al., 2001). 
However, in contrast to this report, we also observed the secretion of proinflammatory 
cytokines by poly(I:C) stimulated BMDCs from MyD88-/- mice to levels comparable 
with that of wildtype BMDCs (IL-6, Fig. 6A; IL-12, data not shown), whereas other 
known MyD88-dependent stimuli, such as Pam3Cys or CpG deoxyoligonucleotides, 
failed to induce the activation of BMDCs from MyD88-/- mice both in earlier 
experiments (Fig. 1) and in the same analysis (data not shown). Why TLR3-mediated, 
MyD88-independent activation of MyD88-/- BMDC rescues the induction of minor H-
specific CTL but not the induction of influenza-specific CTL in CD4-depleted 
MyD88-/- mice is not clear but might by explained by the following reasons. First, the 
induction of minor H-specific CTL by TLR3-activated BMDC took place in the 
presence of CD4+ T cells whereas these cells were depleted during influenza virus 
infection in MyD88-/- mice. Second, poly(I:C) treatment induces a stronger activation 
of BMDCs compared to influenza virus infection (Herter et al., unpublished 
observation) and only the former might be sufficient for CTL activation. 
A comparable MyD88/TLR dependence can be expected for CTL induction against 
other cell restricted antigens, such as tumor antigens. The absence of PAMPs and 
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danger signals in many tumors might contribute to the lack of an efficient tumor-
directed immune response. 
How MyD88-dependent signals contribute to the induction of minor H-specific CTLs 
and which PAMPs, or in this case, which danger signals interact with which upstream 
receptors has still to be determined. Heat-shock proteins released during cell death are 
possible candidates for non-pathogen derived danger signals. For example, Hsp60 and 
the ER-resident Gp96 have been reported to activate APCs via TLR-mediated 
pathways (Vabulas et al., 2001; Vabulas et al., 2002b).  
  
Apart from TLRs, another possible candidate is IL-1, which activates target cells via a 
MyD88-dependent signaling pathway (Adachi et al., 1998). IL-1 is secreted by 
activated macrophages or TH2 cells and is required for TH2 cell proliferation 
(Lichtman et al., 1988; McArthur and Raulet, 1993). Whether this or the general 
immunostimulatory capacities of IL-1 play a role in the observed MyD88 dependence 
of minor H-specific CTL priming still has to be determined. Similarly, IL-18 signaling 
which has also been shown to be MyD88-dependent (Adachi et al., 1998) has to be 
considered, because mice deficient in this cytokine show an impaired NK cell activity 
and T cells from these mice challenged with TH1 inducing pathogens show impaired 
IFN-γ production (Takeda et al., 1998). Nevertheless, IL-1β and IL-18 are not 
generally required for T
 
cell responses, because mice deficient in caspase-1 which 
cannot produce the biologically active forms of IL-1β and IL-18 (Fantuzzi and 
Dinarello, 1999) show a normal antigen-specific TH1 response (Schnare et al., 2001). 
Moreover, rejection of minor H-mismatched skin allografts is dependent on MyD88, 
but not on IL-1 or IL-18, suggesting a TLR involvement (Goldstein et al., 2003). 
However, for prolonged graft survival in the latter study both, donor and recipient 
mice had to be MyD88 deficient. If the MyD88 pathway was disrupted in only one of 
them skin grafts were tolerated for about 8 to 10 weeks but eventually rejected. The 
reason for this obvious difference to our finding where MyD88-deficient cells are not 
able to induce a CTL response in BALB.B mice might be that the injection of minor-H 
mismatched cells is less immunogenic compared to skin grafting. 
Another interesting aspect emerges from our observation that a functional MyD88-
signaling pathway is only required in the cells that are injected, but not in the host cells 
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(Fig. 4C): During the induction of minor H specific CTLs in an H2-matched 
combination, only the injection of C57BL/6 but not MyD88-/- cells into BALB.B mice 
results in the induction of C57BL/6 specific CTL. Obviously, minor H antigens are 
recognized exclusively on donor cells. One explanation might be that minor H 
antigens from MyD88-deficient donor cells are insufficiently transferred to host APCs 
(cross presentation). The efficiency of cross presentation is influenced by the 
expression levels of the antigen (Kurts et al., 1998). However, this cannot explain the 
lack of cross presentation in our case because in an H2-mismatched combination, 
C57BL/6 minor H antigens can be cross presented efficiently by BALB/c mice 
(Arnold et al., 1997). An alternative explanation could be that minor H antigens are 
still transferred from donor cells to host APCs but these APCs do not become activated 
and are therefore unable to induce the priming of minor H specific CTLs. This 
question, and the role of MyD88-dependent stimuli during the induction of minor H-
specific CTLs in an H2-mismatched combination, originally described as cross 
priming (Bevan, 1976a), are currently under investigation. 
In summary, our results show that the TLR / MyD88 pathway does not only play a role 
in pathogen defense, but also during CTL priming against pathogen-free antigens, such 
as minor H antigens. However, the immune response to pathogens does not necessarily 
require MyD88 participation, as shown here and by others (Way et al., 2003). 
Therefore, the requirement for innate immune recognition via the MyD88 pathway for 
CTL priming depends on the nature of the antigen. 
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„Toll“ has first been identified as insect transmembrane protein essential for 
dorsoventral polarity during embryogenesis. The discovery that Toll is additionally 
able to protect the fruit fly drosophila against microbial infections initialized the 
search of homologue receptors in mammals. Until now, eleven human and twelve 
murine Toll-like receptors (TLR) have been identified and characterized. These 
evolutionarily conserved transmembrane receptors play a crucial role in immunity as 
pattern recognition receptors (PRR): they enable the innate immune system to 
recognize pathogen-associated molecular patterns (PAMP) and thus confer a certain 
degree of specificity (Chapter 1, Table 1). They not only signal the presence of danger 
and thus activate an immediate innate immune response. Moreover, TLR-mediated 
signals activate phagocytes and dendritic cells (DCs) to secrete chemokines and 
cytokines and to up-regulate co-stimulatory molecules in response to these alarm 
signals, a prerequisite for the induction of the adaptive immune response.  
The topic of this thesis is the identification of structures recognized by TLRs and the 
investigation of the molecular mechanisms by which TLRs link innate and adaptive 
immunity. Both are important for the development of therapeutics in the fight against 
pathogens and cancerous tissues. 
 
Although the bacterial cell wall component lipopolysaccharid (LPS) has long been 
known to be a PAMP recognized by the innate immune system via TLRs, the question, 
which specific TLR is responsible for recognition, has been the issue of controversial 
discussion. Finally, it has become the common consensus that TLR2 is involved in the 
recognition of LPS from Gram-positive bacteria, whereas TLR4 functions as pattern 
recognition receptor for LPS from Gram-negative bacteria together with the accessory 
molecule MD-2, the LPS-binding protein (LBP) and CD14. However, doubts have 
been casted on this paradigm. Therefore, we focused on the characterization of the 
receptor involved in the recognition of LPS from the Gram-negative bacteria 
Legionella pneumophila, the causative agent of Legionnaires’ disease, which was 
proposed to be structurally and functionally different from those of other Gram-
negative bacteria. We observed that purified L. pneumophila LPS ranks among the 
atypical LPS species, since it activates dendritic cells to secrete pro- inflammatory 
cytokines via a TLR2-dependent mechanism (Chapter 2). Although efficient TLR2-
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signaling can generally take place in the absence of CD14, we found cell activation by 
L. pneumophila LPS to be dependent on CD14. The physiological significance of these 
observations is emphasized by the finding that not only the purified LPS but even the 
micro-organism itself triggers activation signals through TLR2 and CD14. Thus, LPS 
is the main PAMP for the recognition of L. pneumophila by the innate immune system 
(Figure 1). Comparing viable bacteria with killed bacteria revealed that the latter is 
more potent in activating immune cells, arguing for soluble factors secreted by live 
bacteria to be responsible for this suppressive function. Whether these escape 
mechanisms in turn also involve TLRs is still a matter of speculation. 
 
LPS
Legionella
pneumophila
LPS
sCD14
TLR2
mCD14APC
PAMP
IL-6
IL-12
+
 
 
 
 
 
 
 
 
Figure. 1: APC activation by Legionella pneumophila LPS and intact bacteria.                
L. pneumophila LPS is an atypical Gram-negative LPS species, since it activates DCs to 
secrete pro-inflammatory cytokines via TLR2. L. pneumophila LPS also engages CD14, either 
soluble (sCD14) or membrane bound (mCD14). Moreover, the intact bacteria itself triggers 
activation signals via TLR2 and CD14. Thus, LPS is the main PAMP recogized be the innate 
immune system.  
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For antigens of Aspergillus fumigatus, a fungus causing invasive aspergillosis (IA), the 
Toll-like receptor distribution is more complex (Chapter 3). We observed that antigen 
preparations derived from A. fumigatus, i.e. hyphae, PP SAB (ethanol precipitate of A. 
fumigatus culture supernatant), and EC SAB (cellular extract of A. fumigatus), 
activate innate immune cells. They stimulate neutrophils for cytokine release (IL-8), 
phagocytosis and degranulation, and immature DCs for activation and induction of 
maturation. In this process, the different involvement of TLR2 and TLR4 leads to the 
secretion of different pro-inflammatory cytokines by DCs: In response to PP SAB, 
TLR2 and TLR4 can compensate for each other to induce IL-12 release, but TLR2 
cannot compensate for TLR4 in case of IL-6 secretion. In contrast, IL-12 production in 
response to EC SAB is exclusively dependent on TLR2 (Figure 2).  
Since appropriate activation of the innate immunity is crucial for the successful 
clearance of IA, a clear understanding of how TLRs contribute to innate immune 
recognition of A. fumigatus is indispensable. 
Human immature monocyte-derived
DCs
→ activation: upregulation of  
CD40, CD80, CD86, HLA-DR
→ maturation: increased
expression of CD83
Human PMN
→ activation: enhanced phagocytosis
activity
Aspergillus fumigatus antigens
→ invasive aspergillosis
Hyphae - PP SAB - EC SAB
Murine bone marrow-derived DCs
→ EC SAB-mediated activation: 
TLR2-dependent
→ PP SAB-mediated
• IL-12 release: TLR2 and TLR4                                  
compensate for each other
• IL-6 release: TLR2 cannot
compensate for TLR4
+ +
 
 
 
 
 
 
 
 
PP SAB, ethanol precipitate of A. fumigatus culture supernatant; EC SAB, cellular extract of   
A. fumigatus; DC, dendritic cell; PMN, polymorphonuclear neutrophils 
Figure 2. Activation capacity of Aspergillus fumigatus antigens. Yellow ellipse: A. fumigatus 
antigens. Left box: A. fumigatus antigens activate human innate immune cells. Right box: 
Different involvement of TLR2 and TLR4 by A. fumigatus antigens differentially induces the 
secretion of pro-inflammatory cytokines by murine dendritic cells. 
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In addition to exogenous pathogen-associated molecules, TLRs also recognize 
endogenous foreign danger signals, such as viral DNA or RNA (Chapter 1) and, as we 
found, endogenous nonforeign danger signals (Chapter 4). 
By analyzing the molecular mechanisms by which the mammalian ER-resident 
chaperone and heat shock protein Gp96 activates antigen-presenting cells (APC), we 
demonstrated that TLRs are used to sense this endogenously derived nonforeign alarm 
signal. Gp96 is of special immunological interest, since vaccination with Gp96:peptide 
complexes confers protective immunity against the tissue the complex had been 
purified from. Thereby, Gp96 enables APCs to deliver both signals required to trigger 
an effective immune response, the antigen-specific signal and the co-stimulatory 
signal. On the one hand, specificity is obtained by the immunogenic peptide bound to 
Gp96 as a consequence of its chaperone function. After receptor (CD91)-mediated 
uptake of the Gp96:peptide complex by APCs, the associated peptide is transferred to 
the MHC class I antigen-processing pathway for “cross-presentation” to CD8+ T cells. 
On the other hand, Gp96 unspecifically induces activation and maturation of APCs, 
which leads to the secretion of pro-inflammatory cytokines and up-regulation of co-
stimulatory molecules.  
 
In this thesis, the molecular basis for understanding the Gp96-mediated activation of 
APCs could be elucidated. We found that Gp96 activates DCs via TLR4 and, to a 
small extent, via TLR2 signaling pathways and thereby engages classical signaling 
cascades comprising the NF-B pathway and activation of the SAPKs JNK1/2 and p38 
as well as the mitogen-activated protein kinases ERK1/2. Yet, it turned out that DCs 
are not activated until Gp96 is endocytosed. Thus, Gp96 has to be internalized for 
both, the induction of the TLR-mediated maturation signal and the delivery of the 
specific antigen into the cell for major histocompatibility complex class I-restricted 
representation (“cross-presentation”) ensuring that the same APC delivers the antigen-
specific signal as well as the co-stimulatory signal for successful induction of 
cytotoxic T cell (CTL) responses against the associated antigenic peptide. 
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However, it is of severe concern that the TLR involvement observed for Gp96 and 
other HSPs is due to minor endotoxin contaminations in the protein preparations, for, 
endotoxins and HSPs use the same receptors to trigger their activating signals.  
Our group accumulated evidence that at least for Gp96, it is the protein itself that 
induces APC maturation: First, Gp96-mediated, but not endotoxin-mediated DC 
maturation, is heat-sensitive and polymyxin-insensitive (Braedel et al., unpublished 
observations). Second, Gp96-mediated DC activation requires endocytosis of Gp96, 
while LPS-mediated DC activation is endocytosis independent (Chapter 4). Third, 
minimal amounts of LPS, which correspond to the endotoxin level detected in Gp96 
preparations, are unable to mature DCs, and flanking fractions obtained during the 
chromatographic purification of Gp96, which contained no protein but similar amounts 
of endotoxin, do not mature DCs (Chapter 5). Fourth, cells transfected with 
membrane-bound Gp96 (Zheng et al., 2001, Hilf et al., unpublished observations) 
activate APCs in the absence of bacterial contaminations. But the most striking 
argument is provided by the results obtained in Chapter 5: interaction of Gp96 with 
DCs induces maturation signals that promote predominantly the activation and 
expansion of antigen-specific CD8+ T cells in vitro and in vivo, whereas LPS-mediated 
DC stimulation favors the activation and expansion of antigen-specific CD4+ T cells. 
Thereby, the ratio of CD8+ versus CD4+ T cells does not depend on the amount of LPS 
used for DC activation. This bias can neither be explained by differences in the 
production of pro-inflammatory cytokines nor by the expression level of major 
histocompatibility complex or co-stimulatory molecules by Gp96- or LPS-stimulated 
DCs and strongly militates against endotoxin contaminations causing the observed 
activation of TLR2/4 signaling pathways by Gp96.  
To finally rule out speculations about endotoxin contaminations, it remains to 
investigate, whether Gp96 may function in potentiating the effect LPS traces by 
binding to and shuttling LPS inside the cells via receptor-mediated uptake. 
 
Altogether, the differences in the qualitative outcome of adaptive immune responses 
induced by the two TLR4-dependent stimuli, Gp96 and LPS, impressively demonstrate 
the impact of TLR-mediated activation of innate immune cells for the induction and 
control of specific immune responses. 
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Whether or not the minor involvement of TLR2 to the Gp96-triggered cell activation 
contributes for to the observed differences remains to be investigated. Then, it might 
be the combination of the nature of given stimuli (which might vary in their binding 
capacity to the engaged TLR(s)), different expression profiles of the involved TLRs, 
and their signaling specificity that shape adaptive immunity. 
 
To address the issue of TLR signaling on linking innate and adaptive immunity in 
more detail, we analyzed the contribution of TLR-mediated innate immune recognition 
to priming of cytotoxic T lymphocytes (CTL) during the response against viral and 
minor H antigens (Chapter 6). For infection with human influenza virus A, normal 
CTL responses are induced in the absence of MyD88- and TLR-mediated signals. 
However, TLR signaling pathways are required to compensate for an induced lack or 
CD4+ T cell help (Figure 3). Thus, we could demonstrate that innate immune 
recognition via TLRs is able to induce APC maturation levels sufficient for CTL 
priming in vivo even in the absence of antigen-specific CD4+ T cell help. 
 
Figure 3. APC activating signals during CTL priming against viral antigens. During a 
viral challenge APCs are activated at least via two pathways that are each sufficient for CTL 
priming. One signal is provided by specifc CD4+ T cells that recognize MHC class-II 
restricted viral eptiopes. The APCs are activated through the engagement of CD40 by 
CD40L on the T cell. This pathway belongs to the adaptive immunity. The second activation 
signal is provided in a TLR-mediated fashion by viral PAMPs. This pathway is a part of 
innate immune recognition. Each of these signals can provide enough activating signals 
even in the absence of the other to enable priming of CD8+ cytotoxic T cells. From (Hilf, 
2003). 
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For priming against minor H antigens as a model of weaker antigen immunogenicity, 
TLR signaling is indispensable for CTL responses. Certainly, the PAMP and/or danger 
signal involved in APC activation during priming against influenza and minor H 
antigens, respectively, still have to be identified. But the results obtained so far 
emphasize the importance of innate immune recognition for induction adaptive 
immune responses and underline the necessity for further studies in this field. A 
detailed understanding of how innate immunity shapes adaptive immunity provides the 
basis for new strategies to treat infections as well as for the development of effective 
vaccines to fight microbes or tumors. A first highlight in this area represent the 
impressive results of a clinical study conducted by Romero’s group (Speiser et al., 
2005): a synthetic CpG motif containing oligonucleotide, known to be a potent inducer 
of human innate immune reponses triggered via TLR9, proved to significantly enhance 
the immunogenicity of a human tumor vaccine leading to rapid and consistent antigen-
specific CTL responses in vivo. 
 
 
This thesis describes the identification of PAMPs and danger signals recognized by 
TLRs and provides new evidence for the tight link between innate and adaptive 
immunity – mediated by TLRs. 
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